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Christopher B. Mayo, PhD 
University of Connecticut, 2017 
 
Protein Kinase R (PKR) is a central component of the innate immunity antiviral pathway 
and is activated by dsRNA. PKR contains two tandem dsRNA binding domains and a C-terminal 
kinase domain. In the canonical activation model, binding of multiple PKR monomers to dsRNA 
enhances dimerization of the kinase domain, leading to enzymatic activation.  A minimal dsRNA 
length of 30 bp is required for activation. However, short (~15 bp) stem-loop RNAs containing 
flanking single stranded tails (ss-dsRNAs) are capable of activating PKR. Here, we characterize 
the structural features of ss-dsRNAs that contribute to activation. We have designed a model 
ss-dsRNA containing 15 nt single stranded tails and a 15 bp stem and made systematic 
truncations of the tail and stem regions. Activation potency and binding affinity decrease as the 
ssRNA tails are truncated and activation is abolished in cases where the binding affinity is 
strongly reduced. We demonstrate that isolated single-stranded RNAs bind to PKR with 
micromolar dissociation constants and can induce activation. Single-stranded RNAs also 
activate PKR constructs lacking the double-stranded RNA binding domain and bind to a basic 
region adjacent to the N-terminus of the kinase. The length of the duplex regions in several 
natural RNA activators of PKR is below the minimum of 30 bp required for activation and similar 
interactions with single stranded regions may contribute to PKR activation in these cases.  
We have also solved the crystal structure of the PKR kinase domain. PKR forms a 
unique oligomeric assembly of alternating front-to-front and back-to-back interfaces. Within the 
front-to-front interface activation segments from each protomer are exchanged and oriented 
toward the active site of the reciprocal protomer. Similar complexes have been reported for 
other kinases and are interpreted to represent a trans-autophosphorylation complex. This 
structure has profound implications for PKR activation models.  
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Chapter 1: Introduction 
1.1 Introduction 
Protein kinase R (PKR) is a key component of the interferon-induced viral response 
pathway (1). The protein is comprised of tandem N-terminal dsRNA binding domains (dsRBD1 
and dsRBD2) and a C-terminal serine/threonine kinase domain connected by an ~80 residue 
flexible linker (Fig. 1.1). PKR is synthesized in a latent state and is activated by 
autophosphorylation upon binding to double-stranded regions present in RNAs (dsRNA) (2). 
Stimulatory RNAs typically originate from viral infection but several endogenous RNAs have 
also been identified as PKR activators (3-7). Activated PKR phosphorylates the alpha subunit of 
eukaryotic initiation factor 2 (eIF2α) leading to inhibition of protein synthesis and viral replication 
in infected cells (8). The myriad of virally-encoded PKR inhibitors highlights the importance of 
the PKR antiviral pathway (9). PKR also phosphorylates insulin receptor substrate (10) and 
participates in pathways regulating stress response, cellular growth and proliferation, nutrient 
signaling and metabolism (8, 11). 
 
1.2 Interaction with dsRNA 
Nature has produced a variety of RNA-binding modules which are appended to RNA-
binding proteins to bestow specificity toward certain RNA forms. Multiple copies are typically 
present to confer increased binding affinity (12). PKR contains two copies of a highly conserved 
domain, the dsRBD, which binds duplex RNA (13). The structure of the dsRBDs was solved by 
NMR (14) however a structure in complex with dsRNA is unavailable. Both dsRBDs adopt a 
canonical αβββα fold where the two helices pack against a three stranded anti-parallel beta 
sheet (Fig. 1.2A). The dsRBD selectively interacts with A-form RNA duplexes over other forms 
 
Figure 1.1 PKR domain organization. Each dsRBD is ~70 amino acids long and are 
separated by a 25 residue linker. An ~80 residue region separates dsRBD2 from the kinase 
domain which is composed of 300 amino acids.       
2 
 
of nucleic acid (15). Structures of homologous dsRBDs in complex with dsRNA provide insight 
into the recognition mechanism (16-22). The structure of Xlrbpa2 from Xenopus laevis in 
complex with a coaxially stacked RNA duplex (23) is presented in Figure 1.2B as a model for 
how PKR presumably engages dsRNA. Basic and polar residues along the RNA binding surface 
interact with the phosphates and 2′-hydroxyls which decorate the RNA backbone in a geometric 
pattern which is specific for the morphology of the A-form RNA duplex. The interface spans two 
minor grooves and the intervening major groove with a binding footprint of ~15 bp. Three 
regions mediate RNA recognition. Their amino acid composition is highly conserved within the 
dsRBD family (Fig. 1.2B) (13). Regions one and three also contact bases within the minor 
groove however the deep major groove precludes contact with bases at region three. These 
interactions are not sequence specific, which is attributed to minimal interactions with nucleotide 
bases and a lack of sufficient sequence-specific functional groups within the minor groove (13). 
RNA structural features can contribute to the interaction. In Rnt1p RNaseIII and ADAR2, an 
RNA tetraloop engages the dsRBD to orient the catalytic domain of the protein (24, 25). Affinity 
cleavage and NMR experiments indicate loops and bulges can modulate PKR binding although 
the functional relevance is unclear (26-28). 
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1.3 General mechanisms of kinase activation applied to PKR 
Two structural analyses of the PKR kinase domain have yielded three structures all 
solved by X-ray crystallography. One study reports the kinase domain in its active form, as 
categorized by a phosphorylated activation loop, and in complex with its substrate, eIF2α (29). 
Two structures were obtained: one containing AMP-PNP and magnesium in the active site 
(PDB: 2A19) and the other without (PDB: 2A1A). The other study reports a structure containing 
an inactivating mutation, K296R, in the absence of ligands (30) (PDB: 3UIU). Both structures 
exhibit a similar domain architecture and back-to-back dimeric configuration of PKR molecules. 
The kinase domain has a bilobal structure typical of eukaryotic protein kinases (31) consisting of 
 
Figure 1.2 dsRBD interaction with dsRNA. (A) NMR structure of dsRBD1-dsRBD2 from PKR 
(1QU6). Enlarged images of the dsRBD1 (purple) and dsRBD2 (red) are shown below with the 
residues at conserved RNA interaction sites shown as sticks. (B) Crystal structure of the Xlrbpa 
dsRBD2 in complex with dsRNA (1DI2). 10 bp helices coaxially stack to form an extended 
duplex within the crystal. The path of the duplex is indicated by green and purple traces of the 
phosphates. Atoms are colored by the standard coloring scheme (red: oxygen, blue: nitrogen, 
phosphorous: orange). The ribose sugar is yellow. Nucleotide bases are white with exception to 
those involved in protein interaction. Oxygens from water molecules are shown is red spheres. 
Protein residues participating in the interaction are rendered as grey sticks and hydrogen bonds 
are depicted as black dashed lines. An alignment between the structures shown in the Figure is 
included. Side chains which are shown as sticks are indicated in the alignment. The consensus 
RNA-binding residues are included (13). 
4 
 
a smaller N-terminal lobe and larger C-terminal lobe connected by a flexible hinge region (Fig. 
1.3). The active site is formed in the cleft between the two lobes. The back-to-back dimer 
interface is formed between the N-lobes and orients the active sites toward opposite faces of 
the complex (Fig 1.3A). In the structure of K296R PKR a face-to-face dimer is also reported 
which is formed across a crystallographic symmetry axis (30). The biological relevance of the 
interface remains unclear. In PKR and many eukaryotic kinases the transition from an inactive 
to active state is controlled by activation loop phosphorylation (32). An upstream activating 
kinase has not been identified so PKR must phosphorylate its own activation loop indicating a 
basal level of activity in the latent state (33). Both intra (cis) (34) and intermolecular (trans) (35-
38) autophosphorylation mechanisms have been proposed. An allosteric pathway is proposed 
to link the active site to the back-to-back dimer interface via a critical regulatory structural 
element, helix αC (29). The functional relevance of the back-to-back dimer is supported by 
mutagenesis of key interfacial residues which abrogates enzymatic activity (39). The conserved 
structural features of eukaryotic kinases are discussed below and described in the context of 
PKR.      
 
5 
 
 
The inactive conformations of eukaryotic kinases are quite divergent however the active 
state is conserved and characterized by a group of canonical structural motifs and interactions 
(40). The prototypical Ser/Thr kinase PKA has served as a model to define the features of the 
active kinase core structure (41). The nomenclature which has been adopted to describe the 
 
Figure 1.3 Structure of the PKR kinase domain (PDB: 2A19). Color coding in the key 
underneath panel A applies to the entire figure. (A) Back-to-back dimer interface. (B) Enlarged 
view of the dimer interface. Residues contributing to the interaction are shown as sticks with 
hydrogen bonds drawn as black dashed lines. I288 packs into a hydrophobic pocket on the back 
of helix αC shown as a surface representation. (C) View looking into the active site. Canonical 
structural motifs are annotated onto PKR. (D) Enlarged view of C-terminal anchor.   
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anatomy of the kinase is annotated onto PKR in Figure 1.3B. Two hydrophobic spines bridge 
the kinase domain connecting the N- and C-lobes (42). The catalytic spine (C-spine) provides a 
binding pocket for the adenosine purine ring and orients the catalytic loop and is typically 
assembled even in inactive kinases. The regulatory spine (R-spine) is more dynamic and is 
usually disassembled in inactive structures due to conformational changes to αC (43). In PKR, 
the R-spine is intimately linked to the dimer interface by Y323 which completes the spine at the 
back of the N-lobe. Y323 participates in dimerization by engaging in a hydrogen bond triad with 
Y293 and D289 from the reciprocal protomer (Fig. 1.3B).  
The catalytic loop runs along the base of the active site and contains the canonical 
tripeptide motif HRD (NRD in PKR). The aspartate within NRD (D414) acts as a catalytic base 
during the phosphoryl transfer reaction. In kinases regulated by activation loop phosphorylation 
the catalytic aspartate is typically preceded by an arginine (R413) which interacts with the 
phosphorylated moiety in the activation loop (44). Also contained within the catalytic loop are 
N419 which chelates a magnesium ion (MgII) and K416 which typically interacts with the 
terminal phosphate.  
The activation segment is commonly defined as the region lying between two conserved 
tripeptide motifs DFG and APE (SPE in PKR). The aspartate (D432) from DFG chelates a 
magnesium ion (MgI) and the phenylalanine (F433) is a component of the R-spine. When the 
regulatory spine is broken a destabilizing effect is imposed upon the aspartate which impairs 
magnesium binding and catalysis. The SPE motif forms part of a short helix, αEF, at the C-
terminal end of the activation segment. A conserved salt bridge interaction between the glutamic 
acid and an arginine from the base of the C-lobe anchors the C-terminal portion of the activation 
segment (Fig. 1.3D). The activation segment is sometimes further delineated into the activation 
loop and the P+1 loop. The activation loop contains the primary phosphorylation site which 
corresponds to T446 in PKR and is phosphorylated in the structure presented in Figure 1.3. 
Activation loop phosphorylation significantly enhances activity (45) although the nuances of the 
7 
 
structural regulatory mechanism are still a subject of some debate (32, 46). Generally, the 
improved catalytic activity can be ascribed to a disordered to ordered transition of the activation 
loop mediated by coordination of the phosphorylated residue. Kinases regulated by activation 
loop phosphorylation typically contain the tripeptide motif HRD within the catalytic loop and are 
classified as ‘RD’ kinases (44). The histidine is less conserved (32). In PKA, this residue is a 
tyrosine and proposed to contributed to the hydrophobic R-spine (42) however in PKR an 
asparagine fills this position so the hydrophobic character is lost. The arginine from HRD 
promotes folding of the activation loop by an anchoring interaction with the phosphorylated side 
chain. In PKR, basic residues emanating from helix αC also contribute to phosphate 
coordination (Fig. 1.3C). The P+1 portion of the activation segment forms the docking site for 
the substrate peptide. However, PKR may not use this canonical substrate docking platform to 
achieve specificity.  In the structure of PKR in complex with its protein substrate, eIF2α, the 
region containing the substrate serine (S51) is disordered (29). eIF2α binds at a site remote to 
the active site on helix αG. The interaction is postulated to induce a conformational change 
within eIF2α which increases flexibility of the S51 loop to promote a transient interaction within 
the active site (47). PKR possesses a noncanonical secondary phosphorylation site within the 
P+1 loop at residue T451 (48). A serine or threonine residue occupies this position in all Ser/Thr 
kinases however it is not typically phosphorylated (32). In PKA, a catalytic function has been 
proposed (49, 50) although it is unclear whether phosphorylation is compatible with the catalytic 
mechanism.  
The final structural element which will be discussed here is the αC helix. By now, a few 
of its regulatory mechanisms have been addressed. L312 from helix αC interdigitates into the R-
spine to stabilize the active site region. Basic residues (K304 and R307) protrude from the helix 
and interact with T446 to stabilize the activation loop. The final regulatory role is an invariant salt 
bridge formed between a glutamate from helix αC (E308) and a lysine from β3 (K296). This 
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interaction favorably orients the lysine to coordinate the α- and β- phosphates and position ATP 
for catalysis.          
Conformational changes to the activation loop and helix αC are most commonly 
associated with the on/off regulatory switch (51). These dynamic elements form the periphery of 
the active site and the interactions they make with the catalytic machinery rationalizes their 
regulatory role (44). As previously stated, the conformations adopted by inactive kinases are 
quite diverse (40). However, the general molecular motions associated with the switch to the 
active state are characterized by a more closed and rigid conformation. The dynamic elements 
of the kinase which include the glycine rich loop (G-loop) above ATP, helix αC, and the 
activation segment clamp around the active site. These conformational changes protect the 
active site from solvent, provide necessary stabilizing interactions, and provide a docking site for 
the substrate. In PKR, the dimer interface regulates kinase activation by an allosteric pathway 
that involves helix αC (29).  
1.4 Mechanism of PKR activation 
Two models have been proposed to describe how RNA binding at the N-terminus 
activates the C-terminal kinase domain which is separated by an ~80 residue linker. In the 
autoinhibition model, an intramolecular interaction between the dsRBDs and the kinase domain 
maintains PKR in a closed conformation which prohibits access of ATP substrate to the active 
site (52, 53). Interaction with RNA relieves the inhibition activating the kinase. The most 
convincing evidence in support of this model are NMR experiments which demonstrate chemical 
shift perturbations within dsRBD2 and the kinase domain when the isolated components are 
mixed (54, 55). Additionally, affinity cleavage (56), analytical ultracentrifugation, and NMR 
experiments (57) indicate that only dsRBD1 interacts with nonactivating RNAs whereas both 
dsRBDs engage activating RNAs. ATP crosslinking experiments indicate that active site 
becomes more accessible following RNA binding or kinase phosphorylation (53).  
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The dimerization model emphasizes intermolecular interactions mediated by RNA 
binding (58). More recent investigations dispute the aforementioned intramolecular interaction or 
indicate it is insufficient to induce autoinhibition. A dsRBD1/2 construct interacts only very 
weakly with the isolated kinase domain (Kd ~ 250 µM) (59). This is consistent with SAXS 
analysis which indicates PKR samples multiple compact and extended conformations in solution 
with an intramolecular equilibria of ~1-10 (60). These affinities are too weak to maintain the 
closed conformation required for inhibition. Finally, the resonance assignments for the isolated 
dsRBDs and kinase domains superimpose with the NMR spectra of full length PKR indicating 
the two domains behave independently in solution (38).  
Biochemical and biophysical data indicate that dimerization plays a critical role in the 
PKR activation mechanism (61). The structural relevance of the dimer interface was addressed 
in the previous section. PKR dimerizes weakly in solution and dimerization is sufficient to 
activate PKR in the absence of RNA (35). Consistent with the dimerization model, activation by 
dsRNAs requires a lattice length of 30 bp which correlates with the minimal length capable of 
binding at least two PKR monomers (62-64). FRET measurements indicate activating RNAs 
induce kinase domain dimerization (65). Activation of PKR by dsRNA shows a characteristic 
bell-shaped dependence on dsRNA concentration (Fig. 1.4) (64, 66). This behavior is 
rationalized in a model where high dsRNA concentration reduces the number of PKR monomers 
bound to the same dsRNA and thus inhibits dimerization (67). Binding affinity measurements 
can be used to simulate the fractional concentration of PKR contained within a complex 
containing one RNA and two PKR molecules, denoted as the RP2 species. The RNA 
concentration dependence of the simulated RP2 species distributions mirror the bell-shaped 
activation curves with maxima at approximately equal RNA concentrations (63). These 
observations have led to a simple model where the role of RNA is to serve as a scaffold to 
facilitate kinase domain dimerization. Because of the strong correlation between RP2 and 
10 
 
activation we typically characterize PKR activators by their ability to mediate PKR 
oligomerization and will be a predominant theme in the studies presented here.    
 
1.5 Interaction with complex RNAs 
Perfect duplex RNAs have served as a model to establish the basic rules which govern 
RNA mediated activation of PKR. However, the RNAs which PKR interacts with in vivo rarely 
contain 30 bp of uninterrupted duplex RNA. Instead, their structures are punctuated by features 
such as stem-loops, bulges, internal loops, single-stranded regions, and more complex tertiary 
interactions (68) (Fig. 1.5). These structural elements can positively and negatively regulate 
PKR activity and, in some cases, do not adhere to the rubric for duplex lattice length. The 
structural features which differentiate activating RNAs from those which function as inhibitors 
 
Figure 1.4 Dimerization model for activation. A theoretical bell-shaped activation curve is 
shown on the bottom generated by a titration of activating RNA against a fixed concentration of 
PKR. The width of the stylized arrows which follow the path of the curve are meant to represent 
the relative concentrations of RP2 (green) and RP (red) species.  
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remain largely undefined. It has become apparent that a rigorous examination is required to 
characterize the effects of various RNA folded conformations on PKR activation. The effect of 
bent duplex structures introduced by mismatched base pairs has been extensively investigated. 
PKR is able to straighten the duplex (69) although activation is reduced and activation potency 
is determined by the geometry of the kinked structure (70). These types of investigations which 
analyze simple RNA features must be extended to develop a catalog which describes how 
combinations of basic RNA structural building blocks affect PKR activity. 
Several mRNAs activate PKR for regulatory purposes and some utilize complex 
structures which function effectively as noncanonical stimulatory elements. PKR is involved in a 
negative feedback loop which regulates production of interferon-γ during the interferon-
mediated antiviral response. Interferon-γ mRNA attenuates its own translation by PKR 
activation, providing a method to regulate both PKR levels and interferon production within the 
infected cell (71). Activation is dependent on a pseudoknot formed within the mRNA 5′ UTR 
which mimics an extended duplex by coaxial stacking interactions with the neighboring stems 
(4, 6). TNF-α induces PKR gene expression and a positive feedback loop has been proposed 
which upregulates PKR (71). Splicing of TNF-α mRNA is dependent on activation of PKR by a 
17 bp stem-loop found within its 3′ UTR (72, 73). Duplex RNA has not been detected during 
infection from negative sense RNA viruses such as influenza yet cells lacking PKR are deficient 
in viral defense (74, 74, 75). The activating component during influenza infection is postulated to 
be a ~15 bp duplex panhandle formed by the complementary 5′ and 3′ termini of the segmented 
genomic RNA (74, 74, 76).  
In vitro selection experiments have identified a unique class of RNA activators which 
contain a 16 bp duplex stem and flanking 5′ and 3′ single-stranded RNA tails (ss-dsRNAs, Fig. 
1.5A) (77). Activation has been shown to require a 5′-triphosphate (5′-ppp) and minimal ssRNA 
regions of 9 nucleotides on the 5′ tail and 10 nucleotides on the 3′ end (77, 78). A shorter 5′-ppp 
dependent construct has also been described which contains two stems 5 and 4 bp in length 
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flanked by a 13 nt 5′ tail (ssRNA-47, Fig. 1.5A) (78). A 5′-triphosphate is a molecular pattern 
unique to viral transcripts and provides a mechanism to recognize foreign RNA within the 
cytoplasm (79). Thus, 5′-ppp dependence aligns with the role of PKR in antiviral defense (80). 
Short stem-loop regions flanked by ssRNA are common in many of RNAs previously discussed 
and this likely represents a physiologically relevant activation motif. Indeed, a class of small 
nucleolar RNAs have recently been identified which activate PKR in response to metabolic 
stress (7). Some exhibit 5′-ppp dependence and can loosely be categorized as ss-dsRNAs 
based on minimal regions of extended duplex (SNORD113, Fig. 1.5A). The duplex regions of 
the ss-dsRNAs are too short to mediate activation of PKR alone and the function of the single-
stranded regions is unknown. There is evidence that ss-dsRNA- and dsRNA-mediated 
activation are mechanistically different. Duplex RNAs do not require a 5′-ppp to activate PKR 
(78). Incorporation of nucleoside modifications leads to nonequivalent effects in dsRNA versus 
ss-dsRNA activation (81, 82). These effects suggest single-stranded regions may engage a 
different region of PKR.  
Viruses have evolved elaborate mechanisms to inhibit PKR during infection (83, 83). 
Adenovirus and Epstein-Barr viruses produce large quantities RNAs named VAI and EBER, 
respectively, which bind PKR tightly but do not activate thereby sequestering PKR during 
infection (83, 83). We have shown that magnesium modulates PKR-VAI binding stoichiometry 
and that at physiological magnesium concentrations only a single PKR binds (84). However, 
PKR is able to bind the isolated constituent domains of VAI (85). In the context of full length VAI, 
steric hindrance is believed to prevent binding of multiple PKR molecules which prevents 
activation (85). Both VAI and EBER are relatively large RNAs which contain many of the 
stimulatory structural features present in the smaller activating RNAs shown in Figure 1.5A. The 
mechanism by which VAI confers an inhibitory phenotype remains unclear.    
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1.6 Alternative PKR activators 
The canonical PKR activator contains long stretches of duplex RNA derived either from 
the viral genome itself or produced as a replicative intermediate during the viral life cycle (1, 88). 
Alternative activators have also been identified and pose intriguing questions regarding their 
mechanism of activation. PKR is activated by a variety of polyanionic molecules including 
heparin, chondroitin sulfate, dextran sulfate, and poly(L-glutamine) (89). Heparin is the best 
characterized polyanionic activator (90). The heparin binding pocket has been mapped to a 
basic cleft within the kinase domain located between helix αC and the C-lobe (91).  Heparin 
polymers as short as hexasaccharides activate PKR to produce a bell-shape activation profile 
 
Figure 1.5 Activating and inhibiting RNA ligands. Blue lines represent tertiary interactions. 
(A) Activating RNAs. RNAs which exhibit 5′-ppp dependence are indicated by a green cap on 
their 5′ terminus. (B) PKR inhibitors. RNA folds are adapted from the following references: IFN-γ 
5′ UTR: (4), TNF-α 3′ UTR: (72), ssRNA-47 (78), ss-dsRNA (9,11) (77), SNORD113 (7), VAI 
(86), EBER (87).     
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implying heparin mediates activation by acting as a scaffold for the assembly of PKR molecules 
(90, 91). However, this mechanism is not compatible with analytical ultracentrifugation studies 
which indicate a sequential assembly of an activating complex which consists of two PKR and 
two heparin molecules (91). In this model heparin binds to PKR to form a 1:1 complex which 
allosterically enhances the intrinsic PKR dimerization affinity to promote formation of the 
activating 2:2 complex. Dilution of PKR monomers onto heparin molecules is not expected to 
produce the observed inhibitory effect. PKR activated by dsRNA can phosphorylate catalytically 
inactive PKR yet heparin-activated PKR cannot perform the same reaction (90). These results 
imply heparin and RNA mediated activation are fundamentally different and produce different 
forms of activated PKR.    
A protein activator, PACT, has also been identified (92). Like PKR, PACT contains two 
tandem N-terminal dsRBDs at its N-terminus. A third domain at the C-terminus belongs to a 
class of dsRBDs which resemble the dsRBD in sequence yet lack key residues necessary for 
RNA interaction (93). This third domain constitutes the PKR activating component of PACT (94, 
95). PACT activates PKR in response to a variety of stress stimuli including serum withdrawal, 
H2O2, arsenite, and peroxide (96). The stress response signal is mediated by phosphorylation of 
residues within domain 3 which increases PKR binding affinity and activation potency (97). The 
domain 3 interaction site has been mapped to an acidic loop within the N-lobe of the kinase 
domain (98). The same study detected an interaction between dsRBD2 from PKR and a peptide 
containing the loop sequence. A mechanism for PACT activation has been proposed where 
PACT-domain 3 and PKR-dsRBD2 both interact with the same site on the N-lobe. The PKR-
dsRBD2 is autoinhibitory whereas the PACT-domain 3 interaction is stimulatory (98). Note, 
however, that another study mapped the PKR-dsRBD2 autoinhibitory interaction to a region 
within the C-terminal lobe (55). 
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1.7 Objectives  
The work presented in this thesis includes several studies of the mechanism of 
activation of PKR. In Chapter 3 an ss-dsRNA is designed using ss-dsRNA (9,11) (Fig. 1.4A) as 
a template. The parental ss-dsRNA contains 15 nt 5′- and 3′-tails and a 15 bp stem-loop capped 
with a tetraloop. What follows is a rigorous examination of the structural features required for 
activation. Each tail and the stem are systematically truncated in 5 nt or bp increments. The 
effects of truncation are characterized by PKR binding affinity measurements and activation 
assays. The analysis is guided by our previous investigation which characterized the length 
dependence of duplex regions by similar methodologies (63). In that study we found a strong 
correlation between RNA binding affinity and stoichiometry and activation potency where 
activation required formation of an RP2 complex and activation potency was proportional to the 
relative amount of RP2. Under the conditions we have examined, all of the ss-dsRNAs produce 
the RP2 species yet not all activate. In cases where the tails are drastically reduced or 
eliminated we observe a reduction in the maximal population of RP2 which correlates with the 
inability to activate. However, this correlation is lost with some RNAs with intermediate tail 
lengths. The results imply that PKR directly engages single-stranded regions and that this 
interaction can produce a stimulatory effect. The potency of activation may be dictated by 
specific conformational requirements which are only partially determined by tail length.  
The results from Chapter 3 are expanded in Chapter 4 where we investigate the ability of 
PKR to interact with single-stranded nucleic acids. We find that two regions on PKR can 
independently interact with a variety of nucleic acids: the dsRBD and a basic region lying N-
terminal to the kinase domain. An isolated kinase domain construct containing the basic region 
is weakly activated by single-stranded RNA. However, a kinase domain construct lacking the 
basic region is not activated. We propose a model in which a bivalent interaction between the 
dsRBD and the kinase domain gives rise to stronger affinity between PKR and RNAs containing 
single-stranded regions. In some cases this can produce a stimulatory effect.  
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Chapter 5 reports a new atomic resolution crystal structure of the kinase domain. The 
objective of the structural analysis was to gain insight into the nucleic acid binding mechanism 
of the basic region. Diffraction quality crystals were obtained of a kinase domain construct 
containing the basic region. Unfortunately, the basic region is unresolved in the structure. 
However, we observe a unique conformation of the activation segment which has profound 
implications for the PKR activation mechanism. PKR forms alternating back-to-back and front-
to-front interfaces in the crystal. In the front-to-front interface activation segments are 
exchanged between reciprocal protomers suggestive of a trans-autophosphorylation complex.   
Finally, Chapter 6 investigates two proteins reported to interact with PKR and elicit 
opposite effects on enzymatic activity. Influenza viruses express the NS1 protein during 
infection (99) and it has been reported that NS1 interacts with PKR to prevent activation (100-
102). PACT is an endogenous protein which activates PKR in response to stress (96). Both 
PACT and NS1 are proposed to modulate activity by controlling an autoinhibitory interaction in 
PKR between the dsRBD and kinase domain. PACT disrupts the interaction to promote 
activation (98) while NS1 stabilizes the autoinhibited state (101). However, the assays which 
have characterized these interactions are primarily co-immunoprecipitation or yeast two-hybrid 
assays performed in cell lysates which do not assess the oligomeric state of the complex or 
whether additional components are involved in the interaction (92, 95, 96, 100, 101). We have 
purified NS1 and PACT and analyzed their interaction with PKR by sedimentation velocity 
analytical ultracentrifugation.    
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Chapter 2: Materials and Methods 
2.1 Buffers  
All buffers were made from reagent grade chemicals with deionized, distilled water (Mili-
Q, Millipore, MA). Buffers were filter sterilized (0.22 µm) and autoclaved prior to use. Table 2.1 
reports the buffer names, components, and their experimental purpose. 
Table 2.1 Buffers.  
Name Components Purpose 
AU75 75 mM HEPES (pH 7.5), 75 mM NaCl, 0.1 mM EDTA, 0.1 mM TCEP General / Binding 
AU200 75 mM HEPES (pH 7.5), 200 mM NaCl, 0.1 mM EDTA, 0.1 mM TCEP General / Binding 
AU75 / Mg2+ 75 mM HEPES (pH 7.5), 75 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 0.1 mM TCEP 
Activation 
AU200 / Mg2+ 75 mM HEPES (pH 7.5), 200 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 0.1 mM TCEP 
Activation 
P50 20 mM HEPES (pH 7.5), 50 mM KCl, 5 mM MgCl2, 0.1 mM TCEP  
Activation 
AU75 / EDTA 75 mM HEPES (pH 7.5), 75 mM NaCl, 10 mM EDTA, 0.1 mM TCEP Crosslinking 
CD 50 mM NaH2PO4 (pH = 7.0) Circular Dichroism  
Melt 1 10 mM NaPO4 (pH 7.0), 0.1 mM EDTA Thermal denaturation 
Melt 2 20 mM cacodylic acid (pH 7.5), 75 mM NaCl, 0.1 mM EDTA +/- 5 mM MgCl2 
Thermal denaturation 
Hep-A 20 mM HEPES (pH 7.5), 50 mM NaCl, 0.1 mM EDTA, 10% glycerol, 10 mM BME  PKR purification 
Hep-B 20 mM HEPES (pH 7.5), 1.2 M NaCl, 0.1 mM EDTA, 10% glycerol, 10 mM BME PKR purification 
HA1 40 mM KH2PO4 (pH 7.0), 10 mM BME PKR purification 
HA2 400 mM KH2PO4 (pH 7.0), 10 mM BME PKR purification 
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Table 2.1 continued Buffers.  
 
2.2 Protein purification: PKR 
Unphosphorylated PKR was expressed and purified using previously established 
protocols (35, 91). PKR was expressed in BL21 Rosetta 2 (pLysS) (Novagen) cells from a pET-
11a vector (Novagen) under control of the lac operon. Cells were grown in lysogeny broth (LB) 
media in a shaking incubator at 37 °C at 250 rpm until optical density reached 0.7 OD. The 
culture was cold-shocked by incubation on ice for ~15 minutes and protein expression was 
Name Components Purpose 
p20-A0 
20 mM Bicine (pH 8.65), 5% glycerol, 1 mM 
EDTA, 10 mM BME dsRBD purification 
p20-A 20 mM Bicine (pH 8.65), 50 mM NaCl, 5% glycerol, 1 mM EDTA, 10 mM BME dsRBD purification 
p20-B 20 mM Bicine (pH 8.65), 1 M NaCl, 5% glycerol, 1 mM EDTA, 10 mM BME dsRBD purification 
PACT-Lysis 20 mM HEPES (pH 7.5), 50 mM NaCl, 0.1 mM EDTA, 10% glycerol, 10 mM BME 
Full length PACT 
purification 
PACT-Solubilization 20 mM MES (pH 6.0), 4 M Urea, 500 mM NaCl, 30 mM Imidazole, 10% glycerol, 10 mM BME 
Full length PACT 
purification 
PACT-Refolding 20 mM MES (pH 6.0), 500 mM NaCl, 30 mM Imidazole, 10% glycerol, 10 mM BME 
Full length PACT 
purification 
PACT-Elution 20 mM MES (pH 6.0), 500 mM NaCl, 500 mM Imidazole, 10% glycerol, 10 mM BME 
Full length PACT 
purification 
D3-Lysis 20 mM HEPES (pH=7.5), 200 mM NaCl, 20 mM imidazole, 10% glycerol 
PACT domain 3 
purification 
D3-Elution 20mM HEPES (pH=7.5), 200mM NaCl, 500mM imidazole, 10% glycerol, 20 mM BME 
PACT domain 3 
purification 
NS1-Lysis 50 mM Tris (pH=8.0), 75 mM NaCl, 30 mM imidazole, 10 mM BME NS1 purification 
NS1-Elution 50 mM Tris (pH=8.0), 75 mM NaCl, 500 mM imidazole, 10 mM BME NS1 purification 
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induced by addition of 1 mM IPTG. Protein expression was allowed to proceed for 5 hours at 
RT. Cell pellets were stored at -80 °C until use. Pellets were lysed in buffer Hep-A containing 
protease inhibitor cocktail (Sigma) by sonication and clarified by centrifugation. The supernatant 
was applied to a heparin Sepharose column (GE Healthcare) equilibrated in Hep-A and eluted 
by a salt gradient with Hep-B. Fractions containing PKR elute at ~500 mM NaCl and are 
combined and diluted 1:1 with HA1 buffer. The sample is then applied to a hydroxyapatite 
column (HA, CHT ceramic hydroxyapatite; Bio-Rad) equilibrated in 40% HA-2 buffer. PKR is 
eluted from the column by a 40-100% gradient of HA-2 and elutes at ~220 mM potassium 
phosphate. Fractions were concentrated and either stored at -80 °C or applied to size exclusion 
chromatography.   
PKR kinase domain constructs were created by inserting a TEV protease cleavage site 
(ENLYFQ↓G/S) upstream of the desired N-terminus. The 185- and 229-Kinase domain 
constructs contain an extra glycine as the N-terminus. The 242-kinase utilizes the wild-type 
serine to complete the P1′ portion of the protease site. Proteins were treated with TEV protease 
following elution from the heparin Sepharose column overnight at 4 °C. TEV protease was either 
obtained from a commercial supplier (AcTEV protease; Thermo Fisher Scientific) or was 
produced in our laboratory (103). The cleavage reaction was purified on the hydroxyapatite 
column. Chromatography was slightly modified from protocol for full length PKR. The column 
was equilibrated in HA-1 buffer and protein was eluted by a gradient from 0-100% HA-2. The 
kinase domain typically eluted at ~200 mM potassium phosphate and was well separated from 
the N-terminal dsRBD portion of the cleaved protein which eluted at ~100 mM potassium 
phosphate. Fractions were concentrated and either stored at -80 °C or applied to size exclusion 
chromatography.      
The dsRBD (residues 1-184) was expressed and purified as previously described (104). 
The dsRBD was expressed with the same expression system as full length PKR except that 
protein expression was allowed to proceed overnight at 37 °C. The cells were lysed in buffer 
20 
 
p20-A in the presence of 0.1 mg/ml lysozyme by sonication. 0.2% w/v polyethylenimine was 
added to eliminate contaminating nucleic acids from the preparation and the lysate was clarified 
by centrifugation. The supernatant was loaded onto a SP Sepharose Fast Flow column (GE 
Healthcare) equilibrated in buffer p20-A and eluted with salt by a 0-50% linear gradient with 
p20-B. Fractions containing the dsRBD were pooled and diluted with buffer p20-A0 to lower the 
salt concentration and loaded onto a heparin Sepharose column equilibrated in buffer p20-A. 
Another linear salt gradient from 0-50% p20-B was used to elute the dsRBD. Fractions were 
concentrated and either stored at -80 °C or applied to size exclusion chromatography.   
Immediately prior to use, all proteins were further purified by a final size exclusion 
chromatography step on Superdex 75 or 200 HiLoad 16/60 columns (GE Healthcare) into the 
experimentally appropriate buffer, typically AU75. 
2.3 Protein Purification: PACT 
 PACT was expressed in BL21 Rosetta 2 (pLysS) (Novagen) cells from a pET-15b vector 
(Novagen) under control of the lac operon. Cells were grown in LB media in a shaking incubator 
at 37 °C and 250 rpm until optical density reached 0.7 OD. Protein expression was induced by 
addition of IPTG to 1 mM and allowed to proceed for 4 hours at 37 °C. Cells are pelleted by 
centrifugation at 5,000 x g for 10 min and stored at -80 °C until use. The protein is expressed 
into the insoluble fraction of the E. coli lysate. Modifications made to the expression and 
purification protocols including cold-shock, lower expression temperature and time, lysis by 
French press, and different lysis buffers failed to yield soluble protein. Cells were resuspended 
in PACT-lysis buffer, lysed by sonication, and pelleted by centrifugation at 22,000 x g for 20 min. 
The pellet was resuspended in PACT-lysis buffer and submitted to another round of sonication 
and centrifugation. The final pellet was solubilized in PACT-solubilization buffer which contains 
4 M urea. PACT contains a hexahistidine (His) tag at its N-terminus and was purified by Ni2+-
NTA chromatography. The solubilized pellet was loaded onto a pre-packed column of Ni2+-NTA 
agarose beads at a flow rate of 0.5 ml/min. PACT was refolded while bound to the column by 
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running a decreasing urea gradient into refolding buffer at a flow rate of 0.5 ml/min. Urea 
depletion was monitored by conductivity and confirmed by measuring the refractive index of the 
solution. PACT was eluted from the column with a 100 mL gradient into PACT-elution buffer 
(500 mM imidazole) at a flow rate of 0.5 ml/min. Figure 2.1 shows SDS-PAGE analyses of the 
purification steps for full length PACT and a construct of domain 3 (D3). A thrombin protease 
site separates the wild-type PACT sequence from the His-tag. The His-tag was cleaved 
overnight at 4 °C using thrombin-agarose beads (Thrombin CleanCleave Kit, Sigma) following 
the manufacturer’s instructions. The sample was passed over the Ni2+-NTA resin to collect 
uncleaved protein and the cleaved his-tag. The flow through was submitted to size exclusion 
chromatography on a Superdex 200 HiLoad 16/60 columns (GE Healthcare) into the 
experimentally appropriate buffer. Phosphomimetic mutations (S246D and S287D) were 
introduced by standard PCR techniques and the proteins were purified by the same protocol. 
 An isolated PACT domain 3 (D3) construct was created by deletion mutagenesis of the 
parental pET-15b-PACT plasmid. A PACT dsRBD1+2 was also created but the protein has only 
been characterized by a solubility test on a small scale induction. D3 also contains an N-
terminal His-tag separated by a thrombin protease site. D3 was expressed in BL21 Rosetta 2 
(pLysS) (Novagen) cells. Cells were grown at 37 °C at 250 rpm until OD reached 0.7 and 
induced by addition of IPTG to 1 mM. Expression was allowed to proceed for 5 hours. Cells 
were pelleted by centrifugation at 5,000 x g for 10 min and stored at -80 °C until use. The cells 
were resuspended in D3-lysis buffer and lysed by sonication. The lysate was clarified by 
centrifugation at 22,000 x g for 20 min and applied to prepacked Ni2+-Sepharose column 
(HisTrap HP, GE Healthcare) at 1 ml/min. D3 was eluted from the column at 1 ml/min by a 100 
ml gradient into D3 elution buffer (500 mM imidazole). D3 elutes with a peak at 250 mM 
imidazole. The His-tag was cleaved by the same protocol as used for full length PACT. The 
protein was purified by a final size exclusion chromatography step with a Superdex 75 10/300 
GL column (GE Healthcare).  
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2.4 Protein Purification: NS1 
The NS1 effector domain (NS1-ED) was derived from H1N1 influenza A/Puerto 
Rico/8/1934 and encodes residues 74-230 with an N-terminal His-tag. The protein was 
expressed in BL21 Rosetta 2 (pLysS) (Novagen) cells from a pET-15b vector (Novagen) under 
control of the lac operon. Cells were grown at 37 °C at 250 rpm until OD reached 0.7 and 
induced by addition of IPTG to 1 mM. Expression was allowed to proceed for overnight. Cells 
were pelleted by centrifugation at 5,000 x g for 10 min and stored at -80 °C until use. The cells 
were resuspended in NS1-lysis buffer and lysed by sonication. The lysate was clarified by 
centrifugation at 22,000 x g for 20 min and applied to prepacked Ni2+-Sepharose column 
(HisTrap HP, GE Healthcare) at 1 ml/min. NS1 was eluted from the column at 1 ml/min by a 100 
 
Figure 2.1 PACT purification. (A) Full length PACT. (B) Domain 3. Fractions collected from 
chromatography are indicated in mL. For fractions collected from the nickel column (NTA) the 
fractionation volume begins with the elution gradient. For size exclusion chromatography 
(Superdex 75 and 200) the fractionation volume begins with sample injection.   
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ml gradient into NS1-elution buffer (500 mM imidazole). The protein was purified by a final size 
exclusion chromatography step with a Superdex 75 10/300 GL column (GE Healthcare).  
2.5 Nucleic acid synthesis and purification 
ss-dsRNAs were typically produced by in vitro transcription off a plasmid template using 
conditions established by Gurevich and reported in Table 2.2 (105). Templates coding for the 
target RNA sequences were created by PCR and inserted into the plasmid between the T7 
promoter site and a 3′-ribozyme. Plasmids carrying the desired RNA sequence were purified 
and linearized as previously described (106). T7 polymerase has a tendency to prematurely fall 
off the template or add non-coded nucleotides to the 3′-end of the transcript leading to 3′-end 
heterogeneity (107, 108). To produce RNAs with homogeneous 3′-ends the hepatitis delta virus 
(HDV) ribozyme was included at the 3′-end of the transcript. The ribozyme cleaves immediately 
5′ to its own sequence to release the desired RNA transcript (106, 109). Efficient transcription 
using T7 polymerase requires that the transcript begins with two guanosine residues (107). 
Therefore, to create the 3′-strands used to make 15-15-15-∆T which begin with either 5′-
AAGU…-3′ (3′-blunt) or 5′-UCCG…-3′ (3′-UCCG), the hammerhead ribozyme was included at 
the 5′-end of the transcript. The hammerhead sequence was engineered so that cleavage would 
occur immediately 5′ to the desired RNA sequence (106). Synthetic oligoribonucleotides were 
obtained from GE Dharmacon (15-15-15, U30, Het30, 5′-blunt, 5′-UCCG, 3′-blunt, 3′-UCCG, 
ds30, ds40), TriLink Biotechnologies, Inc. (5-15-10, ppp-Het30), or IDT, Inc. (dT30, dHet30). 
RNA obtained from Dharmacon was deprotected according to the manufacturer′s protocol prior 
to use. All RNAs were purified by denaturing 8 M urea PAGE followed by electroelution using an 
Elutrap device (Schleicher and Schuell, NH). Samples were ethanol precipitated from the 
electroeluter and typically resuspended in AU75 for use. ss-dsRNAs were annealed by heating 
~2 µM of RNA in AU75 at 90°C for 5 min followed by snap cooling. Figure 2.3 shows urea-
PAGE analysis of several transcription reactions with the purified RNA shown in two of the gels.  
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Table 2.2 Transcription conditions.  
 
2.6 Determination of ε260 
 Nucleic acid absorbance is largely dependent on structural conformation due to a 
hypochromic effect on nucleotide absorbance induced by base stacking and pairing interactions 
(110). Nearest neighbor calculations are accurate for predicting single-stranded extinction 
coefficients but fail to accurately predict extinction coefficients for nucleic acids with complex 
folds. In these cases, the extinction coefficient must be experimentally determined either by 
measuring the hyperchromicity induced by thermal denaturation, by tedious analysis of 
phosphorous content in a sample, or by hydrolysis of the nucleic acid into its component 
Component Concentration in reaction 
HEPES-KOH, pH 7.5 200 mM 
MgCl2 28 mM 
Spermidine 2 mM  
Dithiothreitol (DTT) 40 mM 
NTP mix (ATP, GTP, CTP, UTP) 6 mM (each) 
DNA template 100 µg/ml 
Murine RNase inhibitor (NEB M0314S) 40 units/ml 
T7 RNA polymerase ~0.7 µM 
 
Figure 2.2 RNA transcription reactions. Predominant species are labeled. In the two gels on 
the right the final purified product is included in the second lane.  
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nucleotides. We employed the latter method to determine the extinction coefficient of ss-
dsRNAs at 260 nm (ε260). The extinction coefficient was estimated by nucleotide composition 
and the sample was folded at 2 µM by the snap-cooling previously discussed. The absorbance 
of the sample was measured and the sample was enzymatically hydrolyzed with 1 U 
RiboShredder RNase Blend (Epicentre). Figure 2.4 shows a time course for the hydrolysis of 
10-15-10. The hyperchromic effect from hydrolysis plateaus around 80 minutes. Reactions were 
left overnight to ensure complete hydrolysis. At a minimum, samples were prepared in triplicate. 
Values for ε260 of the folded RNA were back calculated from the hydrolyzed solution using the 
known extinction coefficients of the component nucleotides (111). Extinction coefficients are 
reported in Appendix 1. 
  
2.7 Enzymatic treatment of RNAs  
RNAs produced by in vitro transcription contain a 5′-ppp and ribozyme cleavage leaves a 
2′,3′-cyclic phosphate (112). The dependence of the 5′-triphosphate on PKR activation was 
tested by dephosphorylation of the RNAs with calf intestinal alkaline phosphatase (CIP). RNAs 
containing a 5′-OH were generated by incubating 100 µL of 2 µM in vitro transcribed RNA with 
10 U CIP (New England BioLabs, MA) in 50 mM Tris pH 7.9, 100 mM NaCl, 10 mM MgCl2, 1 
 
Figure 2.3 Time course for ε260 quantification by enzymatic hydrolysis.  
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mM DTT at 37°C for 1 hour. The 2′,3′-cyclic phosphate was selectively removed with T4 
polynucleotide kinase (T4 PNK, New England BioLabs, MA). T4 PNK is typically used to 
phosphorylate the 5′-end of nucleic acids yet the enzyme contains a phosphatase domain which 
is specific for phosphates on the 3′-terminus (113, 114). The phosphatase activity can be 
promoted by modifying the reaction conditions from those recommended for kinase activity 
(109). The cyclic phosphate was removed by incubating 2 µM RNA with 10 U T4 PNK in 100 
mM MES (pH 5.85), 300 mM NaCl, 10 mM MgCl2, 10 mM BME at RT for 3 hours. A reduction in 
electrophoretic mobility in a denaturing polyacrylamide gel confirmed phosphate removal 
(Figure 3.8D).   
RNAs were 5′-labeled with 32P for enzymatic structure probing and crosslinking studies. 
Transcripts were first dephosphorylated with calf intestinal alkaline phosphatase (CIP, New 
England BioLabs) to remove the 5′-triphosphate and phosphorylated with [γ-32P]ATP (Perkin 
Elmer) by T4 polynucleotide kinase (T4 PNK, New England BioLabs). The labeling reaction was 
performed by incubating 1 µM RNA with 50 U T4 PNK in 70 mM Tris-HCl pH 7.6, 10 mM MgCl2, 
5 mM DTT, and 4 µCi [γ-32P]ATP (Perkin Elmer, MA) at 32 °C for 20 min.  
RNAs were typically purified after any enzymatic treatment by phenol-chloroform 
extraction followed by ethanol precipitation and refolded prior to use. 
2.8 Enzymatic structure probing 
Enzymatic structure probing assays were conducted by incubating 2 µg 5′-32P labeled 
RNA with varying concentrations of RNases T1, V1, or A (Ambion) and 4 µg yeast RNA in 10 
mM Tris pH 7.0, 100 mM KCl, 10 mM MgCl2 at room temperature for 15 min. An alkaline 
hydrolysis ladder was produced by incubating 5′-32P labeled RNA and yeast RNA in 50 mM 
sodium carbonate pH 9.2, 1 mM EDTA at 95 °C for 2, 5, or 15 minutes. The RNase T1 
sequencing ladder was produced by first incubating 5′-32P labeled RNA and yeast RNA in 20 
mM sodium citrate (pH 5.0), 1 mM EDTA, 7 M urea at 50 °C for 5 minutes. Either 1 or 0.1 U of 
RNase T1 was then added and incubated for 15 minutes at RT. The cleavage reactions were 
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stopped by ethanol precipitation and resolved by 12% TBE-Urea PAGE. The gel was dried and 
exposed to a phosphor screen then scanned with a Typhoon phosphorimager. 
2.9 Activation assays 
PKR autophosphorylation was monitored by incorporation of 32P from [γ-32P]ATP 
(Perkin-Elmer). Samples contained a fixed concentration of PKR and a variable concentration of 
activator.   Reactions were typically performed with 100 nM PKR in AU75 / Mg2+ buffer at 32 °C. 
Activation assays with PACT were performed with 200 nM PKR in P50 buffer. Samples were 
equilibrated at the experimentally appropriate temperature for 10 minutes prior to initiating the 
reaction. Reactions containing ssRNA and PACT were prepared on ice. Phosphorylation 
reactions were initiated by addition of ATP to a final concentration of 0.4 mM containing 0.125 
(ss-dsRNAs / PACT) or 0.25 (ssRNA) µCi/µL [γ-32P]ATP. Reactions were quenched with sample 
loading buffer after 20 min and resolved on SDS-PAGE. The gel was then dried and exposed to 
a phosphor screen followed by quantification on a Typhoon phosphorimager (GE Healthcare, 
NJ). For ss-dsRNAs, each gel contained an autophosphorylation reaction performed with ppp-
15-15-15 at 100 nM and a 40mer dsRNA (ds40) at 50 nM. Activation plots were normalized to 
the ppp-15-15-15 control and ds40 served as an internal standard. In assays with ssRNAs, low 
molecular weight heparin (4-6 kDa) (Sigma-Aldrich) is included as a positive control. In assays 
with PACT ds40 is the positive control.   
2.10 Analytical ultracentrifugation 
 Sedimentation velocity analytical ultracentrifugation experiments were performed in a 
Beckman Coulter XL-I analytical ultracentrifuge. Table 2.3 lists the rotor speed, optical system, 
temperature, and buffer used for the experiments. Samples only containing protein were 
monitored by the interference optical system. RNA binding was monitored by the absorbance 
optical system set to 260 nm. Sapphire windows were used with the interference optical system 
and quartz windows were equipped for absorbance. Initial data analysis was performed using 
the time derivative method (115) as implemented in DCDT+, version 2.3.2 (116) to obtain g^(s*) 
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distributions. While not usually shown, the data were also analyzed by the c(s*) method to 
assess homogeneity and RNA degradation (117). Sample heterogeneity is sometimes more 
apparent by c(s*) analysis due to the higher resolution afforded by deconvolution of the 
diffusional broadening assuming a single frictional coefficient, f/f0. Distributions were typically 
normalized by area for presentation. Binding affinities and stoichiometries were extracted by 
global fits of multiple data sets to the Lamm equation incorporating different association models 
using SEDANAL, version 6.01 (118).  Confidence intervals were obtained using the F-statistic to 
define a statistically significant increase in the variance upon adjusting each parameter from its 
best-fit value. Correction of sedimentation coefficients to standard conditions was performed 
using Equation 1.   
   (1) 
where the subscript 20,w refers to the parameter measured at 20ºC in pure water, the subscript 
T,b refers to the parameter measured at temperature T in buffer, s is the sedimentation 
coefficient,  is the partial specific volume, ρ is the buffer density and η is the buffer viscosity. 
Frictional ratios (f/f0) for RNAs and RNA-PKR complexes were calculated using Equation 2. 
   (2) 
where NA is Avogadro′s number and M is the molecular weight. For ssRNA interactions, it was 
not possible to fit for the sedimentation coefficients of some of the RNA-protein complexes due 
to cross-correlation with the binding constants. These parameters were fixed at physically 
reasonably values based on our experience that RNA complexes with PKR have frictional ratios 
(f/f0) near 1.5 (62, 63, 119). Buffer densities, viscosities, and protein partial specific volumes 
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were calculated using SEDNTERP, version 2011120 (120). RNA partial specific volumes were 
fixed at 0.55 mL g-1 (121).  
Table 2.3 Experimental parameters for analytical ultracentrifugation.  
 
2.11 Thermal denaturation analysis of RNAs  
Thermal denaturation experiments were performed on an Agilent Cary 300 UV-Vis 
spectrophotometer. Data were collected by monitoring the absorbance change at 260 nm at a 
heating rate of 0.5 °C/min. Absorbance readings were collected every 0.5 °C. ss-dsRNAs and 
ssRNAs were characterized in 10 mM NaPO4 (pH 7.0) with 0.1 mM EDTA. Thermal 
denaturation experiments were also conducted to determine whether Mg2+ induces secondary 
structure in the single-stranded tails of ss-dsRNAs by comparing thermal denaturation of 15-15-
15 and 0-15-0 in the presence and absence of Mg2+. Those data were collected in 20 mM 
cacodylic acid (pH 7.5), 75 mM NaCl, 0.1 mM EDTA +/- 5 mM MgCl2. The initial absorbance of 
each sample was ~0.5 OD. The first derivative of the melting curves was calculated in 
Kaleidagraph, version 4.5.0 (Synergy Software). The derivative curves were smoothed by 
boxcar averaging over a 5 °C window. Melting points (Tm values) were determined by a 
Gaussian fit to the derivative curves. 
2.12 Small angle X-ray scattering 
 Small angle X-ray scattering (SAXS) data were collected in AU75 buffer at 20 °C on a 
Nanostar instrument (Bruker). RNA data were collected as 4, 1 hour frames and the buffer for 
Project Buffer Rotor Speed (rpm) 
Optical 
System 
Temperature 
(°C) 
ss-dsRNAs AU75 / AU200 40,000 Absorbance 20 
ssRNAs AU75 50,000 Absorbance 20 
ssRNAs:PKR constructs AU75 50,000 Interference 20 
Full length PACT AU200 50,000 Interference 4 
PACT-D3 AU200 / P50 50,000 Interference 20 
NS1 AU200 45,000 / 50,000 Interference 20 
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background subtraction was collected as 15, 1 hour frames. The sample to detector distance 
was 67.4 cm and the wavelength was 1.54 Å. Data were reduced with the Bruker SAXS 
software. All scans overlaid indicating the absence of radiation induced damage in the samples 
and were averaged for analysis. Data were analyzed with the ATSAS software package (122). 
Values for Rg and Io were determined by Guinier analysis of the low q region of the data where 
Rg•q < 1.25. Distance distributions functions (p(r)) were calculated in GNOM (123). The 
maximum scattering vector (Dmax) was determined by increasing the maximum distance of the 
p(r) distribution until it asymptotically approached zero. For 0-15-0, simulated scattering data 
were generated from a modified NMR structure (PDB: 2L2K) computed with CRYSOL (124). 
2.13 UV crosslinking   
Crosslinking reactions were carried out using RNAs containing 4-thiouridine generated 
by replacing UTP with 4-Thio-UTP (TriLink Biotechnologies, Inc.) in the transcription reactions. 
RNAs were labeled at 5′-end with 32P to monitor crosslinked complexes. Spurious 
autophosphorylation of PKR during the crosslinking reaction due to [γ-32P]ATP contamination 
from the labeling reaction would complicate interpretation of the results. Therefore, we took 
extraordinary steps to eliminate free [γ-32P]ATP. The RNA was purified by phenol-chloroform 
extraction followed by ethanol precipitation. The RNA pellet was resuspended in AU75 buffer 
containing 10 mM EDTA and submitted to a series of buffer exchange steps by iterative dilution 
and concentration in a 10,000 MWCO centrifugal filter (Millipore). Crosslinking was performed in 
AU75 buffer containing 10 mM EDTA. Samples contained 0.5 µM RNA and 1 µM protein in 15 
µL. For the dsRBD construct, an additional sample was prepared containing 0.5 µM RNA and 
10 µM protein. Samples were incubated on ice 15 minutes prior to UV exposure. An 8 watt 
ultraviolet lamp (UVP; model 3UV-38) was used to irradiate the samples at 365 nm at a distance 
of 5 cm for 10 minutes on ice.  Samples containing a TEV cleavage site were treated with TEV 
AcTEV protease (Thermo Fisher Scientific) by combining 5 µL of the crosslinking reaction with 
0.5 µL protease and incubating at 32 °C for one hour. Crosslinking reactions were resolved by 
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SDS-PAGE. Gels were fixed in 7.5% acetic acid and stained with SYPRO Orange 
(ThermoFisher) to visualize the location of protein within the gel. Gels were then dried and 
exposed to a phosphor screen followed by imaging and quantification on a Typhoon 
phosphorimager (GE Healthcare). 
2.14 Chemical crosslinking   
 The interaction between PACT and PKR was probed by chemical crosslinking using 
disuccinimidyl suberate (DSS). Samples were prepared in P50 buffer with 10 mM PKR and a 
titration of PACT. Crosslinking reactions were initiated by addition of DSS to 10-fold molar 
excess of the protein concentration. The reaction was allowed to proceed for 30 minutes at RT 
and quenched by addition of 50 mM Tris-Cl. Crosslinked products were resolved by SDS-PAGE 
in a 4-12% acrylamide tris-glycine gel and visualized by Coomassie Blue staining.     
2.15 Circular dichroism 
CD spectra of RNA:PKR mixtures or of refolded full length PACT were measured with an 
Applied Photophysics Pi Star-180 spectrapolarimeter. The RNA:PKR mixtures were collected 
using 2 mm path length cuvettes in AU75 buffer at 20 °C. For each sample, 5 wavelength scans 
were collected and averaged. Scans were collected between 200 and 340 nm with a 1 nm step, 
2 nm bandpass, and time-perpoint averaging of 2 s. Samples contained 5 µM RNA and the 
protein was manually added from a concentrated stock. Dilution effects were corrected for by 
concurrent addition of the appropriate RNA stock. Contribution from the protein to the spectra at 
wavelengths >240 nm was minimal. Both buffer only and protein only spectra were subtracted 
from the RNA:PKR mixtures.  
Spectra of full length PACT were collected from 170 to 270 nm in 1 mm path length 
cuvettes in 50 mM NaH2PO4 (pH = 7.0) at 15 °C. The slits were set to 2 nm and the data were 
collected with a 1 nm step and time-perpoint averaging of 12.5 s. The spectrum presented in 
Figure 6.4A is the average of two measurements.   
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2.16 Limited proteolysis 
Full length PACT(his) was incubated at 0.67 mg/ml with various ratios of PACT/trypsin 
for one hour at 4 °C in AU200 buffer. A 3 hour incubation was also performed and yielded the 
same digestion pattern. Reactions were quenched by addition of SDS loading buffer and heated 
for 5 min at 90 °C. Digestion products were resolved by SDS-PAGE in a 4-14% acrylamide tris-
glycine gel. Peptides were visualized by Coomassie Blue staining.    
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Chapter 3: ss-dsRNAs 
3.1 Introduction 
A novel family of RNA activators of PKR has been described that contain a 16 bp 
imperfect duplex stem capped by a variable length loop with flanking ssRNA regions on the 5′- 
and 3′-ends (ss-dsRNAs) (77, 78). The presence of a 5′-triphosphate (5′-ppp) and minimal 
ssRNA tails of 9 nt on the 5′- and 10 nt on the 3′-side are crucial to PKR activation. Activation is 
also observed for longer (≥ 47 nt) ssRNAs containing short (5 bp) stems. The duplex regions in 
all of these RNAs are too short to mediate PKR activation alone and the mechanism by which 
the 5′-ppp and ssRNA regions elicit activation is not known. A 5′-ppp is an important structural 
feature for activation of RIG-I (125, 126), an intracellular sensor of foreign RNAs. The 5′-ppp 
binding site lies within a positively charged pocket at the C-terminus of RIG-I (127-130). 
However, sites for ssRNA or triphosphate binding have not been identified in PKR (131).  
Here, we characterize the structural features of ss-dsRNAs that contribute to PKR 
binding and activation. We have designed a model ss-dsRNA PKR activator containing two 
single stranded tails of 15 nt and a 15 bp stem capped with a tetraloop (15-15-15) and made 
systematic truncations and modifications to the tail, stem, and loop regions. Our studies confirm 
that stem-loops containing flanking ssRNA regions function as PKR activators. However, we 
obtain disparate results regarding the dependence of the 5′-ppp for activation. Synthetic RNAs 
containing either a 5′-OH or 5′-ppp do not activate PKR. However, RNAs created by in vitro 
transcription (IVT) activate PKR in both 5′-OH and 5′-ppp forms. The chemical difference(s) 
between synthetic and IVT RNA which leads to opposing regulation of PKR activity is unclear. 
The investigation into the role of the tetraloop is marred by the use of synthetic oligonucleotides 
to create some constructs and a critical control experiment in which ligation of RNAs containing 
a broken tetraloop does not restore activation. Systematic truncation of the 5′- and 3′- ssRNA 
arms generally causes a decrease in binding affinity and activation potency. ss-dsRNAs lacking 
either 5′- or 3′- arm bind weakly and do not activate. However, activity and tail length is not 
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correlated with binding for ss-dsRNAs with intermediate affinities. These data support a model 
where ss-dsRNA induced PKR dimerization is required but not sufficient to activate the kinase. 
Results 
3.2 Characterization of ss-dsRNAs  
We have designed a series of ss-dsRNAs to characterize the length dependence of 
ssRNA tails and stem-loop region and the contribution of the 5′-triphosphate to the binding 
energetics and activation of PKR. Truncations were made to a model ss-dsRNA with a 15 bp 
duplex stem capped by a stable UCCG tetraloop (132) flanked by 15 nt single stranded tails 
(Fig. 3.1A). The sequences of the ssRNA tails have been designed to prevent formation of 
unwanted secondary structure. Tail truncation constructs were designed by deletion of 
nucleotides immediately flanking the stem. Additional mutations within the single stranded 
regions were required in some cases to disrupt formation of alternative secondary structures. 
The sequences are deposited in Appendix 1. Analysis of the sequences using MFOLD (133) 
indicate the absence of alternative folded conformations (data not shown). Enzymatic structure 
probing experiments confirm the predicted secondary structure of the model 15-15-15 ss-
dsRNA (Fig. 3.1A,B). Thermal denaturation measurements indicate a single cooperative 
transition associated with unfolding of the stem region (Fig. 3.1C). RNAs with 15 bp duplex 
regions exhibit a single cooperative melting transition between 72 – 75 °C. The Tm decreases to 
66 °C when the duplex is reduced to 10 bp in 15-10-15. Importantly, we do not detect additional 
cooperative unfolding transitions indicating the absence of alternative folded conformations 
within the tail regions. The monotonically increasing baseline prior to the cooperative unfolding 
of the duplexes is due to decreased stacking interactions within the tails. Thus, the tails do no 
adopt unwanted secondary structure.  Self-complementary RNA hairpins have the potential to 
dimerize, which can complicate analysis of their interactions with PKR (134, 135). 
Sedimentation velocity analysis indicates that all of the ss-dsRNAs are homogeneous and 
monomeric (Appendix 2). Small angle X-ray scattering (SAXS) provides further evidence for the 
35 
 
appropriately folded structures (Fig. 3.1D-G). SAXS analysis was performed on the parental 
model construct, 15-15-15, a construct lacking tails, 0-15-0, and a construct lacking the 
tetraloop capping the stem, 15-15-15-∆T. All constructs contain a 5′-ppp and 15-15-15-∆T was 
created by hybridizing synthetic oligonucleotides. Transformation of the data into real space, 
represented as a weighted distribution of interatomic distances, P(r), provides information on the 
general shape of the molecules in solution (Fig. 3.1G). As expected for an RNA duplex, the 
distributions exhibit characteristic features of rod shaped molecules (136). The curves have a 
maxima at ~20 Å which corresponds to the cross sectional diameter of an A-form helix. For 0-
15-0, the maximum interatomic distance (Dmax) is determined by the distance from the base of 
the stem to the top of the tetraloop (expected distance = ~55 Å). For a 15 bp duplex capped by 
a tetraloop the expected distance is ~55 Å and 0-15-0 has a fitted Dmax of 60 Å. Scattering data 
for 0-15-0 are validated by theoretical scattering data calculated using Crysol (124) from the 
solution structure of a 15 bp stem-loop RNA (PDB: 2L2J). In 15-15-15 and 15-15-15-∆T, the 
tails increase Dmax to ~100 Å.  
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Figure 3.1 Structural analysis of ss-dsRNAs. (A) Predicted secondary structure of 15-15-15 
and enzymatic cleavage sites for RNases T1 (red), V1 (cyan) and A (green). (B) Enzymatic 
cleavage products of 15-15-15 resolved by urea-PAGE. (C) Thermal denaturation analysis of 
ss-dsRNAs. The top panel shows the absorbance melting curves, vertically adjusted to 0 OD at 
20 °C. The first derivative of the melting curves is shown in the bottom panel. Tm values were 
determined by a Gaussian fit to the derivative curves. (D-G) SAXS analysis of ss-dsRNAs. 
Scattering data (points) and the p(r) fit (solid red line) for 0-15-0 (D), 15-15-15 (E), and 15-15-
15-∆T (F). Guinier analyses with calculated Rg are shown in the insets. The scattering profile for 
a 15 bp stem loop was calculated from PDB: 2L2J using Crysol (124) and is shown as a dashed 
teal curve in (A). The predicted Rg from the Crysol simulation is 17.3 Å. (G) p(r) distributions 
calculated by an indirect Fourier transform of the data using GNOM (137).   
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3.3 Effect of tail deletions on binding  
The PKR binding stoichiometries and affinities of the ss-dsRNAs were measured using a 
sedimentation velocity analytical ultracentrifugation method (138). Initial experiments were 
performed in a buffer containing 200 mM NaCl (AU200) to correlate with our previous PKR-RNA 
binding measurements (63, 84, 134).  The data were first analyzed by the time derivative 
method (115, 116) to determine the qualitative behavior of the system and to define the correct 
association model to use for subsequent global analysis (138).  As shown in Figure 3.2A, the 
peak of the g^(s*) distribution for ppp-15-15-15 shifts to the right from ~3 S to ~5 S when PKR 
binds due to formation of a protein-RNA complex with a higher sedimentation coefficient. The 
shift is saturated upon addition of six equivalents of PKR. Assuming a 1:1 binding stoichiometry, 
a sedimentation coefficient of ~5 S corresponds to a frictional ratio f/f0 ~1.5 (Appendix 2), which 
is in the range that we typically observe for PKR-RNA complexes (138).  Thus, the 
sedimentation data are consistent with binding of a single PKR to ppp-15-15-15 in AU200. 
PKR dissociation constants were obtained by globally fitting the sedimentation velocity 
data using SEDANAL (118).  We obtain an excellent fit of the ppp-15-15-15 data to a 1:1 
binding model with Kd = 360 nM and a low RMS deviation of 0.00587, which is on the order of 
the noise level of the absorbance optics (Table 3.1).  Hydrodynamic calculations indicate that 
each of tail deletion RNAs also binds a single PKR in AU200 (Appendix 2). Deletion of the 5′-tail 
has a negligible effect on Kd whereas deletion of the 3′-tail or both tails decreases binding affinity 
by about three-fold (Table 3.1).  
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Figure 3.2 Sedimentation velocity analysis of PKR binding to ppp-15-15-15. Normalized 
g^(s*) distributions obtained in (A) 200 mM NaCl (AU200 buffer) or (B) 75 mM NaCl (AU75 
buffer). Samples contain 0.7 µM 15-15-15 and the indicated equivalence ratio of PKR. Fitted 
sedimentation coefficients for the RNA, 1:1 species (RP), and 2:1 species (RP2) obtained from 
the 75 mM NaCl dataset are indicated by vertical lines across both distributions. (C) Global 
analysis of the sedimentation difference curves. The fit corresponds to the 75 mM NaCl data 
shown in panel B. Scans were subtracted in pairs to remove time-invariant background and fit to 
a sequential 2:1 binding model using SEDANAL (118). The top panels show the data (points) 
and the fitting results (continuous lines) using the parameters presented in Table 3.2 and 
Appendix 2. The bottom panels show residuals. Only every other difference curve is shown for 
clarity.  A similar analysis was used for the 200 mM NaCl data although the data were fit to a 1:1 
binding model. Measurements were performed at 20 °C and 40,000 rpm using absorbance 
detection at 260 nm. 
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Table 3.1 PKR binding to tail deletion constructs measured in AU200. 
Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments. 
The values in parentheses represent the 95% joint confidence intervals obtained using the F-statistic.  
a Root mean square deviation in absorbance units. 
3.4 Enzymatic effect of tail deletion 
Activation of PKR by ss-dsRNAs was assayed by measuring PKR autophosphorylation 
in AU200. Deletion of either of the flanking ssRNA tails abolishes the ability to activate (Fig. 
3.3). At the PKR concentration used in the assay, the maximum level of activation occurs at 1 
µM and PKR is inhibited at higher RNA concentrations, giving rise to a bell shaped curve similar 
to activation by simple dsRNAs (Fig. 3.3B).  Our previous analysis of a truncation series of 
dsRNAs revealed a correlation between the ability to activate PKR autophosphorylation and the 
binding of two or more monomers in AU200 (62, 63).  Thus, it is noteworthy that ppp-15-15-15 
functions as a potent activator without detectable formation of a 2:1 species in 200 mM NaCl. 
The bell shape activation curve suggests that like duplex RNAs, ss-dsRNAs activate PKR by 
facilitating dimerization of PKR on the RNA. The amount of 2:1 species populated may be below 
the detection limits for the sedimentation velocity analysis. 
RNA Kd (nM) RMSDa 
ppp-15-15-15 360 (304, 420) 0.00587 
ppp-15-15-0 1240 (1169,1319) 0.00483 
ppp-0-15-15 449 (409, 491) 0.00652 
ppp-0-15-0 935 (840, 1042) 0.00607 
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3.5 Measurements in 75 mM NaCl 
The affinity of PKR binding to dsRNA is strongly dependent on monovalent ion 
concentration (15, 139) and the stoichiometries can increase upon decreasing [NaCl] from 200 
to 75 mM (62, 63).  Figure 3.2B shows the normalized g^(s*) distributions of a PKR titration 
against ppp-15-15-15 in 75 mM NaCl (AU75 buffer) directly beneath the distributions obtained in 
200 mM NaCl (AU200). Addition of a large molar excess of PKR increases the sedimentation 
coefficient to ~8 S whereas the maximal sedimentation coefficient in 200 mM NaCl is only ~5 S 
(Appendix 2). A sedimentation coefficient of 8 S is larger than expected for a 1:1 complex (RP) 
of PKR and ppp-15-15-15 but is consistent with formation of a 2:1 complex (RP2). Reducing the 
NaCl concentration to 75 mM also induces a large increase in the maximum sedimentation 
coefficient for PKR binding to the nonactivating RNAs ppp-0-15-15, ppp-15-15-0, and ppp-0-15-
0 (Appendix 2). Again, the limiting sedimentation coefficients of the protein-RNA complexes 
 
Figure 3.3 Activation of PKR by tail deletion constructs in 200 mM NaCl. Experiments 
were performed in AU200 buffer plus 5 mM MgCl2 at 32 °C. Each reaction contains 200 nM 
PKR, 400 µM ATP, 2 µCi γ-32P-ATP and the indicated amount of RNA. The reaction was 
allowed to proceed for 20 min before quenching with SDS loading buffer and products were 
resolved on 12% denaturing SDS-PAGE. The incorporation of 32P into PKR was measured by 
phosphorimager analysis. (A) ppp-15-15-15 and ppp-0-15-0 (top), ppp-15-15-0 and ppp-0-15-
15 (bottom). (B) Quantitation of gels shown in panel (A). PKR activation level is plotted as a 
function of RNA concentrations. ppp-15-15-15 (black), ppp-15-15-0 (blue), ppp-0-15-15 (red), 
ppp-0-15-0 (green). 
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indicate that two PKR monomers also bind to these RNAs under these conditions. Despite the 
ability to bind two PKR monomers, the tail deletion constructs are deficient in enzymatic 
activation measured at 75 mM NaCl (Figure 3.5).  Thus, the binding stoichiometries alone 
cannot explain the difference in PKR activation among these ss-dsRNAs.  
Global analysis reveals significant differences in the PKR binding affinities for the activating 
and non-activating ss-dsRNAs measured in AU75.  PKR binds strongly to ppp-15-15-15 with Kd1 
and Kd2 lying in the low and mid nanomolar region, respectively (Table 3.2). Deletion of the 3′-
tail increases Kd1 by about 6-fold and Kd2 by about 3-fold. Deletion of the 5′-tail results in a 30-
fold increase in Kd1 and a 2.5-fold increase in Kd2. The largest penalty is observed when both 
tails are deleted. 
For a panel of dsRNAs of increasing length, the rate of PKR autophosphorylation is 
proportional to the maximum population of PKR that is contained in RNA complexes containing 
two PKR monomers, denoted RP2 (62, 63). Table 3.2 shows the maximum percentage of RP2 
for the ss-dsRNAs calculated using the experimentally determined dissociation constants. The 
activating ppp-15-15-15 RNA produces a maximum of about 13% RP2 and the nonactivating tail 
deletion constructs induce about half as much. 
Table 3.2 PKR binding to tail deletion constructs measured in AU75. 
Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments. 
The values in parentheses represent the 95% joint confidence intervals obtained using the F-statistic.  
a The maximum population of the RNA-PKR2 species calculated from Kd1 and Kd2 at the concentration of 
PKR used in activation assays (100 nM). 
b Root mean square deviation in absorbance units. 
 
 
RNA Kd1 (nM) Kd2 (nM) Maximum % RP2a RMSDb 
ppp-15-15-15 4 (2, 6) 294 (252, 343) 12.9 0.00821 
ppp-15-15-0 26 (20, 34) 928 (782, 1108) 4.9 0.00667 
ppp-0-15-15 128 (96, 170) 746 (568, 1003) 5.9 0.00620 
ppp-0-15-0 138 (105, 178) 1662 (1311, 2131) 2.8 0.00906 
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3.6 Magnesium effects 
 Further analysis of the ss-dsRNA structure-activity relationships was carried out in 
75 mM NaCl so that correlations could be made between the population of the RP2 species 
and activation potency. Magnesium is required for kinase activity and is present in 
autophosphorylation assays at 5 mM. However, addition of 5 mM MgCl2 to the buffer 
containing 75 mM NaCl causes a significant decrease in binding affinity which complicates 
measurement of the second dissociation constant (Table 3.3). We performed experiments to 
examine the effect of magnesium on ss-dsRNA structure and PKR affinity. Divalent ions can 
diffusely interact with the phosphate backbone or site specifically bind to facilitate RNA 
folding (140). PKR affinity to dsRNAs is not regulated by divalent ion (15) but the interaction 
of PKR with a large, complex RNA, Adenovirus VAI, is modulated by Mg2+ (84). Shielding of 
the phosphate backbone by diffuse interaction is expected to cause a similar decrease in 
PKR binding affinity for both RNAs. We asked whether the interaction of PKR with ss-
dsRNAs is affected by Mg2+ by comparing binding affinities in AU75 and AU60 / 5 Mg 
buffers, where the increase in ionic strength conferred by the addition of 5 mM Mg2+ to AU75 
is compensated for by reducing the NaCl concentration to 60 mM.  For both ppp-15-15-15 
and ppp-0-15-0, which lacks single stranded tails, the binding affinities decrease strongly in 
AU60 / 5 Mg (Table 3.3). This observation is consistent with previous studies indicating that 
Mg2+ is ~100-fold more efficient at charge screening of RNAs compared to monovalent 
cations (141, 142). As indicated by a similar reduction in the maximum RP2 for the two 
RNAs, there are no specific Mg2+ effects conferred by the single stranded tails. Furthermore, 
thermal denaturation measurements indicate that Mg2+ does not induce formation of 
additional secondary structure in ss-dsRNAs (Figure 3.4). In the absence of Mg2+, 15-15-15 
exhibits a monotonic increase in absorbance followed by cooperative unfolding of the duplex 
region at ~85 °C.  The presence of Mg2+ does not induce additional unfolding transitions for 
15-15-15 but simply shifts the duplex unfolding to higher temperature. Additionally, 
enzymatic structure probing experiments (Figure 3.1) were performed in the presence of 10 
mM MgCl2 and indicate the absence of folded regions within the ssRNA tails although the 
entire tail region is not resolved on the gel. 
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Table 3.3 Effect of Mg2+ on PKR binding. 
Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments. 
a Maximum % RP2 relative to AU75 (in percent). 
b Root mean square deviation in absorbance units 
c 20 mM HEPES pH 7.5, 60 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 0.1 mM TCEP. 
d 20 mM HEPES pH 7.5, 75 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 0.1 mM TCEP.
 
RNA Buffer Kd1 (nM) Kd2 (nM) Maximum % RP2 
Relative  
RP2a RMSD
b 
ppp-15-15-15 AU75 4 294 12.9 - 0.0082 
ppp-15-15-15 AU60 / 5 Mgc 21 2,104 2.3 18 0.0101 
ppp-15-15-15 AU75 / 5 Mgd 42 3,704 1.3 10 0.0108 
ppp-0-15-0 AU75 138 1,662 2.8 - 0.0090 
ppp-0-15-0 AU60 / 5 Mgc 331 11,627 0.4 14 0.0110 
ppp-0-15-0 AU75 / 5 Mgd 267 13,918 0.4 14 0.0880 
 
Figure 3.4 Thermal denaturation analysis in the presence of Mg2+. (A) Absorbance melting 
curves. Thermal denaturation was analyzed by monitoring the absorbance change at 260 nm at 
a heating rate of 0.5 °C/min. Data were collected every 0.5 °C. The measurements were 
conducted in 20 mM cacodylic acid (pH 7.5), 75 mM NaCl, 0.1 mM EDTA +/- 5 mM MgCl2. The 
absorbance of each sample was 0.5 OD. (B) First derivative of the melting curves. The 
derivative curves were smoothed by boxcar averaging over a 5°C window.  
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3.7 Effect of tail truncations.  
We further examined the contribution of each single-stranded tail to binding affinity and 
activation by creating a series of ss-dsRNAs with 5 nt incremental symmetric and asymmetric 
truncations of the tails. The portfolio of ss-dsRNAs was designed to resolve the minimum length 
requirements for activation and test whether the 5′- and 3′-tails are equivalent in their 
contribution to affinity and activation. Measurements were obtained in AU75 to investigate 
whether ss-dsRNAs exhibit a similar correlation between %RP2 and activation potency as we 
have previously observed with duplex RNAs (62, 63). Figure 3.5 shows the RNA concentration 
dependence of activation for all of the tail truncation constructs. Panels C and D show the 
effects of a series of 5 nt incremental truncations made to either 5′ or 3′ tail while maintaining 
the 15 nt opposing tail length. Some RNAs exhibit a bell shape activation profile while other 
activation profiles show a monotonic increase with RNA. The absence of a maximum in the 
activation profile is correlated with weaker binding (vide infra). Activity measurements at ss-
dsRNA concentrations greater than 1.5 µM are precluded by potential dimerization of the self-
complementary sequences. Truncation of either tail leads to a gradual decrease in activation 
potency indicating a direct relationship between tail length and stimulation of enzymatic activity. 
Truncations made to the 5′ tail have a slightly greater effect on PKR activation than those made 
to the 3′ tail. In particular, ppp-15-15-5 retains its ability to activate PKR where little or no 
activation is detected for ppp-5-15-15. 
Figure 3.5B shows the percentage of PKR molecules contained in the RP2 species 
plotted as a function of RNA concentration for the 3′-tail truncation series. The distributions 
mirror the trend in the activation plot (Fig. 3.5C). Binding affinity, and maximum %RP2, decrease 
in parallel with activation potency as the 3′-tail is reduced in 5 nt increments (Table 3.4). 
However, the correlation does not hold for the 5′ tail truncation series (Fig. 3.5D). ppp-10-15-15 
exhibits weaker PKR binding than the full-length ss-dsRNA, removal of an addition 5 nt from the 
5′-tail results in enhanced affinity such that the ppp-5-15-15 has a maximal  %RP2 close to ppp-
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15-15-15.  Despite the similar population of the RP2 species, ppp-15-15-15 is a potent activator 
whereas ppp-5-15-15 fails to activate, indicating that these parameters are not well correlated 
for all ss-dsRNAs.  
The next series of truncations were made to both tails. Activation plots are grouped 
according to the symmetry of the truncations. Asymmetric truncation (Fig. 3.5E) to produce ppp-
5-15-10 shifts the maximum to slightly higher RNA concentration whereas ppp-10-15-5 shows 
weaker activation. The effects of symmetric truncation (Fig. 3.5F) of both tails are more 
dramatic:  deletion to 10 nt or less essentially abolishes activation. Within the asymmetric 
truncation group the relative binding affinity and activation potency are somewhat correlated: 
ppp-5-15-10 populates a higher percentage of RP2 and is a more potent activator than ppp-10-
15-5 (Table 3.4). The correlation is less clear for the symmetric constructs. PKR binding to ppp-
10-15-10 is only slightly reduced relative to the parent ppp-15-15-15 yet it does not activate. 
Curiously, addition of three nucleotides to create 13-15-10 restores stimulatory properties (Fig. 
3.5G).  
Table 3.4 PKR binding to tail truncation constructs measured in AU75. 
Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments. 
The values in parentheses represent the 95% joint confidence intervals obtained using the F-statistic.  
RNA Kd1 (nM) Kd2 (nM) Maximum % RP2a RMSDb 
ppp-15-15-15 4 (2, 6) 294 (252, 343) 12.9 0.00821 
ppp-10-15-15 30 (21, 41) 685 (581, 812) 6.4 0.00859 
ppp-5-15-15 31 (22, 43) 272 (225, 329) 13.7 0.00870 
ppp-15-15-10 4 (2, 6) 483 (418, 557) 8.6 0.00579 
ppp-15-15-5 20 (13, 28) 647 (558, 752) 6.7 0.00782 
ppp-13-15-10 93 (64, 133) 601 (475, 776) 7.2 0.00655 
ppp-13-15-5 95 (67, 136) 358 (273, 472) 11.1 0.00697 
ppp-5-15-10 49 (38, 62) 520 (440, 617) 8.1 0.00645 
ppp-10-15-5 30 (21, 41) 1062 (885, 1280) 4.3 0.00679 
ppp-10-15-10 22 (11, 37) 400 (323, 498) 10.1 0.00821 
ppp-5-15-5 67 (43, 99) 838 (650, 1094) 5.3 0.00848 
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a The maximum population of the RNA-PKR2 species calculated from Kd1 and Kd2 at the concentration of 
PKR used in activation assays (100 nM). 
b Root mean square deviation in absorbance units. 
 
 
 
 
 
Figure 3.5 Activation of PKR by tail truncation constructs in 75 mM NaCl. (A) 
Phosphorimages for one of the three experiments quantified in panels C-F. Experiments were 
performed in AU75 buffer plus 5 mM MgCl2 at 32 °C. Activation is monitored by incorporation of 
32P. Each reaction contains 100 nM PKR, 400 µM ATP, 2 µCi γ-32P-ATP, and the indicated 
amount of RNA. (B) Simulated distribution of RP2 species. Kd measurements presented in 
Tables 3.2 and 3.4 were used to solve for the percentage of PKR molecules contained in the 
RP2 species as a function of RNA concentration. PKR concentration was held at 100 nM. The 
maximum %RP2 for each distribution is indicated on the graph. Distributions produced in Igor 
Pro (Wavemetrics Inc.). (C-F) Quantification of 32P incorporation. The signals quantified by 
phosphorimager analysis were normalized to the 32P incorporation in control samples containing 
100 nM 15-15-15 (lane 4 in panel A). Error bars represent the standard deviation of three 
experiments. (C) 3′ tail truncations. (D) 5′ tail truncations. (E) Asymmetric truncations to both 
tails. (F) Symmetric truncations to both tails. (G) Activation by 13-15-10 and 13-15-5. The 
standard for activation, 15-15-15, was not included in these assays. The data are plotted as raw 
counts.  
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3.8 Effect of stem truncations  
The effects of decreasing the length of the duplex stem were investigated by creating 
ppp-15-10-15 and ppp-15-5-15. PKR is potently activated by ppp-15-10-15 with a maximum 
level about equal to the control ss-dsRNA (Fig. 3.6). Further reduction of the stem to 5 bp 
abolishes RNA-induced autophosphorylation. In the case of the stem deletions, the binding 
affinities correlate with activation. For the 10 bp stem construct, Kd1 is increased somewhat but 
Kd2 is essentially unchanged, resulting in a similar %RP2. For the 5 bp construct, both Kd values 
are significantly increased, consistent with the loss of measureable activation. 
Table 3.5 PKR binding to stem truncation constructs measured in AU75. 
Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments. 
The values in parentheses represent the 95% joint confidence intervals obtained using the F-statistic.  
a Root mean square deviation in absorbance units. 
 
RNA Kd1 (nM) Kd2 (nM) Maximum % RP2 RMSDa 
ppp-15-15-15 4 (2, 6) 294 (252, 343) 12.9 0.00821 
ppp-15-10-15 72 (44, 115) 303 (201, 458) 12.6 0.0103 
ppp-15-5-15 118 (93, 150) 853 (673, 1103) 5.3 0.00667 
ppp-0-5-0 5402 (4929, 5896) - - 0.00460 
 
Figure 3.6 Activation of PKR by stem truncation constructs in 75 mM NaCl. (A) 
Phosphorimage for the data quantified in panel B. Experiments performed as described in 
Figure 3.5 (B) Quantification of 32P incorporation. The signals quantified by phosphorimager 
analysis were normalized to the 32P-incorporation in control samples containing 100 nM 15-15-
15 (lane 4 in panel A). Error bars represent the standard deviation of three experiments.  
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3.9 0-5-0: A 5 bp stem loop 
 The dsRBD binding footprint is ~15 bp (143) so it is surprising that 15-5-15 
accommodates multiple PKRs with relatively high affinity. To gain insight into the contribution of 
the single stranded regions to affinity and stoichiometry we prepared a 5 bp stem loop construct 
lacking the flanking tails (0-5-0). Analysis of PKR binding was complicated by the propensity of 
the construct to dimerize. Decreasing the RNA refolding and assay concentration minimized the 
relative population of the dimeric species. However, at the concentrations required for 
absorbance detected sedimentation velocity, a significant population of the dimeric species 
persisted (~10 %). The g^(s*) distributions for 0-5-0, PKR mixtures are shown in Figure 3.7A 
with 15-5-15 in 3.7B for comparison. The distributions are plotted on the same x-axis scale to 
highlight the difference in binding stoichiometries. Only one PKR binds 0-5-0 to shift the 
distribution to a maximal sedimentation coefficient of ~4 S whereas distributions containing 15-
5-15 are shifted to a limiting sedimentation coefficient of ~6.5 S due to sequential binding of two 
PKR molecules. Depletion of the RNA peak upon PKR addition provides a qualitative 
assessment of the relative binding affinities. Freely sedimenting 15-5-15 is depleted by addition 
of 1.5 equivalents of PKR however 0-5-0 requires ~10 equivalents to achieve similar reduction. 
This behavior is reflected in the fitted dissociation constant reported in Table 3.5. Due to the 
contaminating dimer the 0-5-0 affinities should be interpreted with some trepidation. The fitting 
procedure cannot differentiate whether PKR binds the monomeric or dimeric form of the RNA 
and parameters for the monomeric form were used in the fit. Regardless of which form PKR 
interacts with the data provide further evidence for single stranded interactions. In the context of 
a 15 bp duplex the single stranded regions confer increased affinity (15-15-15 and 0-15-0, Table 
3.2). Yet when appended to a 5 bp duplex the single-stranded regions provide additional binding 
sites resulting in both increased affinity and stoichiometry. 
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3.10 Interaction of dsRBD with ss-dsRNAs 
 Tail truncation leads to decreased binding affinity and reduced activation potency even 
though PKR lacks a defined ssRNA binding motif. We performed binding experiments with a 
domain construct of the dsRBD (residues 1-184) to investigate whether this is the region on 
PKR which interacts with ssRNA. Binding affinities were determined for 15-15-15 and 0-15-0 
and reported with the corresponding measurements obtained for the full length protein in Table 
3.6. Unlike the full length protein, our measurements detect a weak, third binding event in the 
mixture of the dsRBD and 15-15-15 resulting in the RP3 species. Steric occlusion by the linker 
 
Figure 3.7 Contribution of single stranded regions to PKR binding a 5 bp duplex. g^(s*) 
distributions normalized by area are shown for (A) 0-5-0 and (B) 15-5-15. The sequence and 
predicted secondary structure of the RNA constructs are shown in each panel. The 0-5-0 data 
were obtained with a rotor speed of 50,000 rpm whereas the 15-5-15 data were obtained at 
40,000 rpm. Higher rotor speed leads to decreased diffusional broadening making the 0-5-0 
distributions narrower. The 0-5-0 data were fit to an association model in SEDANAL where a 
single PKR binds. The resulting parameters are reported in the Table 3.5 and in Appendix 2.  
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and kinase domain may prevent the interactions which facilitate RP3 formation in the context of 
the full length protein. Alternatively, the RNA may interact with regions outside the dsRBD so 
that the full length protein occupies a larger footprint than the isolated dsRBD construct 
preventing formation of the RP3 species.  
Similar to the full length protein, the dsRBD binds to 15-15-15 with higher affinity than 0-
15-0 indicating that the dsRBD interacts with single stranded regions. However, the increase in 
affinity for 15-15-15 is not nearly as dramatic as is seen in the full length protein. The relative 
affinities of the first binding event provide evidence that the single stranded regions also engage 
PKR outside of the dsRBD. The values of Kd1 for full length PKR binding 0-15-0 and dsRBD 
binding to both 15-15-15 and 0-15-0 are all similar. However, Kd1 for interaction of full length 
PKR with 15-15-15 interaction is ~28-fold tighter indicated a significant contribution of the 
single-stranded regions. These observations are corroborated in Chapter 4 where an RNA 
binding region is identified near the N-terminus of the kinase domain.  
Table 3.6 dsRBD and full length PKR binding to 15-15-15 and 0-15-0 measured in AU75. 
Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments. 
The values in parentheses represent the 95% joint confidence intervals obtained using the F-statistic.  
a Root mean square deviation in absorbance units. 
3.11 5′-Triphosphate  
It has been reported that a 5′-triphosphate (5′-ppp) is crucial for activation of PKR by 
canonical ss-dsRNAs as well as ssRNAs containing short duplexes (78, 131). Host RNAs are 
typically capped at their 5′-end prior to export into the cytoplasm while most viral RNAs contain 
a 5′-ppp. Thus, the 5′-ppp is an important motif which provides the host cell with a structural 
Protein RNA Kd1 (nM) Kd2 (nM) Kd3 (nM) RMSDa 
Full length ppp-15-15-15 4 (2, 6) 294 (252, 343) - 0.00821 
Full length ppp-0-15-0 138 (105, 178) 1662 (1311, 2131) - 0.00906 
dsRBD ppp-15-15-15 111 (76, 160) 190 (121, 279) 2784 (2102, 3930) 0.00358 
dsRBD ppp-0-15-0 218 (155, 300) 1097 (961, 1249) - 0.00493 
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element to discriminate between self and non-self RNA (79). Because of the critical role 
ascribed to the 5′-ppp in the context of ss-dsRNAs and the function of PKR in the innate 
immunity pathway (80), we have investigated the contribution of 5′-ppp to PKR binding and 
activation. The series of experiments which emerged from some preliminary measurements are 
separated for organizational purposes into three sections: 3.11 5′-Triphosphate, 3.12 Synthetic 
RNA, and 3.13 Tetraloop. However, each section is inherently linked and briefly summarized 
here so that the reader can be mindful of the results. Our experiments indicate that 
dephosphorylation of in vitro transcribed (IVT) ss-dsRNAs does not inhibit PKR stimulation. 
Curiously, synthetic versions of ss-dsRNAs containing either a 5′-ppp or 5′-OH do not activate 
PKR. This surprising and alarming result was not revealed until an important control experiment 
was performed while investigating the role of the tetraloop. ss-dsRNAs lacking a tetraloop were 
created by annealing two synthetic RNAs and do not activate PKR. However, ligation of the loop 
does not restore activation. The corresponding ∆-tetraloop constructs were created by in vitro 
transcription and exhibit the same phenotype as their synthetic counterparts. The constructs fail 
to activate and cannot be rescued by ligation. In summary, RNAs which should be chemically 
identical exhibit different stimulatory effects which are dependent on the method of production. 
Only ss-dsRNAs produced in their entirety by in vitro transcription activate PKR. The 
experiments described in the following sections seek to establish protocols for complete 5′-
dephosphorylation and identify the chemical differences between IVT and synthetic RNA.        
RNAs transcribed by T7 RNA polymerase contain a 5′-triphosphate. Constructs were 
converted to the 5′-OH form by dephosphorylation with calf intestinal alkaline phosphatase 
(CIP). Dephosphorylation of ppp-15-15-15 and ppp-5-15-10 by treatment CIP has no significant 
effect on the extent of PKR activation (Fig. 3.8A). Several experiments verify that the 5′-ppp is 
removed by the phosphatase. ppp-15-15-15 and ppp-5-15-10 cannot be labeled with a 5′-32P by 
treatment with T4 polynucleotide kinase and [-32P]ATP because of the presence of a 5′-ppp, 
but the corresponding dephosphorylated RNAs are substrates (Fig. 3.8B). Additionally, an ss-
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dsRNA labeled during in vitro transcription in the presence of [-32P]GTP displays complete 
removal of the 5′-ppp after phosphatase treatment (Fig. 3.8C), indicating that the activity of the 
5′-OH RNAs is not due to the presence of residual triphosphate-containing RNA. RNAs used in 
this study are produced by transcription off a template that encodes the HDV ribozyme at the 3′-
end of the transcript. The ribozyme is included to circumvent the problem of 3′-end 
heterogeneity which can plague RNA production using standard run-off transcription techniques 
(108). Cleavage results in a 2′-3′-cyclic phosphate (144) and we postulated that it may 
compensate for the absence of the 5′-triphosphate. RNAs are treated with CIP to 
dephosphorylate the 5′-end yet the activity of CIP on 2′-3′-cyclic phosphates is unknown. T4 
polynucleotide kinase (PNK) possesses a phosphatase domain specifically evolved to liberate 
2′-3′-cyclic phosphates (113, 145). The phosphatase activity can be promoted by altering the 
reaction conditions and dephosphorylation can be monitored by a slight mobility shift in a urea 
PAGE gel (109). We subjected 15-15-15 to sequential treatments with T4 PNK then CIP to 
dephosphorylate both 5′- and 3′-termini. PNK treatment results in a slight retardation of 
migration in a urea PAGE gel (Fig. 3.8D). Consistent with other reports, subsequent 
dephosphorylation of the 5′ end with CIP results in faster migration in urea PAGE (Fig 3.8D, Fig. 
3.10B) (146, 147). The relative migration differences indicate that the enzymatic treatments are 
resulting in the expected activities and the complete shift of the bands provides evidence that 
the reactions are complete. Neither treatment results in a loss of PKR stimulation (Fig. 3.8E). 
Finally, MALDI-ToF mass spectrometry analysis provides further evidence that CIP treatment 
results in homogenous dephosphorylation of both ppp-15-15-15 (Fig. 3.8G) and ppp-5-15-10 
(Fig. 3.8F). CIP treated RNAs exhibit a mass decrease of 300-315 Da consistent with the 
removal of both 5′-ppp and 2′-3′ cyclic phosphate (predicted change of 300 Da). These control 
experiments indicate that activation by enzymatically dephosphorylated ss-dsRNAs is not due to 
a residual population of 5′-ppp. 
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Removal of the 5′-ppp does affect PKR binding affinity (Table 3.7). Kd1 increases about 
10-fold and Kd2 increase slightly. However, the maximum %RP2 does not change substantially 
and the binding parameters remain in the range of ss-dsRNAs that activate, such as ppp-15-15-
5 and ppp-5-15-10.  
Table 3.7 PKR binding to in vitro transcribed and synthetic HO-15-15-15 measured in AU75. 
Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments. 
The values in parentheses represent the 95% joint confidence intervals obtained using the F-statistic.  
a Root mean square deviation in absorbance units. 
 
RNA Kd1 (nM) Kd2 (nM) Maximum % RP2 RMSDa 
IVT ppp-15-15-15 4 (2, 6) 294 (252, 343) 12.9 0.00821 
IVT HO-15-15-15 36 (26, 49) 411 (357, 473) 9.9 0.00861 
Synthetic HO-15-15-15 28 (21, 37) 481 (421, 551) 8.7 0.00754 
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Figure 3.8 Activation by ss-dsRNAs does not require a 5′-triphosphate. (A) Activation by 
5′-ppp and 5′-OH ss-dsRNAs. 5′-OH RNAs were prepared by treatment with CIP. Samples 
contain 300 nM RNA. Autophosphorylation activity is indicated under the gel as a percentage 
normalized to activation by ppp-15-15-15. (B) Assay for dephosphorylation by 5′-32P labeling by 
T4 PNK. RNAs containing a 5′-OH are substrates for T4 PNK whereas 5′-ppp prevents 
phosphorylation. (C) A ppp-18-15-15 RNA containing a 32P at the 5′-γ-phosphate was 
incubated with Antarctic phosphatase at 37 °C. Aliquots were removed at time points as 
indicated in the figure and quenched with denaturing gel loading buffer and resolved by 10% 
TBE-Urea PAGE. The gel was exposed to a phosphor screen and scanned on a Typhoon 
phosphoimager. Removal of the 5′-ppp is complete at 30 min. γ32P-labeled 18-15-15 was made 
by in vitro transcription in the presence of γ-32P GTP. RNAs dephosphorylated by Antarctic 
phosphatase activates PKR. (D) Sequential enzymatic treatment of 15-15-15 visualized by a 
slight mobility change by 12% TBE-Urea PAGE. (E) Activation by the enzymatically treated 15-
15-15 shown in (D). In the mock reactions, 15-15-15 was submitted to the enzymatic reaction 
conditions but enzyme was not added. Autophosphorylation activity is indicated under the gel 
as a percentage normalized to the initial RNA sample labeled as ‘Standard’. (F) MALDI-ToF 
analysis of dephosphorylation of ppp-15-15-15. RNAs. (G) MALDI-ToF analysis of 
dephosphorylation of ppp-5-15-10. ppp-15-15-15 exhibits a mass loss of 300 Da and ppp-5-15-
10 exhibits a mass loss of 315 Da. The predicted mass loss is 300 Da (removal of the 5′-ppp 
and the 2′-3′-cylic phosphate resulting from HDV ribozyme cleavage).  
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3.12 Synthetic RNA 
 Chemical oligonucleotide synthesis provides a mechanism to produce RNAs of defined 
sequence devoid of terminal phosphates. We obtained synthetic RNAs to directly test 5′-
triphosphate dependence after initial dephosphorylation reactions failed to deactivate ss-
dsRNAs produced by IVT. Synthetic versions of two potently activating RNAs, 15-15-15 and 5-
15-10, were acquired from two different commercial entities. 15-15-15 was supplied by 
Dharmacon and 5-15-10 was obtained from Integrated DNA Technologies. Both RNAs contain a 
5′-OH. Binding affinity measurements detect a similar reduction in affinity for synthetic HO-15-
15-15 as was observed for IVT HO-15-15-15 supporting the idea that PKR recognizes the 5′-
ppp (Table 3.7). Despite similar binding behavior, the two forms of 5′-OH RNA differ in their 
stimulatory properties. As shown in Figure 3.9A the synthetic forms of both 15-15-15 and 5-15-
10 fail to activate while the IVT versions potently stimulate PKR in the same assay. 
Furthermore, synthetic HO-15-15-15 inhibits activation by IVT ppp-15-15-15 (Fig. 3.9B). The 
inhibition potency provides additional evidence that activation by 5′-OH IVT RNA is not due to 
residual 5′-ppp. In a mixture containing equal concentrations of synthetic and IVT 15-15-15, the 
activity is reduced by ~37 % (Fig. 3.9B). Dephosphorylation reactions induce no reduction in 
activity (Fig. 3.8A) implying the reactions are very inefficient or that synthetic and IVT HO-15-15-
15 are not chemically equivalent. Finally, we have used enzymatic ligation to create synthetic 
15-15-15 capped by a 5′-ppp yet this RNA also does not activate PKR. This evidence suggests 
there are unidentified chemical differences between RNA produced by in vitro transcription and 
chemical synthesis. 
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Synthetic RNAs are available from a variety of commercial suppliers which typically 
employ nucleoside phosphoramidite chemistry to build oligonucleotides. Synthesis reactions 
vary depending on the commercial entity but all utilize a general organic synthesis protocol 
which relies on selective deprotection to coordinate the appropriate coupling reactions between 
nucleoside monomers and the oligonucleotide chain. The reaction scheme employed by 
Dharmacon is summarized below (148, 149). The outline is meant to illustrate the complexity of 
the procedure to support the hypothesis that chemical impurities can contaminate the synthetic 
preparation and interfere with PKR activation. Oligonucleotide chains are assembled on a solid 
phase support in the 3′- to 5′-direction. The building blocks are nucleoside phosphoramidites 
which contain chemically protected functional groups to prevent undesired reactions. The 
synthesis cycle involves addition of the desired nucleoside phosphoramidite and an activator 
which catalyzes the coupling reaction between the newly added nucleoside and free 5′-OH on 
the anchored oligonucleotide chain. Unreacted 5′-OH termini are chemically protected from 
subsequent coupling steps via a reaction which yields a 5′-acetyl. Nucleosides successfully 
coupled to the oligonucleotide contain a 5′-O-silyl ether which is converted to a 5′-OH for 
subsequent coupling reactions in a reaction catalyzed by fluoride (triethylamine trihydrofluoride). 
 
Figure 3.9 Activation assays with synthetic RNA. (A) Activation by synthetic 5-15-10 and 15-
15-15. IVT versions are positive controls at 100 nM. (B) Inhibition of IVT ppp-15-15-15 by 
synthetic 15-15-15. Samples contain 100 nM PKR and 100 nM IVT ppp-15-15-15 with a titration 
of synthetic 15-15-15. Dashed lines indicate where blank lanes were cropped out of the gel. 
Band intensity is quantified in the plot below the phosphorimage. Activation is expressed as a 
percentage of the band intensity measured for the sample containing only IVT ppp-15-15-15 
(lane 3).    
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The cycle is repeated until the desired chain length is achieved. Following synthesis, exocyclic 
amines present on nucleotide bases are deprotected and the oligonucleotide is released from 
the solid phase support. Dharmacon provides RNA in a form where the 2′-OH is chemically 
protected (2′-ACE, 2′-O-bis(2-hydroxyethoxy)methyl orthoester) and is deprotected by the 
customer with a mildly acidic aqueous solution. Production of synthetic RNA free of chemical 
impurities is dependent on the use of pure ribonucleoside phosphoramidite building blocks and 
complete deprotection of the appropriate functional groups during every phase of the synthesis 
cycle. Mild reaction conditions are utilized to prohibit formation of undesired chemical adducts. 
However, numerous impurities have been identified in chemically synthesized oligonucleotides. 
These include shorter sequences resulting from incomplete chain elongation (150-152), various 
protecting groups remaining from synthesis (150-152), depurinated bases (152),  the presence 
of 5-methylcytosine presumably from impure nucleoside phosphoramidite precursors (153), and 
branched chain oligonucleotides where chain elongation occurs off a deprotected nucleobase 
exocyclic amine (154, 155). PKR is sensitive to nucleoside modifications although the effects 
manifest in the RNA stimulatory properties rather than binding affinity (82). This is potentially in 
agreement with our observations where the synthetic and IVT forms bind with comparable 
affinities yet exhibit different stimulatory phenotypes.         
Analysis of RNA size and shape fails to identify any significant differences between the 
IVT and synthetic forms. Urea-PAGE analysis of the 2′-ACE-protected form of 15-15-15 
provided by Dharmacon indicates that nucleoside modifications can be detected by gel 
migration differences. RNA containing the 2′-protecting group (2′-ACE) migrates faster through 
the gel than RNA in the 2′-OH form (Fig. 3.10A). Presumably the increased electronegative 
charge imparted by the protecting group causes faster migration through the gel. However, the 
dephosphorylated IVT versions of both 15-15-15 and 5-15-10 run at the same position as their 
synthetic equivalents in urea-PAGE (Fig. 3.8D and Fig. 3.10B). Hydrodynamic analysis 15-15-
15 by sedimentation velocity analytical ultracentrifugation detects slight variation between the 
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synthetic and IVT forms (Fig. 3.10C). The sedimentation coefficient of synthetic HO-15-15-15 is 
slightly lower than the IVT forms indicating either the synthetic form has a smaller molecular 
weight or folds into a slightly more extended structure. Both IVT and synthetic forms of 15-15-15 
produce similar digestion patterns from enzymatic structure probing experiments (not shown) 
indicating cleavage is not affected by chemical impurities which may be present on the RNA.     
 
Conventional binding assays and analytical ultracentrifugation measurements can 
determine how many PKRs are bound to an RNA but do not directly assay dimerization via the 
kinase domain interface. Therefore, we recently developed a sensitive homo-FRET anisotropy 
assay to directly probe PKR kinase domain dimerization on RNAs (65). Activating duplex RNAs 
containing ≥30 bp bind two PKRs and induce dimerization detected by depolarization of 
fluorophore emission using steady-state anisotropy measurements. However, some 
nonactivating RNAs that also produce a high population of the RP2 species, as detected by 
 
Figure 3.10 Analysis of synthetic RNA. (A) 10% TBE-Urea PAGE analysis of protected (2′-
ACE) and deprotected (2′-OH) forms of 15-15-15. Note that the deprotected RNA was analyzed 
directly after the deprotection reaction. RNAs are purified before use by urea PAGE to eliminate 
the impurities that are present on the gel. (B) 12% TBE-Urea PAGE analysis of 5-15-10. An in 
vitro transcription reaction is shown along with purified ppp-5-15-10 and dephosphorylated IVT 
HO-5-15-10. The dephosphorylated RNA co-migrates with synthetic HO-5-15-10. (C) 
Sedimentation velocity analysis of 15-15-15. c(s*) distributions for IVT ppp-15-15-15, IVT HO-
15-15-15, and synthetic HO-15-15-15 are shown. Best fit sedimentation coefficients obtained by 
fitting the time difference curves to an ideal species model in SEDANAL are shown in the plot.    
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analytical ultracentrifugation, either fail to induce dimerization or produce an alternative, inactive 
dimer configuration. This behavior may rationalize the failure of synthetic RNA to induce 
activation despite populating a similar amount of the RP2 species as IVT RNA (Table 3.7). 
Figure 3.11 shows the anisotropy change upon addition of either IVT ppp-15-15-15 or synthetic 
HO-15-15-15. The amplitude is the same for both RNAs although the IVT form achieves its 
maxima at slightly lower RNA concentrations. By all measurements synthetic HO-15-15-15 
should activate to a similar extent as IVT ppp-15-15-15. Both RNAs populate a similar amount 
of RP2 species as measured by analytical ultracentrifugation and both induce kinase domain 
dimerization to a similar extent. The nature of the chemical differences between IVT and 
synthetic RNA forms remains elusive. 
 
3.13 Tetraloop  
There are 256 unique nucleotide combinations for tetraloop sequences yet detailed 
analysis of 16S ribosomal RNA (156) and bacteriophage T4 mRNA (157) has revealed a biased 
frequency toward certain nucleotide arrangements which can be categorized as 5′-UNCG-3′ or 
5′-GNRA-3′ tetraloops (N = any nucleotide; R = purine). The bias is thermodynamic in origin and 
 
Figure 3.11 Analysis of kinase domain dimerization on 15-15-15 measured by homo-FRET 
anisotropy. Alexa Fluor 488 is conjugated to p-azidophenylalanine which was incorporated at 
position 261. Dimerization is detected by a change in anisotropy induced by depolarization of 
homo-FRET emission (65). Samples contain 200 nM PKR and a titration of RNA. The assay 
was performed in AU75 buffer at 20 °C. Both IVT 5′-ppp and synthetic 5′-OH 15-15-15 induce a 
similar anisotropy change.     
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can be attributed to the stability conferred by noncanonical base pair interactions between 
nucleotides in positions 1 and 4, 2′-OH hydrogen bonds, and base stacking (158). Structural 
differences between UNCG and GNRA tetraloops arise from variations in sugar puckering and 
glycosidic bond orientation primarily within nucleotides in positions 2 and 3 (159). These 
nucleotides pucker out into the solvent to facilitate bending of the RNA backbone and present 
an additional surface not present within duplex regions to stabilize protein interaction. Five 
structures are available for dsRBDs bound to stem-loop RNAs and in four of the structures the 
α1 helix interacts with nucleotides projecting from the loop, thereby orienting dsRBD binding 
(Fig. 3.11A). In Rnt1p RNaseIII and ADAR2, the positioning of the dsRBD is believed to play a 
functional role by orientating the catalytic domains for specific modification of the RNA substrate 
(24, 25). There are some reports indicating that loops modulate PKR binding although the 
functional relevance is unclear (26-28). Given that the dsRBD binding footprint is ~15 bp (143) it 
is likely that PKR interacts with tetraloop residues during complex formation with ss-dsRNAs 
containing shorter duplex regions. To test this interaction the tetraloop within the parental 15-15-
15 ss-dsRNA was altered. Figure 3.11B shows schematic representations of the constructs and 
the nomenclature adopted to describe them. Tetraloop variations include changes to loop 
sequence (GAAA and UUUU), deletion of the tetraloop (∆T), and broken loops with the tetraloop 
sequence projecting from 5′-, 3′-, or both strands (5′-UCCG, 3′-UCCG, 5′/3′-UCCG).  
The original 15-15-15 sequence contains a UNCG type tetraloop (5′-UCCG-3′). Versions 
of 15-15-15 were made which contain the loop sequence 5′-GAAA-3′ or 5′-UUUU-3′ and 
characterized by PKR binding affinity and activation measurements. The UUUU tetraloop is 
expected to exhibit a greater degree of conformational flexibility (160, 161) due to the minimal 
contribution of uridines to base stacking interactions (162). The constructs were created by in 
vitro transcription. Perturbations to the loop sequence have a minimal effect on PKR binding 
(Table 3.8) and activation (Fig. 3.11C).  
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Figure 3.12 Characterization of the tetraloop. (A) dsRBD interactions with tetraloops. Rnt1p 
RNase III dsRBD1 is shown on the left (1T4L) (47) and ADAR2 dsRBD1 on the right (2L3C) 
(17). The nucleotide which puckers out of the tetraloop and contacts helix α1 is shown in red. 
The length of the stem and tetraloop sequence is indicated underneath the structure. (B) 
Schematic representation of constructs designed to probe the tetraloop. Coloring scheme is 
maintained throughout the figure. (C) Activation assays. Constructs containing a broken loop 
created by in vitro transcription (IVT) are assayed in the bottom gel. The data are quantified in 
the plot beneath the gels. Data are normalized to the wild-type 15-15-15 construct labeled as 
‘UCCG’ in each gel. (D) Inhibition of IVT ppp-15-15-15 by synthetic ∆T. (E) g^(s*) distributions 
normalized by area comparing PKR interaction with 5′-UCCG (top) and 3′-UCCG (bottom).   
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Constructs lacking or containing a broken loop were created by hybridizing two synthetic 
oligonucleotides to mimic the loop containing 15-15-15. These constructs were analyzed prior to 
recognition that the full-length synthetic ss-dsRNAs do not activate PKR. Constructs 
corresponding to 5′-UCCG and ∆T were created by IVT; however, purity and yield from 
purification were insufficient for detailed analysis. The material was used for activation assays 
but binding experiments were not performed. Figure 3.11C shows the activity assays performed 
with all the synthetic and IVT constructs. The synthetic constructs do not mediate activation 
which is not surprising given the analysis of full-length synthetic constructs presented in the 
previous section. Note, however, that the synthetic constructs analyzed here contain a 5′-ppp 
whereas the full-length constructs contain a 5′-OH. Like the full-length synthetic constructs ∆T 
inhibits activation mediated by IVT ppp-15-15-15 (Fig. 3.12D). The constructs created by IVT 
also do not activate however a control ligation experiment presented below necessitates 
cautionary interpretation of this result.     
The binding affinity measurements are reported in Table 3.8. Deletion of the tetraloop 
from 15-15-15 (∆T) reduces affinity of the first binding event by ~15-fold and decreases the 
second by ~2-fold indicating that the loop contributes to complex formation. Constructs 
containing a broken tetraloop exhibit drastically different binding behavior dependent on which 
strand the loop sequence is placed on. A comparison of the g^(s*) distributions is shown in 
Figure 3.12E. A construct containing the loop sequence on the 5′-strand (5′-UCCG) exhibits 
similar binding behavior as the canonical 15-15-15 where two PKR monomers sequentially bind 
to produce an RP2 species at ~8 S. The binding affinities are decreased, indicating PKR prefers 
a folded structure at the top of the stem (Table 3.8). When the loop sequence protrudes from 
the 3′-strand (3′-UCCG), mixtures containing a molar excess of PKR produce a larger species 
which sediments at ~11 S. An appropriate model to describe the 3′-UCCG data was not 
attained. Both the 5′-UCCG and 3′-UCCG constructs have nearly identical distributions for 
mixtures containing 0.5, 1, and 1.5 equivalents of PKR. A cooperative transition appears to 
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occur upon addition of 2 equivalents potentially indicating that the second PKR mediates a 
structural alteration within the RNA which permits formation of higher order complexes. One 
possibility is that PKR stabilizes an interaction analogous to kissing loop complexes (68) which 
dimerizes the RNA via the broken tetraloop at the top of the stem. However, it is unclear why a 
similar complex would not form with the 5′-UCCG construct. Equally puzzling is why a complex 
of this nature, or any complex which mediates higher-order assembly of multiple PKR 
molecules, does not stimulate activation. In the PKR mediated RNA dimerization scenario, 
coaxial stacking of nucleotides at the top of the stem would form a 34 bp duplex interrupted by a 
two nucleotide bulge in the center. Perfect duplexes 30 bp in length formed by hybridization of 
synthetic oligonucleotides activate PKR (63).    
Table 3.8 Effect of loop on PKR binding affinity measured in AU75 buffer. 
Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments. 
The values in parentheses represent the 95% joint confidence intervals obtained using the F-statistic.  
Sedimentation coefficients are fixed to best fit values for UCCG: s (RP) = 4.88 S; s (RP2) = 8.02. 
a Root mean square deviation in absorbance units. 
b Denotes constructs created by hybridization of synthetic oligonucleotides. All RNAs contain a 5′-ppp. 
c An appropriate model to describe this interaction was not attained. Refer to Fig. 3.12E for g^(s*) 
distributions. 
Constructs corresponding to ∆T and 5′-UCCG that were created by IVT do not activate 
PKR (Fig. 3.12C) suggesting that the loop is a critical element which mediates activation. 
However, an essential control experiment disputes the relevance of this finding. Enzymatic 
ligation of synthetic (3.13A) and IVT constructs (3.13D) does not restore PKR activation.  The 
Loop sequence Kd1 (nM) Kd2 (nM) Maximum % RP2 RMSDa 
UCCG 4 (2, 6) 294 (252, 343) 12.9 0.00821 
GAAA 17 (12, 22) 345 (324, 366) 11.4 0.00753 
UUUU 35 (28, 44) 319 (300, 339) 12.1 0.00798 
∆Tb 68 (58, 81) 611 (579, 644) 7.1 0.00842 
5′-UCCGb 112 (96, 131) 583 (548, 619) 7.4 0.00896 
3′-UCCGb NDc NDc - - 
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full length synthetic constructs previously analyzed contained a 5′-OH. However, the ligated 
constructs contain a 5′-ppp. Failure to activate provides further evidence for the chemical 
differences between IVT and synthetic forms. Analysis of the ligated RNA by denaturing gel 
electrophoresis (3.13A, D) and mass spectrometry (3.13C) indicates that ligation was 
successful, although the product was typically contaminated with the constituent single-stranded 
RNAs. Purification of the ligated reaction by size exclusion chromatography or denaturing PAGE 
did not rescue activation (not shown).     
 
3.14 Discussion 
We have systematically dissected a model ss-dsRNA activator to determine the 
contributions of the single-stranded tails, stem-loop, and the 5′-triphosphate to PKR activation 
 
Figure 3.13 Ligation of the tetraloop. (A) Ligation of synthetic constructs. The ligation key 
indicates the combination of tetraloop sequences which were ligated in the gel below. (B) 
Activation on the ligation reactions shown in (A). (C) MALDI-ToF analysis of ligation #3 (5′-
UCCG). (D) Ligation of IVT RNA. The 5′-UCCG construct produced by IVT reactions was 
ligated (left) and assayed for PKR activation (right) 
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and binding. The model ss-dsRNA activates PKR autophosphorylation strongly and the 
presence of both flanking 5′- and 3′-ssRNA tails are required for activation. When either tail is 
truncated, the activation potency drops with tail length and truncation of the 5′-tail is more 
deleterious to activation than the 3′-tail. However, the effects of tail truncations are not simply 
additive as the lengths of the tails are reduced.  For example, the symmetric construct 
containing 10 nt 5′ and 3′ tails does not activate PKR yet ppp13-15-10, ppp13-15-5, ppp-10-15-
5, and ppp-5-15-10 stimulate autophosphorylation. Activation is also sensitive to stem length: 
the titration is shifted to higher RNA concentrations for the 10 bp construct and the 5 bp 
construct is inactive.   
The bell shaped curve for activation by ss-dsRNAs supports a model in which lower 
RNA concentrations activate by inducing PKR dimerization and high RNA concentrations 
dissociate active, RNA-bound PKR dimers onto separate molecules of dsRNA (61, 67). 
However, at high salt (200 mM NaCl), our AUC experiments detect the binding of only one PKR 
monomer to both activating and nonactivating RNAs. Possibly, the observed activation is 
mediated by very weak binding of a second PKR monomer.  At lower salt (75 mM NaCl) ss-
dsRNAs bind two PKRs. In cases where the binding affinity is strongly reduced, such that the 
maximal RP2 <10%, activation is abolished or greatly attenuated. However, is it not possible to 
predict activation based on Kd1, Kd2, or maximal % RP2 for the ss-dsRNAs with intermediate 
binding affinities: some (e.g., ppp-5-15-15) are inactive and others (e.g., ppp-5-15-10) are quite 
active.  Thus, a threshold concentration of RP2 is required, but not sufficient, to elicit PKR 
autophosphorylation by ss-dsRNA. Potentially, specific sequences in the tail regions may 
contribute to the relative activation potencies. 
Our results implicate the 5′- and the 3′- ssRNA regions in the mechanism of activation of 
PKR by ss-dsRNAs. The presence of 5′- and 3′-tails in ss-dsRNAs enhance PKR binding affinity 
suggesting that the tails directly bind to PKR.  It has been reported that dsRNA binding domains 
do not bind to ssRNA (163, 164) and PKR is not activated by ssRNAs (66, 165). However, our 
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analysis of ssRNA interactions (presented in Chapter 4) reveals two regions on PKR which bind 
ssRNA with micromolar affinity: the dsRBD and a basic region N-terminal to the kinase domain. 
Complex formation with ss-dsRNAs is presumably mediated by the nanomolar affinity of the 
dsRBD for duplex regions (104). Auxiliary interactions with single-stranded regions tethered to 
the duplex would be promoted by the effect of increased localized concentration (166). An 
isolated kinase domain construct containing the basic region is weakly stimulated by ssRNA. In 
the context of full length PKR and ss-dsRNAs direct engagement of the basic region by the 
single-stranded tails may elicit activation. The lack of correlation between tail length, binding 
affinity, and activation potency for constructs with intermediate tail lengths may reflect specific 
conformational requirements of the interaction.  
There is evidence that the single-stranded regions may contribute to PKR activation in 
complex, natural RNAs. In the context of perfect duplex dsRNA, a length of at least 30 bp of 
dsRNA is required to activate PKR autophosphorylation (62-64).  Interestingly, the length of the 
duplex regions in several natural RNA activators of PKR, including HCV IRES (167, 168), TNF 
mRNA (72), interferon- mRNA (6), and the 3′-UTR regions of several cytoskeletal muscle 
mRNAs (3) are below the 30 bp required for PKR activation. Similarly, influenza B 
ribonucleoprotein is a potent PKR activator that contains only a short 14-16 bp “panhandle" 
(169). Thus, the single-stranded regions may contribute to PKR activation in these complex 
natural RNAs. 
It has been reported that a 5′-ppp is crucial for activation of PKR by the canonical ss-
dsRNAs as well as ssRNAs containing short duplexes (78, 131). In contrast, for RNAs produced 
by in vitro transcription, we find that this moiety does not contribute to PKR activation and only 
slightly affects binding affinity. RNAs produced by chemical synthesis do not activate in both 5′-
ppp and 5′-OH forms.  We also obtain similar results using a previously described ss-dsRNA 
(ss-dsRNA 9,11 see Fig. 1.4A) (77, 78). ss-dsRNA 9,11 activates PKR potently when prepared 
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by IVT. However, the synthetic counterpart containing a 5′-OH does not activate. 
Dephosphorylation reactions on the IVT preparation does not eradicate PKR activation (C. 
Mayo and J.L. Cole, unpublished observations). snoRNAs, which contain short duplexes 
interspersed with single-stranded regions, were recently reported to activate PKR. In some case 
activation is dependent on a 5′-ppp whereas others are active in 5′-OH and 5′-p states (7), 
suggesting that the structural context can modulate the triphosphate dependence. We are 
currently investigating the chemical differences between synthetic and IVT RNAs.  
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Chapter 4: Interaction with single-stranded nucleic acids 
4.1 Introduction 
Although the antiviral kinase PKR was originally characterized as a double-stranded 
RNA activated enzyme it can be stimulated by RNAs containing limited secondary structure and 
alternative structural elements are proposed to modulate activity. Single-stranded regions and a 
5′-triphosphate appear to be an important determinant for activation yet PKR lacks defined 
binding sites for both. Stimulatory RNAs typically originate from viral infection but several 
endogenous RNAs have been identified as PKR activators (3-7). In addition to the canonical 
activators containing ≥ 30 bp dsRNA regions, PKR is activated by RNAs that contain limited 
secondary structure and include single-stranded regions or tertiary structure. Examples include 
a 17 bp stem loop within the 3′-UTR of TNF-α mRNA (72), a pseudoknot within the 5′-UTR of 
IFN-γ mRNA (4, 6), siRNAs containing short ssRNA overhangs (170, 171), several snoRNAs 
induced under metabolic stress (7), and certain bacterial RNAs (172, 173). Notably, short stem-
loop RNAs with flanking ssRNA tails (ss-dsRNAs) have been identified as a potent PKR 
activation motif (77, 78). Truncations to the ssRNA regions result in decreased binding affinity 
and activation potency, and complete deletion of either the 5′- or 3′- flanking tail abolishes 
activation (119). Surprisingly, a duplex region as short as 10 nt with 15 nt 5′- and 3′- flanking 
tails binds two PKR monomers and functions as an activator. These observations imply that 
single-stranded regions can play a role in RNA-mediated activation of PKR.  
PKR does not contain a canonical ssRNA binding domain yet there is precedent for 
ssRNA interactions with both the dsRBD and kinase domain. Complex formation between 
ssRNAs and dsRBDs from other proteins has been reported (174, 175) although in one case 
the dsRBD contained a novel C-terminal extension which coordinated a zinc ion as well as an 
unusually long β1-β2 loop (175). PKR mutations within the dsRBDs that block dsRNA binding 
do not prevent photocrosslinking to an RNA with minimal secondary structure, suggesting that 
ssRNA binding may be mediated by other regions of the enzyme (131). Other potential 
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interaction sites include a basic region adjacent to the N-terminus of the kinase domain (Fig. 
4.1) that is important for kinase function (176) as well as a basic cleft lying on the kinase domain 
which mediates heparin activation (91). The cluster of basic residues N-terminal to the canonical 
kinase domain boundary was previously implicated in mediated PKR interactions with the 
ribosome (177). In addition to dsRNA, PKR can be activated by other polyanions (89) the most 
well characterized of which is heparin (90). The coarse structural similarity between ssRNA and 
heparin suggests that they could share a similar binding site and activation mechanism. 
Activation by heparin does not require the dsRBD (178) and the heparin binding site has been 
mapped to multiple nonoverlapping basic sites within the kinase domain (91, 179).  A 5′-
triphosphate (5′-ppp) is reported to be critical for PKR activation by RNAs with limited secondary 
structure, including the ss-dsRNA motif (7, 78, 131, 169, 172) (but see (119)). Duplex RNAs 
exhibit no triphosphate dependence so it is likely that ssRNA and the 5′-ppp bind to the same 
site (78).  
Here, we seek to provide insight into the role of ssRNA and the 5′-ppp during enzymatic 
activation by identifying the regions on PKR that interact with free ssRNA and the contribution of 
the 5′-ppp on binding. We demonstrate that ssRNAs can bind to PKR at both the dsRBD and 
the basic region with micromolar affinities and can induce activation of the isolated kinase 
domain. Photocrosslinking measurements demonstrate that that the basic region interacts with 
RNA in the context of full length PKR. We propose that bivalent interactions with the double 
stranded RNA binding domain and the basic region underlie the ability of RNAs containing 
limited structure to activate PKR by enhancing binding affinity and thereby increasing the 
population of productive complexes containing two PKRs bound to a single RNA. Our data 
support a model where PKR activation by RNAs is regulated in vivo by interaction with both 
duplex and single-stranded regions. 
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Results 
Based on the critical contribution of single-stranded regions to the binding and activation 
of PKR by ss-dsRNAs, we have investigated the interactions of PKR with isolated ssRNAs. 
Domain constructs, depicted in Figure 4.1, are used to localize the ssRNA binding site on the 
full length protein. The Results section begins with an analysis of the individual components 
used in the interaction studies. While somewhat tangential to the present study, a previously 
unappreciated role for the basic region during enzymatic activation is identified.  
 
4.2 Characterization of protein constructs 
 This study utilizes a number of protein constructs which have never been created in our 
laboratory. Characterization of both their hydrodynamic and catalytic properties were a 
necessary prerequisite to analysis of nucleic acid interactions. Notably, active kinase domain 
constructs were created by insertion of a TEV protease site into full length PKR which is cleaved 
 
Figure 4.1 PKR domain schematic. (A) PKR domain organization. Canonical domain 
boundary positions are indicated above each domain. (B) Linker sequence alignment. The 
alignment was generated with ClustalW (180) and prepared in JalView (181). Residues are 
colored using the Zappo coloring scheme. (C) PKR domain constructs used in this study. (D) 
Nucleic acids used in this study.  
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during the purification procedure to liberate the kinase domain. This circuitous methodology was 
required due to low yield of the isolated kinase domain when expressed in E. coli. Presumably 
the autocatalytic activities of the kinase domain are deleterious to expression since constructs 
containing the inactivating mutation K296R are not problematic (59). Sedimentation velocity 
analysis indicates each of the constructs is homogeneous and monomeric up to the highest 
concentration assayed in nucleic acid binding measurements (Fig. 4.2A, Table 4.1). The RNA-
independent autophosphorylation activities were measured by the protein concentration 
dependence on 32P incorporation and reveal a previously unappreciated contribution of the 
basic region to enzymatic activation. Samples were resolved by SDS-PAGE and imaged by 
Sypro Orange protein staining and phosphor screen exposure. The protein stain confirms that 
equivalent amounts of each construct are added to the appropriate lanes. Relative yields of 32P 
incorporation indicate the basic region contributes to enzymatic activity. The 242-kinase domain 
construct lacking the basic region requires ~3-fold higher protein concentrations to achieve 
similar levels of phosphorylation activity as the 229-kinase construct (Fig. 4.2D). In full length 
constructs deletion of variable lengths of the basic region cause a similar reduction in activity 
(Fig. 4.2E). The 229-kinase construct requires ~3-fold more protein than full length PKR to 
achieve similar levels of 32P incorporation (compare D and E). Note however that PKR contains 
14 autophosphorylation sites and the full length enzyme contains more phosphorylation sites 
per mole than the kinase domain constructs (182). It is likely that this difference contributes to 
increased PKR autophosphorylation. In contrast, 229-kinase and 242-kinase contain the same 
number of phosphorylation sites so that the differences in the extent of phosphorylation can be 
attributed to a difference in intrinsic activity. The contribution of the basic region to activation is 
unclear although it is adjacent to the dimer interface and stabilization of the dimer would 
presumably lead to enhanced activity.  
 The full length protein constructs containing TEV cleavage sites provide a method to 
map PKR phosphorylation sites with very course resolution. The data indicate that the previous 
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assignment of 14 autophosphorylation sites (182) is underestimated. Full length constructs with 
a cleavage site located at position 185, 229, or 242 were phosphorylated, cleaved with TEV, 
and resolved by SDS-PAGE. The gel was stained with Sypro Orange and exposed to a 
phosphor screen. Both images are shown in Figure 4.2F. The N-terminal portion of cleaved 
PKR containing the dsRBD stained poorly with Sypro Orange and its position is indicated by a 
yellow arrow. Protein fragments resulting from cleavage at positions 185 and 229 can be 
resolved in both images yet the N- and C-terminal fragments which arise from 242 cleavage 
cannot be resolved in the phosphor image. The relative intensities of the cleavage fragments 
indicate that a majority of autophosphorylation sites are located in the linker region between 
residues 185 and 229 (Figure 4.2E). When cleaved at position 185 the C-terminal fragment 
containing the linker and kinase domain produces ~70% of the measured signal. Cleavage at 
position 229 inverses the relative intensities so that the N-terminal fragment which now consists 
of the linker and dsRBD contains ~90% of 32P. Analysis of PKR phosphorylation sites by mass 
spectrometry identified 14 sites with 71% coverage of the total sequence (182). Yet the missing 
segment of the analysis corresponds primarily to residues 175-233 which is overrepresented in 
serine and threonine residues (Fig. 4.1). TEV cleavage of phosphorylated constructs provides 
only course resolution of the phosphorylation sites yet indicates the linker is the most heavily 
phosphorylated portion of PKR.  
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Figure 4.2 Characterization of protein constructs. (A) Sedimentation velocity analysis of 
PKR domain constructs. g^(s*) distributions are normalized by area. Protein concentrations: 
PKR, 16 µM; kinase domain constructs, 30 µM; dsRBD, 12 µM. Fits reported in Table 4.1. (B-E) 
RNA-independent autophosphorylation of PKR constructs. Samples were resolved by SDS-
PAGE and stained with Sypro Orange to visualize protein and exposed to a phosphor screen to 
measure autophosphorylation. Kinase domain constructs are shown in (B). Wild-type PKR and 
constructs containing internal deletions are shown in (C). Protein stain is shown on the top and 
phosphorimage is shown on the bottom. The marker band, M, in (C) corresponds to BSA (66 
kDa). (D, E) Quantitation of 32P incorporation and Sypro stain as a function of protein 
concentration. Kinase domain constructs are shown in (D) and full length constructs are shown 
in (E). The data are plotted on a log-log scale. 32P data are shown as a solid line and the Sypro 
intensities are shown as a dashed line. (F) TEV cleavage of phosphorylated PKR. Two images 
of the same gel are shown with Sypro Orange protein stain on the left and phosphorimage on 
the right. Molecular weights of the Mark 12 protein ladder are indicated. TEV protease is present 
in each lane and runs at ~30 kDa. The position of the cleaved fragment containing the dsRBD is 
indicated by a yellow arrow. (G) Quantitation of 185 and 229 cleavage positions. Normalized to 
the sum of the intensity of the cleaved fragments.  
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Table 4.1 Sedimentation velocity analysis of PKR domain constructs. 
Parameters obtained by global nonlinear least square analysis of the sedimentation velocity data to a 
single ideal species model. Protein concentrations used in the global analysis: dsRBD, 12 µM; kinase 
domains, 5, 15, 30 µM; Full length PKR, 16 µM 
a Masses predicted based on amino acid sequence.  
b Sedimentation coefficient corrected to standard conditions (water at 20 °C). 
c Root mean square deviation in fringes.  
d Data from (91) 
4.3 Characterization of ssRNAs  
Experiments were initially performed with the heteropolymeric synthetic oligonucleotide 
used to create the 5′ side of the 15-15-15-∆T construct (Chapter 3). The RNA was available in 
both 5′-ppp and 5′-OH forms and was used to probe the contribution of the triphosphate to 
binding energetics. At the temperature that binding affinities were measured (20 °C), the 
heteropolymeric sequence is predicted to fold into two short duplex regions 2 and 3 bp in length 
(133) (Fig. 4.3A). However, the Gibbs free energy of the structure (-4.01 kcal/mol) indicates the 
folded form is not stable. Thermal denaturation results in a slight absorbance increase that 
could be associated with weak secondary structure formation or unstacking but there is no 
transition which can be assigned to cooperative unfolding (Fig. 4.3B). Transient duplex 
formation could possibly be further stabilized by PKR binding. To confirm that interactions are 
specific for single stranded regions we repeated binding analysis with homopolymers of 
uridylate which should exhibit minimal structure due to lack of stacking interactions between 
uridines (162). Thermal denaturation of a 30 nt poly-uridylate (U30) verifies the absence of 
structure (Fig. 4.3B). The small absorbance decrease can be attributed to thermal expansion of 
the solution.  
Protein  Predicted Massa Fitted Mass 
s20,w 
(Svedbergs)b RMSD
c 
dsRBD 20,262 19,797 1.83 0.0061 
242-kinase 35,811 32,830 2.89 0.0207 
229-kinase 37,436 38,608 2.91 0.0168 
185-kinase 41,907 41,626 2.92 0.0221 
Full lengthd 62,095 60,774 3.71 0.0211 
75 
 
 
4.4 Analysis of protein:nucleic acid interactions 
Protein:nucleic acid interactions were monitored by sedimentation velocity analytical 
ultracentrifugation in order to detect transient, lower affinity interactions that may not be reliably 
measured in gel shift (183) or filter binding (184) assays. All of the interactions reported in this 
chapter are weak and rapidly reversible. Reequilibration of the complexes during sedimentation 
results in sedimentation profiles which represent reaction boundaries rather than discrete 
species. The shape of the reaction boundaries are a representation of both the sedimenting 
particles and association kinetics. In some cases, this behavior led to cross correlation between 
the dissociation constants and complex sedimentation coefficients during the fitting procedure 
making assignment of the sedimentation coefficients a critical determinant of affinity and 
complex stoichiometry. To interpret the data, we chose an approach that would emphasize 
comparison of binding affinities for different nucleic acids to different regions of PKR. 
Sedimentation coefficients of complexes were fixed so that their frictional coefficient (f/fo) was 
1.5 which is typically what we observe for protein:RNA complexes (138). This was often in good 
agreement with fitted sedimentation coefficients for systems which exhibited stability during the 
 
Figure 4.3 Thermal denaturation analysis of ssRNAs. (A) Predicted secondary structure of 
Het30.  Secondary structure was computed at 20 °C using MFOLD (133). The free energy of 
folding is -4.01 kcal/mol. (B) Absorbance melting curves. Thermal denaturation was analyzed by 
monitoring the absorbance change at 260 nm at a heating rate of 0.5 °C/min. The 
measurements were conducted in 10 mM NaPO4 (pH 7.0) with 0.1 mM EDTA.  
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fit. The fitted dissociation constants for all the protein:nucleic acid mixtures reported in this 
Chapter are presented together in Table 4.2 so they may be readily compared. The 
sedimentation coefficients used in the fits can be found in Appendix 2.  
Table 4.2 Sedimentation velocity analysis of PKR constructs binding to RNA.  
Parameters obtained by global nonlinear least square analysis of the sedimentation velocity data using a 
model of sequential binding of two proteins monomers. The values in parentheses represent the 95% 
joint confidence intervals obtained using the F-statistic. 
a Root mean square deviation in absorbance units. 
b Good fits required that the sedimentation coefficients for the protein-RNA complexes be allowed to float 
to their best-fit values. 
c Not determined. More than two protein monomers bind to the RNA and the data could not be reliably fit 
to an association model. Plots of the normalized g^(s*) distributions for these experiments are in Figure 
4.9. 
d These fits were obtained from only one PKR:nucleic acid mixture.  
Protein Nucleic Acid Kd1 (µM) Kd2 (µM) RMSDa 
Full length U30 3.51 (3.49, 3.52) 39.9 (39.4, 40.5) 0.00662 
 U15 32.51 (30.27, 34.99) - 0.00611 
 ppp-Het30 0.825 (0.761, 0.894) 3.81 (3.49, 4.15) 0.00876 
 Het30 1.07 (1.01, 1.12) 10.8 (10.1, 11.6) 0.00667 
 dT30d 5.28 (4.13, 6.28) >100 0.00875 
 dHet30d 10.70 (10.15, 11.26) >100 0.00911 
dsRBD U30 8.42 (7.98, 8.88) 52.3 (47.6, 57.7) 0.00514 
 ppp-Het30b 5.36 (4.60, 6.31) 9.66 (8.03, 11.6) 0.00810 
 Het30b  8.21 (7.38, 9.18) 19.4 (16.3, 23.0) 0.00701 
 dT30d 40.68 (30.99, 55.50) 46.28 (29.95, 72.07) 0.00476 
 dHet30d 55.25 (53.42, 59.69) >100 0.00352 
185-kinase U30 31.9 (29.8, 34.2) 68.9 (51.8, 97.5) 0.00452 
229-kinase U30 1.91 (1.79, 2.05) 7.87 (7.16, 8.64) 0.00706 
 ppp-Het30 NDc NDc  
 Het30 NDc NDc  
 ds30 3.80 (3.37, 4.33) 3.27 (2.82, 3.77) 0.00457 
 dT30 2.59 (2.44, 2.76) 16.2 (14.5, 18.2) 0.00630 
242-kinase U30 96.1 (88.1, 106.8) >100 0.00539 
 ds30 24.3 (20.7, 29.1) >100 0.00452 
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4.5 PKR interaction with ssRNA  
Figure 4.4A shows a titration of a model ssRNA, U30, with full length PKR depicted as 
an overlay of g^(s*) sedimentation coefficient distribution functions. Addition of PKR results in a 
decrease in the amplitude of the peak at 1.5 S associated with free U30 and formation of a peak 
at higher sedimentation coefficients due to complex formation. A similar titration against the 
heteropolymeric RNA, Het30, is shown in Figure 4.9A. The data are plotted as an overlay of 
g^(s*) distributions for Het30 in 5′-ppp and 5′-OH forms. This representation provides qualitative 
insight into the contribution of the triphosphate to ssRNA binding energetics which is discussed 
subsequently. Comparison of g^(s*) distributions for U30 and Het30 reveals significant 
differences in binding behavior. Complex formation with U30 results in a single broad peak 
which forms at ~4 S. Addition of 15 equivalents of PKR to Het30 results in a bilobal distribution 
with a feature at ~3.6 S corresponding to freely sedimenting PKR and a complex which appears 
at ~6 S. Hydrodynamic constraints restrict the maximal sedimentation coefficient for a 1:1 
complex to values less than 6.57 S and it is likely the feature at ~6 S corresponds to a 
multivalent complex. The time derivative method employed to generate g^(s*) distributions is a 
model independent analysis and can be used to guide interpretation of the data. In order to 
define the interaction stoichiometry and obtain dissociation constants the sedimentation velocity 
profiles were subtracted in pairs to remove systematic noise and the difference curves were fit 
to alternative association models. A fit of the U30 binding data to a model where two PKR 
monomers sequentially assembly on a single RNA is shown in Figure 4.4B and the affinities are 
reported in Table 4.2. Similar to PKR interactions with duplex RNAs, the first PKR binds with the 
highest affinity, with a Kd1 = 3.5 µM, and the second binds weaker, Kd2 = 40 µM. PKR binds 
about three-fold more strongly to the heteropolymeric ssRNA of the same length with a similar 
decrease in affinity for the second PKR (Het30, Table 1).  Increased affinity toward Het30 may 
reflect weak secondary structure formation by the heteropolymeric sequence (Fig. 4.3A) or 
some slight nucleotide identity preferences. PKR gains specificity for dsRNA over other nucleic 
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acid conformations via its dsRBD which recognizes the register of 2′-OH groups and 
phosphates presented by the A-form geometry of the RNA helix (23). The requirement for 
appropriate spatial distribution of 2′-OH is demonstrated by a lack of interaction with dsDNA, 
RNA/DNA hybrids, or chimeric RNAs partially substituted with either 2′-deoxy or 2′-OCH3 (15, 
65). We asked whether single-stranded nucleic acid interactions exhibit the same specificity by 
analyzing the DNA versions of U30 and Het30. PKR binds both dT30 and dHet30. Affinity is 
reduced ~1.5-fold for dT30 and ~10-fold for dHet30 relative to their respective RNA forms 
indicating the 2′-OH contributes to single-stranded nucleic acid interactions but is not required.       
Binding to U30 activates PKR autophosphorylation weakly (Figure 4.4C) to a level about 
1.5-fold above the background in the absence of RNA. As in the case of duplex RNAs (67), the 
bell-shape activation curve implies that ssRNAs induce PKR dimerization. The low extent of 
activation is likely a consequence of the relatively weak binding affinity. Higher ssRNA 
concentrations inhibit, consistent with dilution of PKR dimers by the excess nucleic acid.   
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Figure 4.4 Interaction of PKR with U30.  PKR binding to U30 ssRNA was assayed by 
sedimentation velocity analytical ultracentrifugation. Measurements were performed in AU75 
buffer at 20 °C and 50,000 rpm using absorbance detection at 260 nm.  (A) Titration of U30 with 
PKR represented as an overlay of g^(s*) sedimentation coefficient distribution functions.  The 
samples contained 1 µM U30 (black) and 1 µM U30 plus 0.5 eq. (orange), 1 eq. (blue), 2 eq. 
(red), 5 eq. (green), 10 eq. (cyan), and 15 eq. PKR (purple). The decrease in the U30 peak and 
appearance of the peak at higher S are due to complex formation. (B) Global analysis of the 
time difference curves.  Scans within each data set were subtracted in pairs to remove time-
invariant background noise and fit to a sequential 2:1 binding model using SEDANAL (53). The 
data are indicated by points and the fit by solid lines. The residuals are plotted as a grayscale 
image in the x-y plane at z=0. The best-fit parameters are in Table 1. (C) Activation of PKR by 
U30.  500 nM PKR was incubated with variable concentrations of U30 in AU75 buffer with 5 mM 
MgCl2 for 20 min at 32 °C.  Samples were resolved by SDS-PAGE and 32P-PKR was quantified 
with a phosphorimager. The data are normalized to activation of PKR in the absence of 
activator. 
4.6 PKR interaction with U15  
Initial binding measurements with poly-uridylate were performed with a 15 nucleotide 
RNA to match the single-stranded length of the model 15-15-15 RNA characterized in Chapter 
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Figure 4.5 Interaction of PKR with U15. Two g^(s*) plots are shown which correspond to 
scans acquired during different time intervals of sedimentation. The plot in (A) was created by 
analysis of scans taken starting ~124 minutes after rotor acceleration and ending at ~260 
minutes. (B) Corresponds to scans taken from ~303 to ~440 minutes. The data are plotted on 
different x-axis scales. Note that the sample of U15 alone contains 2-fold more RNA than the 
RNA:PKR mixtures. The samples contained 2 µM U15 (black) and 1 µM U15 plus 1 eq. (blue), 5 
eq. (red), and 15 eq. PKR (green).  The progressive decrease in the U15 peak with addition of 
PKR is indicative of binding.  
3. Figure 4.5 shows two g^(s*) distributions produced from different time intervals from the 
experiment. Binding is difficult to assess by g^(s*) analysis because the RNA is small and does 
not form a discrete peak in the same scan range that a complex would appear (Fig. 4.5A). 
Analysis of scans collected later during the sedimentation process contain only the freely 
sedimenting RNA and provide some qualitative insight into binding (Fig. 4.5B). In both plots, 
addition of PKR causes a decrease in the feature corresponding to free RNA which is indicative 
of complex formation. Indeed, the data fit better to a model which incorporates formation of a 
1:1 complex with a weak binding affinity of 33 µM (Table 4.2) than to a model of freely 
sedimenting species (not shown). Further characterization of single-stranded interactions in the 
context of a homopolymer was performed with U30 to avoid ambiguity associated with weak 
interactions.            
4.7 Localization of ssRNA binding: the dsRBD  
We characterized U30 and Het30 binding to individual PKR domain constructs to define 
the region(s) responsible for interaction with ssRNA and the contribution of the 5′-ppp. The 
dsRBD (residues 1-184) binds U30 (Fig. 4.6A) and Het30 with affinities slightly reduced relative 
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to the holoenzyme (Table 4.2), indicating that ssRNA can also bind to this canonical dsRNA 
binding site. Similar to full-length PKR, affinity is greater for the heteropolymer. The dsRBD also 
exhibits a preferences for the 2′-OH as affinities are slightly reduced toward DNA versions of the 
nucleic acids.     
Binding of the dsRBD to dsRNA distorts the helix causing a slight opening of the major 
groove and changing the number of bp per helical turn (143). This conformation change can be 
exploited to monitor binding of the dsRBD to dsRNA by circular dichroism spectroscopy since 
ellipticity near 260 nm is related to the helix winding angle (110). CD spectroscopy has 
previously been employed to measure stoichiometries between PKR’s dsRBD and RNA 
duplexes of varying lengths (57). Here, we have used the technique to ask whether the dsRBD 
induces any structural change detectable by spectroscopy during complex formation with U30. 
Figure 4.6 shows the CD spectra resulting from titration of the dsRBD against either U30 (B), a 
25 bp dsRNA (C), or 0-15-0 (D). The spectra of each nucleic acid agrees with published reports 
with the duplex absorption maxima at ~260 nm (185) and U30 maxima at ~270 nm (186). As 
expected, addition of the dsRBD to dsRNA causes an increase of ellipticity at 260 nm. However, 
the spectra for U30 remains unchanged upon addition of the dsRBD. Although CD spectroscopy 
only probes some of the possible structural changes associated with binding, these 
measurements indicate that neither intra or intermolecular base stacking interactions, which 
typically accompany protein:ssRNA interactions (187), occur between PKR and U30. 
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4.8 Localization of ssRNA binding: the kinase domain  
Single-stranded nucleic acids bind the dsRBD yet data indicate that this may not be the 
only binding site. The dsRBD binds single-stranded nucleic acids with affinities that are slightly 
reduced relative to the holoenzyme. Removal of the single stranded regions from 15-15-15 has 
a disproportionate effect on the relative binding affinities for full length PKR and the dsRBD 
(Chapter 3, Table 3.5). Affinities are compared for the first binding event (Kd1). Full length PKR 
binds 0-15-0 with about 35-fold reduced affinity relative to 15-15-15 but removal of the tails 
reduces dsRBD binding by only about two-fold, indicating that the tails predominantly interact 
 
Figure 4.6 Interaction of dsRBD with U30. (A) g^(s*) distributions normalized by area 
depicting the interaction between U30 and the dsRBD. Samples were prepared as a titration of 
the dsRBD against 1 µM U30. The dsRBD has a sedimentation coefficient of 1.8 S and begins 
to appear as it is added in sufficient quantity for detection. (B-D) Spectroscopic analysis of 
dsRBD:RNA interaction by circular dichroism. Samples were prepared as a titration of the 
dsRBD against 5 µM of U30 (B), ds25 (C), or 0-15-0 (D). Spectra are an average of 5 scans per 
sample with the contribution of buffer and protein subtract. Data were collected in AU75 buffer 
at 20 °C.     
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with regions outside of the dsRBD. In the absence of the tails the two constructs bind about 
equally well, confirming that binding to duplex regions is mediated primarily by the dsRBD. 
In the human enzyme, the dsRBD is separated from the kinase domain by an ~80 
residue unstructured linker. The length of the linker is highly variable among PKR orthologs (Fig. 
4.1B). This length variability arises within the N-terminal acidic portion of the linker, but a cluster 
of basic residues within the C-terminal portion is conserved. This portion of the linker is 
implicated in kinase function (176) and ribosome association (177) and represents a potential 
RNA interaction site. Alternatively, the heparin binding site is located on the kinase domain (91, 
179) and represents another possible ssRNA binding motif.  We prepared PKR domain 
constructs (Fig. 4.1C) to probe the role of the linker, basic region, and isolated kinase domain in 
ssRNA binding.  
Figure 3 shows titrations of U30 and ds30 RNAs with PKR kinase constructs that contain 
(229-kinase) or lack (242-kinase) the basic region. Addition of stoichiometric 229-kinase to U30 
causes a decrease in the RNA peak and a shift of the distribution to higher sedimentation 
coefficients, indicating that this construct binds to ssRNA. The distribution at the highest protein 
concentration is bilobal due to the contribution of free 229-kinase at 2.8 S and a protein:RNA 
complex which sediments at 4.7 S.  In contrast, addition of the 242-kinase construct lacking the 
basic region results in only a minimal decrease in the free RNA peak.  The new feature which 
appears at 2.8 S is primarily due to absorbance of the free protein.  The 229-kinase data fit well 
to the sequential 2:1 binding model with Kd1 = 1.9 µM and Kd2 = 7.9 µM.  However, the 242-
kinase binds very weakly (Table 4.2).  Thus, the basic region mediates ssRNA binding to the C-
terminal portion of PKR.  Affinity is substantially reduced when the remainder of the linker is 
included in the 185-kinase construct presumably due to the electrostatic effect of the added 
negatively charged and polar amino acids (Table 4.2). These measurements may be more 
representative of the affinity of the basic region for ssRNAs in the context of full-length PKR. 
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Figure 4.7 Interaction of the PKR kinase domain / basic region with RNA. Each panel 
shows a titration of RNA with protein depicted as a g^(s*) sedimentation coefficient distribution.  
Addition of 229-kinase to U30 or ds30 causes a shift in the distributions to the right, indicating 
complex formation. In contrast, 242-kinase induces only a slight decrease in the peak 
corresponding to free U30, indicating a very weak interaction.  The peak at 2.8 S at higher 
protein concentrations is due to free 242-kinase.  The sedimentation coefficients of 242-kinase 
and ds30 are similar and the increase in the peak amplitude is primarily due to free protein.  The 
data were fit to a sequential 2:1 binding model to extract the binding parameters displayed in 
Table 1. 
 
Interestingly, 229-kinase also binds a 30 bp dsRNA and the dissociation constants are 
similar to those observed with U30.  Thus, the basic region interaction is not specific for ssRNA. 
Indeed, 229-kinase also binds to a 30 nt ssDNA, dT30, albeit with reduced affinity indicating a 
small contribution from the 2′-OH (Table 1).  The 242-kinase and ds30 have similar 
sedimentation coefficients (3.2 and 2.8 S, respectively) so that the two species are not resolved 
by time derivative analysis.  Although the affinity is weak and the 2:1 complex is inadequately 
populated to obtain a reliable fit the data are best described by models which account for 
complex formation. 
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Given the strong binding of ssRNA to 229-kinase we asked whether it could mediate 
activation. For comparison, we also assayed activation of the 242-kinase construct. The 229-
kinase is activated by U30 with a bell-shaped activation curve (Fig. 4A and C). As observed for 
the full-length enzyme, the maximum extent of activation by ssRNA is fairly weak, 
corresponding to about 3-fold over the basal level. Consistent with the lower ssRNA binding 
affinity, 242-kinase is not activated by U30. 
The heparin binding site is located on the kinase domain and the 242-kinase construct 
binds heparin (91). Fig. 4C and D show that both 229- and 242-kinase are activated by heparin, 
with the maximum shifted to about 100-fold higher heparin concentration for the 242-kinase.  
Although ssRNA and heparin are both flexible polyanions, the basic region is not required for 
heparin binding. These data are consistent with a model where ssRNA and heparin bind to 
different sites on the kinase. Previously, we localized the heparin binding site to a pocket 
adjacent to helix αC (91) that is distinct from the basic region. The shift in the maximum to 
higher heparin concentration upon removal of the basic region in 242-kinase may be due to 
weaker, nonspecific contribution of the basic region. Consistent with this interpretation, heparin 
binds more weakly to 242-kinase than to the full length enzyme (91). 
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4.9 Analysis of the 5′-ppp recognition site  
Previous reports indicate that a 5′-ppp contributes to PKR activation by certain RNAs 
with limited secondary structure (7, 78, 169, 172), yet the 5′-ppp recognition site remains 
undefined (131). We probed the effect of this moiety on binding affinity in the context of the 
heteropolymer, Het30, and analyzed the domain constructs to localize the 5′-ppp binding 
pocket. Figure 4.9 shows the measurements for each protein construct as an overlay of g^(s*) 
distributions for Het30 in 5′-ppp and 5′-OH forms. This representation is meant to provide 
qualitative insight into the relative contribution of the 5′-ppp to binding affinity toward different 
 
Figure 4.8 Activation of PKR kinase domain by ssRNA.  Autophosphorylation reactions were 
carried out with a fixed concentration of protein and titrated with either U30 (A, C) or heparin (B, 
D).  The basal (RNA-independent) activities of 229- and 242-kinase are much lower than the 
full-length enzyme and are different from each other (Fig. 4.2).  Thus, the protein concentrations 
were adjusted to give approximately equal extents of autophosphorylation in the absence of 
RNA: 1.5 µM 229-kinase and 5 µM 242-kinase.  Phosphorimager scans of SDS-PAGE gels are 
shown in (A) and (B).  The quantitation of 32P-incorporation is shown in (C) and (D). The error 
bars correspond to the standard deviation from three replicates.  In (C), the activation by U30 is 
plotted relative to samples containing no activator.  In (D), activation by heparin is normalized to 
the maximum signal because heparin is a potent activator and quantitation relative to the low 
signal in the absence of activator is not accurate.  The ~100-fold increase in the heparin 
concentration required for maximal activation of the 242-kinase persists when the protein 
concentration is reduced to the same concentration used for 229-kinase (1.5 µM). 
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regions of PKR. In each distribution, samples prepared with equal concentrations of Het30 and 
protein exhibit a shift to higher sedimentation coefficients when the RNA is capped with a 5′-
ppp. Qualitatively, the relative shift between 5′-ppp and 5′-OH forms appears similar for each 
protein construct. Sedimentation coefficients for complexes calculated with frictional ratios of 1.5 
are indicated along the x-axis of each g^(s*) distribution. This assumption of macromolecular 
shape indicates that the dsRBD (Figure 4.9B) and 229-kinase (Figure 4.9C) form complexes 
larger than RP2 with Het30. However, fits to models which accommodate a sequential assembly 
process to form RP4 produced unreasonable dissociation constants (not shown) indicating the 
fitting procedure applied to the other interactions reported in this Chapter could not be used 
here. Reasonable fits to the dsRBD data were obtained by allowing the sedimentation 
coefficients to float to their best fit values (sRP = 3.55 S, sRP2 = 5.02 S, Appendix 2) in a 2:1 
sequential binding model. However, after exhaustive attempts, a model to accurately describe 
the 229-kinase association could not be obtained.    
In full length PKR, the presence of a 5′-ppp enhances affinity, reducing Kd2 by a factor of 
about 3 relative to the 5′-OH RNA (Table 4.2).  A similar magnitude effect of a 5′-ppp is 
observed for Het30 binding to the dsRBD. Dissociation constants describing 229-kinase affinity 
are unavailable yet the qualitative comparison provided by Figure 4.9 indicates the 5′-ppp 
confers a similar increase in affinity as full length PKR and the dsRBD. Thus, the enhancement 
of ssRNA binding to PKR by the 5′-ppp is not associated with a distinct binding site, as previous 
suggested (131) but is nonspecific and likely attributable to electrostatic interactions.   
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4.10 Analysis of RNA interaction by crosslinking  
Our results indicate that PKR contains two RNA binding loci. The dsRBD and the basic 
region interact with single-stranded nucleic acids with comparable affinities. Both regions also 
interact with duplex RNA yet the dsRBD binds with ~100-fold tighter affinity with an intrinsic 
dissociation constant in the low nanomolar range (104). Complex formation with an RNA 
containing both duplex and single-stranded regions is presumably driven by the high affinity 
interaction between the duplex and dsRBD. However, the binding affinities do not indicate 
where the single-stranded regions interact. The relative binding affinities of full length PKR 
versus the dsRBD construct for 15-15-15 and 0-15-15 suggests that single-stranded regions 
engage the protein outside the dsRBD (Section 4.7, Table 3.5). We have designed a 
Figure 4.9 Triphosphate effects on binding.   
Each panel shows an overlay of g^(s*) 
distributions normalized by area depicting the 
effect of a 5′-ppp on binding affinity to Het30. 
Filled circles correspond to the 5′-ppp form and 
open circles correspond to 5′-OH. Samples 
contain 1 µM Het30 and the indicated 
equivalence ratio of protein. For reference 
sedimentation coefficients of RNA:protein 
complexes calculated with a frictional ratio of 
1.5 are indicated along each x-axis. Protein 
constructs are depicted as domain schematics 
with full length in (A), dsRBD (B), and 229-
kinase (C).       
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photocrosslinking assay to directly probe the RNA interaction sites on full length PKR. A 
schematic of the protocol is provided in Figure 4.10A. 15-15-15 and 0-15-0 were transcribed in 
the presence of 4-thiouridine triphosphate (s4U), resulting in incorporation of the modified 
nucleotide throughout the RNA, radiolabeled at the 5′-end, and crosslinked to PKR by exposure 
to 365 nm light. Reactions were performed with wild-type PKR, kinase and dsRBD domain 
constructs, and full length PKR constructs containing a TEV protease cleavage site located at 
position 185, 229, or 242.  Following crosslinking, samples were cleaved by TEV protease, 
separated on SDS-PAGE, and visualized by both phosphorimaging and Sypro Orange protein 
staining. Crosslinking of the ss-dsRNAs to wild type PKR is dependent on s4U and the adduct is 
not cleaved by TEV protease (Fig. 4.10C lane 3, 4.10D lane 3). The mutants containing TEV 
sites are efficiently cleaved by the protease giving two predominant products. The relative 
intensities of the cleavage products provides coarse resolution for the RNA crosslinking site 
which is further resolved by comparing the fragment intensities produced from the different 
protease sites. Distributions of the cleavage pattern were generated by measuring pixel intensity 
vertically across the gel (Fig. 4.10E and F). The cleavage distributions are similar for both 15-
15-15 and 0-15-0. When cleaved at positions 185 or 229 that are N-terminal to the basic region, 
most of the 32P-labeled RNA is associated with the C-terminal kinase domain. Cleavage at 
position 242 shifts the distribution so most of the label is attached to the N-terminal fragment 
containing the dsRBD and basic region. This switch in band intensity indicates that the basic 
region interacts with the ss-dsRNA in the context of full length PKR. The residual crosslinking of 
the C-terminal fragment may reflect the weak interactions observed between the 242-kinase 
construct and RNA.  
Crosslinking of the ss-dsRNA to the isolated domain constructs mirrors the trends 
observed with the full-length protein. The kinase domain requires the basic region for 
crosslinking to both 15-15-15 and 0-15-0. Crosslinking of ss-dsRNAs to the dsRBD is weak and 
requires addition of 10-fold molar excess of protein relative to the other samples to generate a 
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similar amount of adduct. An explanation for low crosslinking yields toward the dsRBD is not 
readily available however several hypothesis are presented. The low amount of product is not 
due to weak binding. The dsRBD binds duplex RNA strongly (intrinsic Kd ~100 nM (104)) 
whereas the basic region in the context of the 229-kinase binds a 30 bp duplex with only 
micromolar affinity (Table 4.2). One possibility is that variations in how the dsRBD and basic 
region engage the RNA lead to differences in accessibility for s4U. The mechanism for duplex 
RNA recognition by the dsRBD is well established (13). The dsRBD primarily binds the 
backbone and makes only a few interactions with the bases all of which occur along the shallow 
minor groove (23). The basic region loosely resembles arginine rich motifs (ARMs), short 
peptides enriched in basic residues which bind their cognate RNA by inserting into the deep 
major groove (188). The reactive sulfur projects into the major groove which may be more 
accessible to the binding mode of the basic region. However, these proposed differences in 
binding mechanism only provide rationale for lower crosslinking efficiency toward 0-15-0. The 
dsRBD also produces less crosslinked product with 15-15-15. Binding affinity may provide the 
explanation. The dsRBD preferably binds the duplex region which could preclude the ssRNA 
interaction. In this scenario, crosslinking with single-stranded regions occurs only after duplex 
binding sites have been saturated.   
Sulfur and oxygen have similar electrochemical properties and uridine containing sulfur 
in the 4′ position rather than oxygen is expected to make canonical base-pairing interactions 
(189). We had hypothesized that s4U incorporated into duplex regions would only crosslink to 
its Watson-Crick base pair partner so that crosslinking would specifically map the single-
stranded binding site. Yet, we observe crosslinking reactions between 0-15-0 and PKR. Note, 
however, that the uridine in position one of the tetraloop is more accessible to solvent than 
duplex residues. A sheared base pair interaction with the guanosine in position four orients the 
4′ sulfur toward the solvent (190). This residue could be responsible for crosslinking with 0-15-0 
but requires mutagenesis to prove. Crosslinking with 15-15-15 is much more efficient than 0-15-
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0, indicating the single-stranded regions substantially contribute to the reaction. Because 15-15-
15 and 0-15-0 were labeled to the same specific activity and the gels were exposed 
simultaneously, the crosslinking efficiency can be directly compared. 0-15-0 yields ~10-fold less 
complex than 15-15-15 indicating that the single stranded regions enhance crosslinking 
efficiency (compare y-axis values, Figure 4.10E and F). Thus, while a background of 
crosslinking toward the duplex region exists, it seems that a majority of the complex is formed 
from s4U within the single-stranded regions. This assay confirms that the basic region engages 
both single- and double-stranded regions in the context of the full length protein. 
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Figure 4.10 Crosslinking analysis of PKR binding to ss-dsRNA.  (A) Protocol schematic. 
TEV cleavage positions are indicated. RNAs are labeled at the 5′-end with 32P. (B) Secondary 
structure of the ss-dsRNAs and chemical structure of 4-thiouridine. Modified uridines are 
highlighted red in the secondary structure and the modified sulfur is highlighted in red in 4-
thiouridine. (C) Phosphorimage of 15-15-15 crosslinking. (D) Phosphorimage of 0-15-0 
crosslinking. Samples contained 0.5 µM RNA and 1 µM protein. One sample of dsRBD 
contained 10 µM protein (labeled 10x). Lanes labeled as (-) s4U contained unmodified ss-
dsRNA. (E) Quantitation of 15-15-15:protein adducts following TEV cleavage. Distributions 
created from panel C lanes 7, 10, and 13. (F) Quantitation of 0-15-0:protein adducts. Created 
from lanes 6, 9, and 12 from panel D. (G) Sypro stained gels from panels C and D. (H) 
Visualization of crosslink mobility change. WT phosphorylated PKR is run next to the full-length 
crosslinked species.       
  
93 
 
4.11 ThioU incorporation abolishes activation 
Certain nucleoside modifications are deleterious to RNA-stimulated activation of PKR. 
Incorporation of 4-thiouridine into a mostly single-stranded RNA reduces PKR activation and 
abolishes activation by a perfect duplex (82). Curiously, EMSA demonstrates that the affinity of 
the dsRBD for dsRNA is not significantly perturbed by nucleoside modifications suggesting that 
kinase domain dimerization may somehow be diminished. Based on these data, we assayed 
s4U-modified ppp-15-15-15 for activation and find PKR activation is eliminated (Fig. 4.11). The 
implications of this result with respect to the crosslinking data are unclear since the mechanism 
of PKR inhibition by nucleoside modification is unknown. Oxygen and sulfur have similar 
electrochemical properties yet replacement of the 4′-keto oxygen with sulfur may produce slight 
changes to base pair hydrogen bonding and base stacking interactions. Both stabilizing (191) 
and destabilizing (192) effects on duplex thermodynamics have been reported and the effects of 
s4U incorporation into single-stranded regions are unknown. The previously reported 
disproportionate effect of s4U incorporation on activation mediated by unstructured versus 
perfect duplex RNA (82) is partially in agreement with our crosslinking analysis. Activating RNAs 
which contain less than 30 bp of duplex presumably bind PKR with the duplex:dsRBD 
interaction with auxiliary interactions involving the single-stranded regions serving to elicit 
stimulatory effects.              
                                                                                                                                                                                                                                                                                                         
 
 
 
Figure 4.11 Activation by s4U 15-15-15. Titration of PKR by s4U modified 15-15-15. 
Unmodified 15-15-15 is included as a positive control.  
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4.12 Deletion of the basic region  
 PKR constructs with internal deletions to the basic region have been created to directly 
probe its contribution to activation by ss-dsRNAs. One construct contains a deletion of residues 
229-241 (∆229-241) to complement the kinase domain constructs and the other contains an 
extended deletion from residue 229 to the canonical kinase domain boundary at position 254 
(∆229-254) (Figure 4.1C). As shown previously, these deletions decrease PKR auto-
phosphorylation activity as measured by the protein concentration dependence on 32P 
incorporation (Figure 4.2E). Activation by U30, 15-15-15, and a 40 bp duplex were measured for 
each construct (Figure 4.12). In the U30 assay, protein concentrations were adjusted based on 
the auto-phosphorylation measurements (Figure 4.2E) so that the basal level of phosphorylation 
activity would be equal. WT PKR was assayed at 400 nM and the two internal deletion 
constructs were assayed at 800 nM. The level of background activity in the absence of activator 
is indicated as a dashed line on the graph in Figure 4.12A. Despite the attempt to normalize the 
basal activity the wild-type protein is ~3 times more active than the deletion constructs. 
Quantitation of the band intensities indicates that the samples containing U30 are more intense 
than the corresponding protein alone suggesting U30 activates the internal deletion constructs. 
These experiments must be repeated to confirm the results. Measuring weak activation is an 
experimentally challenging task. To reduce basal level activity, samples are prepared at low 
PKR concentrations. However, within this regime autophosphorylation activity increases 
considerably. From 250 to 500 nM PKR autophosphorylation activity, as measured by 32P 
incorporation, increases ~10-fold (Figure 4.2E). Thus, small pipetting errors can produce 
substantial changes to the sample activity. For strong activators, such as dsRNA, these effects 
are negligible. However, for weak activators such as U30 this may produce false positive 
results.  
 Deletion of the basic region also reduces stimulation by duplex RNAs (Fig. 4.12B) and 
15-15-15 (Fig. 4.12C). The reduction in activity indued by duplex RNAs may be related to the 
95 
 
apparent reduction in enzyme activity measured in the absence of activators (Fig. 4.2). Because 
of the effect on activation by duplex regions we cannot make definitive conclusions regarding 
the reduced stimulation by 15-15-15 (Fig. 4.12C).       
 
4.13 Discussion 
This study provides the first direct evidence that PKR binds to and is activated by single-
stranded RNAs and rationalizes previous reports (78, 119, 172) that single-stranded regions 
present in structured RNAs contribute to PKR interactions.  The relatively weak binding of 
ssRNAs to PKR and the modest activation indicates that isolated single-stranded RNAs are 
unlikely to form a stable complex with PKR or to promote significant activation in vivo.  However, 
these interactions provide a rationale for the contribution of single-stranded regions to PKR 
binding and activation in the context of structured RNAs. Invariably, potent RNA activators of 
 
Figure 4.12 Internal deletions of basic region. (A) Activation by U30. Protein concentrations: 
400 nM WT, 800 nM ∆229-241, and 800 nM ∆229-254. Heparin (average MW = 5,000 Da) at 3 
µM was a positive control. The dashed line on the graph indicates the level of protein 
phosphorylation in the absence of activator. (B) Activation by 40 bp duplex (ds40). (C) 
Activation by 15-15-15. For each trial data are normalized to the activation of the WT protein by 
0.3 µM 15-15-15. In both B and C protein concentration of each construct was 200 nM. All of the 
phosphorimages consist of two merged gels. The site of merger is indicated by a dashed line.     
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PKR possess some secondary and tertiary structure (193). Some of these RNAs lack the 
minimum 30 bp of duplex required to support PKR activation by simple dsRNAs but can form 
extended double stranded regions by coaxial stacking of shorter helices (4) or by dimerization of 
self-complementary stem loops (134, 135). Other RNA activators contain a single duplex as 
short as 10 - 15 bp (77, 119) or two hairpins of 5 and 4 bp (78), implying a substantial 
interaction of PKR with the unstructured regions. The crosslinking results demonstrate that both 
the dsRBD and the basic region-kinase domain interact with RNAs containing structured and 
unstructured regions.  Despite the presence of these two RNA binding sites, sedimentation 
velocity data for full length PKR binding to ssRNAs and ss-dsRNAs only fit to a model where 
two monomers sequentially assemble onto a single RNA. The data do not fit well to models 
which incorporate binding of multiple RNA ligands to a single protein. The ~80 residue region 
separating the dsRBD and the basic region (Figure 4.1) is intrinsically disordered and PKR 
adopts multiple conformations in solution (38, 60).  NMR data indicate that dsRBD2 can 
transiently interact with the kinase domain (54, 55)  suggesting a model in which PKR exists in 
an equilibrium between open and closed states (59).  In the closed conformation, the dsRBD 
and basic region/kinase domain would be in close proximity and capable of binding to a single 
RNA. 
The protein:RNA binding behavior is similar to our observations for duplex interactions 
and follows the expected trend for interaction with a ligand possessing multiple identical binding 
sites (194). The reported binding affinities are macroscopic measurements influenced by the 
ensemble of binding conformations. Sequential binding of multiple proteins becomes weaker 
due to statistical effects (195). Previously, we have applied a binding model which 
accommodates the statistical effects associated with multiple proteins to an RNA duplex lattice 
to extract the intrinsic (microscopic) binding affinity for the dsRBD to dsRNA (104). It is unclear 
whether similar methodology could be applied to determine the intrinsic binding affinity for 
single-stranded RNA.  
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The weak dependence of binding affinity on a 5′-ppp is consistent with the absence of a 
distinct binding site for this moiety in PKR. A 5′-ppp also increases the affinity in the context of a 
ss-dsRNA containing a 15 bp stem and 15 nt 5′- and 3′-tails (15-15-15) but it is not required to 
detect kinase activation (Chapter 3, (119)). A 5′-ppp may play a role in PKR activation by RNAs 
with limited secondary structure (7, 78, 169, 172) by increasing binding affinity and thereby 
increasing the maximum population of  active PKR dimers. However, a 5′-ppp is not absolutely 
required for activation of PKR, or the 229-kinase, by unstructured RNAs. Proteins with defined 
5′-ppp recognition sites, supported by structural analysis, provide the basis for the expected 
contribution of the triphosphate to binding energetics. The canonical cytosolic sensor for RNAs 
bearing a 5′-ppp is RIG-I. This protein contains a helicase domain which binds duplex RNA and 
a regulatory domain which binds the 5′-ppp (196). For RIG-I, the presence of a 5′-ppp increases 
the binding affinity by >100-fold relative to the 5′-OH form, but the enhancement is only 2.4-fold 
for the isolated helicase domain (197). The latter is similar in magnitude to PKR and presumably 
represents the contribution of nonspecific electrostatic interactions. The antiviral proteins IFIT1 
and IFIT5 recognize ssRNAs containing a 5′-ppp via a deep, positively-charged cavity (198, 
199).  IFIT5 binds a 5′-ppp ssRNA with nanomolar affinity yet does not form a detectable 
complex with ssRNA bearing a 5′-OH (200, 201). The origin of the 5′-ppp effect in RIG-I and 
IFITs is attributable to well-defined structural information correlated with a large energetic 
contribution to binding affinity. In the absence of similar information in the context of PKR it is 
difficult to infer the relevance of the 5′-ppp and the source of experimental differences regarding 
the dependence of the 5′-ppp for enzymatic activation (Chapter 3, (119)). 
We propose that bivalent interactions underlie the ability of RNAs containing limited 
structure to activate PKR by enhancing binding affinity and thereby increasing the population of 
productive complexes containing two PKRs bound to a single RNA. In this model, a major 
contribution driving complex formation is the well-characterized interaction of duplex regions 
with the dsRBD (62, 104).  This interaction is stabilized by adjoining unstructured regions 
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binding to the basic region. The bivalent interaction gives rise to strong (Kd ~ 100 nM) binding 
even for ss-dsRNAs containing a stem as short as 5 bp. In addition to enhancing binding, the 
bivalent interactions may serve to orient the kinase domains to increase the propensity for the 
formation of active dimers (65).  
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Chapter 5: Structural analysis of the kinase domain 
Authors Note: I would like to acknowledge the contribution of Dr. Heidi Erlandsen to the 
findings reported in this chapter. Without her expertise in the analysis of X-ray diffraction data 
and unbridled excitement for science we would not have obtained the atomic resolution models 
presented here. I crystallized the PKR kinase domain and Heidi solved the structure. Also note 
that the structural models presented here are still being refined.  
5.1 Introduction 
The experiments described in Chapter 4 have identified the basic region N-terminal to 
the canonical kinase domain boundary as an RNA binding site which binds single-stranded and 
duplex nucleic acids with micromolar affinity. The data indicate that the basic region mediates 
very weak activation by ssRNA and may also play a role during activation by more complex 
RNAs. Additional stimulatory properties attributed to the basic region include activation by 
heparin and activation induced by self-association. The basic region is proximally located in 
primary sequence to the region which forms the back-to-back dimer interface (29). This dimeric 
configuration is critical for PKR activation (39) suggesting the basic region may produce its  
stimulatory effects by facilitating complex formation. SAXS analysis of full length PKR 
demonstrates that the region lying between the dsRBD and kinase domain is intrinsically 
disordered (60). This is corroborated by structure prediction of the linker region (residues 170-
260) using the Phyre2 web server (202). However, the basic region is predicted to fold into a 
helix (Fig. 5.1). Models were also built from 30 residue blocks iterated over a 10 residue step 
size and support the prediction using the full length linker sequence. Note, however, that while 
the Phyre2 web server relies on homology modeling, homologs for the basic region were not 
identified. Instead, the models were built primarily by the PSIPRED algorithm (203) which is 
utilized for secondary structure prediction during the Phyre2 protocol. The length of the linker is 
variable among PKR orthologs yet the basic region remains relatively conserved supporting a 
role for PKR function (see Chapter 4, Fig 4.1). These observations have provided the impetus 
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for structural analysis of the kinase domain construct containing the basic region (229-kinase). 
Here, we describe the process of protein crystallization and the atomic models we have 
obtained by X-ray diffraction. Unfortunately, the basic region is unresolved in the current 
structures yet we observe a unique assembly of PKR molecules which has profound 
implications for the mechanism of PKR autophosphorylation.   
 
Structures of the kinase domain have previously been solved by X-ray diffraction yet the 
constructs used for structure determination lacked the basic region and contained mutations. In 
two structures, the kinase domain begins at residue 258 and is phosphorylated on threonine 
446, representing the active form. The kinase domain was crystallized as a complex with eIF2α 
in the presence (PDB code: 2A19) and absence (PDB code: 2A1A) of AMP-PNP (29). Mutations 
 
Figure 5.1 Structure prediction of the linker.  Structures were predicted using the Phyre2 
web server (202). The large model in green was generated using the entire linker sequence 
(residues 170-260). Residues which may contribute to RNA binding are indicated as sticks with 
Cα atoms are shown as spheres. The smaller models were generated from 30 residue 
segments of the linker as indicated. The same residues are shown as sticks but their identity is 
not annotated. N- and C-termini are indicated as blue and red spheres, respectively.     
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were introduced to facilitate protein expression and crystallization including H412N, C551A, and 
a 13 residue deletion of residues 338-350. Another study reports the structure of a kinase 
domain beginning at residue 254 containing the inactivating mutation K296R (PDB code: 3UIU) 
(30). In all the structures a similar back-to-back dimer is formed mediated by the N-terminal lobe 
of the kinase. A face-to-face dimer interface is also reported in the 3UIU structure along a 2-fold 
crystallographic symmetry axis so that alternating back-to-back and face-to-face interfaces 
contribute to the crystalline lattice.  
In many eukaryotic kinases the transition from an inactive to active state is controlled by 
activation loop phosphorylation and conformational changes in the αC helix. A network of 
interactions stabilize catalytic residues in the active site, αC helix orientation, and a disordered 
to ordered transition of the activation loop. PKR belongs to the ‘RD’ kinase family which contain 
an invariant arginine neighboring a catalytic aspartate (44). The aspartate plays a critical role in 
catalysis by accepting a proton from the substrate hydroxyl (31). In the active state, the 
phosphorylated moiety in the activation loop interacts with the conserved ‘RD’ arginine to 
position the aspartate for phosphoryl transfer. The interaction also stabilizes the inherently 
disordered activation loop, making the active site accessible to substrate. In PKR, the 
conformational states of the activation loop and αC helix are linked by additional anchoring 
interactions between the phosphorylated moiety and basic residues emanating from the helix. 
Correct positioning of the αC helix is critical for catalysis as exemplified by the myriad of 
conformational arrangements associated with the kinase on/off switching mechanism. In the 
active orientation, a conserved salt bridge is formed between an αC helix glutamate (E308 in 
PKR) and lysine (K296 in PKR) residue from the N-lobe which stabilizes ATP phosphates for 
catalysis. Additionally, a hydrophobic spine is completed in the active orientation which 
improves catalytic efficiency by reducing conformational dynamics (204). Kinases in an inactive 
conformation are typically characterized by rotations or translations of the αC helix which disrupt 
these key interactions. In PKR, the back-to-back interface is partially formed by the αC helix 
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providing a mechanism coupling dimerization to the catalytic state of the enzyme. It is likely that 
dimerization controls αC helix orientation rather than activation loop phosphorylation since the 
helix adopts a similar conformation in both phosphorylated (2A19, 2A1A) and unphosphorylated 
(3UIU) structures. A structure of the monomeric PKR kinase domain is unavailable but the 
structural rearrangements which occur upon dimerization may be inferred from structural 
homologs. Ire1 (205) and the Pkn kinase family (206-209) form a similar back-to-back dimer. In 
their monomeric structures, distortions to the αC helix break the key interactions addressed 
above (40). In PKR, the functional importance of the interface is demonstrated by mutagenesis 
of key interfacial residues which results in both decreased autophosphorylation and 
phosphorylation of eIF2α (39). Out of the 374 identified ‘RD’ kinases, 167 require activation loop 
phosphorylation for full catalytic activity and 94, including PKR, have no upstream kinase (33). 
These kinases must phosphorylate their own activation loop either through a cis or trans 
mechanism. The back-to-back arrangement adopted by the PKR kinase domains disqualifies 
trans-autophosphorylation within the dimer. Instead, dimerization may promote cis-
phosphorylation or dimers may phosphorylate other dimers or monomers in trans. Experiments 
designed to resolve between these scenarios have relied primarily analyzing whether PKR 
molecules containing inactivating mutations are phosphorylated by wild-type PKR. Data 
supporting both cis (34) and trans (35-38) mechanisms have been reported.  
 Here, we report a structural model for a putative PKR kinase domain trans-
autophosphorylation complex solved by X-ray diffraction. We have obtained two structures of 
the kinase domain from crystals grown under different conditions and into different space 
groups. Back-to-back and front-to-front interfaces similar to those which have previously been 
reported (29, 30) are present in the crystals. However, a unique front-to-front configuration is 
also observed involving activation segments which are exchanged between reciprocal 
protomers. Functional analyses to investigate the complex have not yet been performed 
although the significance of the structure is interpreted from structural homologs. Similar kinase 
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domain complexes have been reported and are interpreted to represent a mechanism for trans 
activation segment phosphorylation (33). Our structure shares many of the conserved features 
of activation segment exchange. Additionally, proteins which form functionally important back-
to-back dimer arrangements analogous to PKR have subsequently been shown to form 
additional interfaces suggestive of a similar requirement for trans-autophosphorylation. The 
back-to-back Ire1 interface mediates assembly of a larger oligomer which includes an interface 
in which an activation loops interdigitate into neighboring protomers (210). A face-to-face Ire1 
structure has also been reported (211). PknB has been crystallized in both back-to-back (206, 
208) and face-to-face (212) orientations and a structural model for activation is proposed which 
resembles the complex observed in our asymmetric unit (212). Thus, although the functional 
analyses which typically accompany a crystallographic report are not included, evidence from 
the literature provides precedent for the structures reported here.  
Results and Discussion 
5.2 Crystallization and optimization 
  Both 229-kinase and 242-kinase were initially screened using reagents supplied by 
Hampton Research. In total, 192 reagents have been tested (Crystal Screen; HR2-110, Index; 
HR2-144, and PEG/Ion Screen; HR2-126) yielding three excellent hits and two promising leads. 
Proteins were concentrated, passed through a 0.02 µm syringe filter, and diluted to 10 mg/ml 
(~285 µM) in a solution consisting of 20 mM HEPES (pH 7.5), 75 mM NaCl, 0.1 mM EDTA, and 
0.1 mM TCEP. Samples were mixed in a 1:1 ratio (either 1 µL + 1 µL or 2 µL + 2 µL) with 
crystallization solution and screened by hanging drop vapor diffusion at 20 °C. The first solution 
to yield crystals was composed of 0.1 M HEPES (pH 7.5), 2 % v/v polyethylene glycol 400 
(PEG-400), and 2.0 M ammonium sulfate. Proteins crystallized into a shower of microcrystals 
with a plate like appearance over ~ 5 days (Fig. 5.2A). A grid search strategy was employed to 
optimize the solution pH and reagent concentrations to produce larger crystals suitable for 
analysis by X-ray diffraction. Changes to pH and ammonium sulfate concentration did not yield 
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better results than the initial condition yet increasing PEG-400 concentration to 6-7 % v/v 
produced much larger crystals. Like the initial hit, crystals were numerous throughout the drop 
indicating that crystal nucleation was occurring too frequently effectively reducing free protein 
concentration for further growth. Therefore additional elements of optimization included 
approaches designed to reduce the rate of crystal nucleation by decreasing the speed of 
equilibration between crystal drop and well solution. These included growth at 4 °C and 
crystallization by sitting drop vapor diffusion yet neither method improved crystal size. 
Increasing protein concentration was also ineffective since only the number of protein crystals 
within the drop was amplified rather than their size. Changes to the mixing ratio between protein 
and crystallization solution proved most effective to obtaining less crystals of larger size within 
each drop. This approach has the advantage of sampling both protein concentration and the 
equilibration path along the crystallographic phase transition in a single experiment. The optimal 
crystallization condition was identified as a drop prepared by mixing of 3 µL 10 mg/ml protein 
with 1 µL crystallization solution consisting of 0.1 M HEPES (pH 7.5), 6-7 % v/v PEG-400, and 
2.0 M ammonium sulfate and equilibrated over ~5 days by hanging drop or sitting drop vapor 
diffusion at 20 °C. Crystal production has focused on the 229-kinase although 242-kinase 
behaves similarly in trials. We have also obtained crystals of the kinase in complex with the ATP 
analog adenosine-5′-(β,γ-imido)triphosphate (AMP-PNP) and magnesium using the conditions 
described above. 10 mM of each ligand was added to 10 mg/ml protein solution and allowed to 
equilibrate for 15 minutes prior to crystallization. A change in crystal morphology provided 
evidence that ligands were incorporated (Fig. 5.2A) which was subsequently confirmed during 
structure determination. Curiously, the terminal phosphate from AMP-PNP is hydrolyzed and 
bound proximal to the active site.  
 Screening has identified additional conditions including a similar condition to that listed 
above consisting of 0.05-0.15 M Bis-Tris (pH 5.5) and 2.0 M ammonium sulfate which yielded a 
crystal used to solve one of the structures reported here. A very promising initial hit has also 
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been obtained from a solution of 0.1 M HEPES (pH 7.0), 5% v/v Tacsimate, and 10% w/v 
polyethylene glycol monomethyl ether 5,000 (Fig. 5.2). Optimization trials similar to those 
reported above are currently underway.   
 
5.3 Data Collection and analysis 
X-ray diffraction data were initially collected on our home source but the crystals 
diffracted poorly with the highest resolution shell typically occurring at ~6 Å. High quality data 
were obtained from the more intense X-rays generated by synchrotron radiation sources. To 
date, we have collected high quality diffraction data from several crystals grown under different 
conditions and have solved 2 structures. All structures are obtained from crystals of 229-kinase. 
Data were processed and scaled using iMosflm in the CCP4i2 suite (213). Phases were solved 
by molecular replacement in CCP4i2 with the PHASER module (214) using the phosphorylated, 
 
Figure 5.2 Crystal growth conditions and optimization. (A) Optimization of the initial crystal 
hit. The size of protein crystals grown in the original condition was increased by changing the 
mixing ratio between protein and precipitant solutions and by increasing the concentration of 
PEG-400. Crystals grown in the presence of AMP-PNP and MgCl2 have a more cubic 
appearance than the apo form. Structure two, reported below, was solved from crystals shown 
in the bottom drop. (B) An additional condition has been identified which yields oval shaped 
crystals but has not yet been optimized.    
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AMP-PNP-bound PKR kinase domain as the search model (molecule B, 2A19). Rebuilding was 
performed in COOT and refinement using Refmac5 in CCP4i2 (215). The first structure was 
obtained from a crystal grown in a 1:3 molar ratio of heparin (dp8) to protein, 0.1 M Bis-Tris pH 
5.5, and 2.0 M AmSO4. The crystal was cryoprotected using a 30 s - 2 min soak in high 
concentration of Na-malonate (between 1.5 - 1.7 M final concentration) and frozen in liquid 
nitrogen for transportation to the synchrotron. The crystal diffracted to approximately 3.1 Å and 
a complete dataset was collected at the NSLS-II FMX beam line at NSLS-II. The structure was 
solved using one monomer of the 2A19 PKR structure, with one molecule in the asymmetric unit 
and the following unit cell parameters: a = 92.69 Å, b = 92.69 Å, c = 123.33 Å, α, β = 90°, γ = 
120°, and space group P 61 2 2. The crystal used to solve the second structure was grown in 
0.1 M HEPES (pH 7.5), 2.0 M ammonium sulfate, and 6 % PEG-400 and the protein was 
complexed with AMP-PNP and Mg2+. Crystals were cryoprotected in 2 M LiSO4 for several 
weeks, frozen in liquid nitrogen for transportation to the synchrotron, and a dataset was 
collected at SSRL beamline 14-1. The crystals diffracted to 2.6 Å. Three protein chains 
comprise the asymmetric unit and the unit cell parameters are: a = 106.48 Å, b = 159.60 Å, c = 
172.99 Å, α, β, γ = 90°, and space group C 2 2 21. Figures were made in PyMOL (The PyMOL 
Molecular Graphics System, Schrödinger, LLC).    
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Table 5.1 Crystallographic data collection and refinement statistics.  
 Structure 1 Structure 2 
Data Collection   
Beam line FMX, NSLS-II 14-1, SSRL 
Wavelength (Å) 0.9790 0.9795 
Space group P 61 2 2 C 2 2 21 
Unit cell dimensions   
a, b, c (Å) 92.69 92.69 123.33 106.48, 159.60, 172.99 
α, β, γ (°) 90, 90, 120 90, 90, 90 
Resolution (Å) 123.33-3.10(3.10-3.181) 172.99-2.6 (2.6-2.667) 
Molecules/ASU 1 3 
Rmeas 0.268 (0.070) 0.098 (0.034) 
I/σI 9.1 (3.2) 9.4 (0.8) 
Completeness (%) 100 (100) 97.1 (98.1) 
Refinement   
Rwork/Rfree (%) 25.9 / 34.7 (38.3 / 38.6) 20.9 / 27.3 (39.9/40.5) 
Reflections Unique / Free 5801 / 296 (410 / 16) 42,089 / 2245 (3,154 / 157) 
r.m.s deviations from ideal   
Bonds (Å) 0.0108 0.013 
Angles (°) 1.560 1.774 
B-factor analysis   
Molecule A (Å2) 89.8 78.8 
Molecule B (Å2) - 86.8 
Molecule C (Å2) - 92.6 
Model   
Nonhydrogen atoms 2046 6480 
Water molecules - 52 
Metals - 1 Mg2+ 
Ligands - ADP, 1 PO4, 7 SO4 
Values corresponding to the highest-resolution shell are indicated in parentheses 
5.4 Comparison of structures one and two 
 Both structures of the kinase domain exhibit similar interactions in the crystalline lattice 
but contain different numbers of protein chains in the asymmetric unit. Figure 5.3 shows the 
arrangement of molecules in the lattice with the asymmetric units (ASU) labeled. In the first 
structure, one molecule occupies the asymmetric unit and a filamentous assembly is formed by 
alternating face-to-face and back-to-back interfaces so that two unique interfaces are formed 
between each protomer. Each front-to-front interface is stabilized by activation segment 
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exchange interactions. Structure two has a similar assembly except that three protein chains 
comprise the asymmetric unit. Each protomer is in complex with AMP-phosphoramidate (AMP-
PN), a magnesium ion, and what is presumed to be the hydrolyzed phosphate. The protein 
chains within the asymmetric unit are assigned a label A, B, and C. Unlike structure one, 
activation loops do not swap in one face-to-face interface (C:C). Consequently, there are three 
unique interfaces in the filament: front-to-front with activation segment exchange (IF1, A:B), 
back-to-back (IF2, B:C and A:A), and front-to-front without exchange (IF3, C:C). Analysis of the 
interfaces was guided by PDBePISA (216) and calculated parameters are reported in Table 5.3. 
Note that the back-to-back interface formed by interactions between molecules B and C is 
nearly identical to the A:A interface which bridges asymmetric units. Additional interactions 
occur within the crystal between neighboring C-lobes but have a low buried surface area and 
are presumably an artifact of crystal packing. Structure 2 is the subject of further discussion 
since the dataset used to generate the structure is generally of better quality than structure 1. In 
particular, the higher resolution allows for more accurate modeling of the activation segment 
exchange region. It should be noted, however, that crystals used to generate each dataset were 
grown in slightly different solutions and structure one was grown in the absence of ligands. The 
molecules are arranged by different space groups (Table 5.1) each belonging to a different 
crystal family. Thus, activation segment exchange is likely not an artifact of crystal growth 
conditions or crystal packing arrangements and is not induced by AMP-PNP or magnesium.   
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5.5 Architecture of the kinase domain  
 The features of the kinase structure are annotated onto molecule C in Figure 5.4. Note 
that with the exception of the exchanged region, the structural deviations between monomers 
are minimal (Table 5.2, Fig. 5.5). Each monomer adopts the typical kinase domain architecture 
with a smaller N-lobe (olive) and larger C-lobe (cyan) connected by a flexible hinge. The protein 
is bound by AMP-phosphoramidate, a phosphate, and a magnesium ion in the ATP binding 
pocket between the two lobes. The N-lobe begins with a short noncanonical α-helix, α0, which 
contains residues forming a critical salt-bridge in the back-to-back interface, R262 and D266 
(Fig. 5.6). The lobe is composed primarily of a five stranded antiparallel β sheet (β1-β5) and the 
 
Figure 5.3 Comparison of structures one and two. A surface representation of the filament 
formed within the crystalline lattice is shown on the top with cartoon representations of four 
protein chains on the bottom. Structure 1 is shown in (A) and structure 2 is shown in (B). One 
protein chain occupies the asymmetric unit (ASU) in structure 1. Three protein chains comprise 
the ASU in structure 2 and are labeled A, B, and C. In structure 2, AMP-PN and a phosphate 
are shown as ball and stick representations and magnesium is shown as a grey sphere. Unique 
interfaces (IF) are indicated in the cartoon representation of each structure. 
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crucial αC helix.  A short hinge connects the N- and C-lobes and forms the back of the ATP 
binding pocket. The structural elements of the larger C-lobe include eight α helices (αD-αJ), two 
antiparallel β sheets (β7-β8 and β6-β9), and the activation segment. PKR and other eIF2α 
kinases contain a slightly elongated αG helix which is also displaced from the canonical position 
occupied in other kinases (29, 217, 218). The helix forms the docking site for eIF2α (29) thus, it 
is noteworthy that it occupies that same position in the absence of a binding partner (Fig. 5.4  
and 5.5). In eukaryotic kinases, the activation segment is typically defined as the region 
between two tripeptide motifs DFG and APE (SPE in PKR) and is colored red in Figure 5.4 (32). 
An important step in the structural analyses presented below is to establish that the catalytic 
machinery within the active site is appropriately oriented for phosphoryl transfer. One signature 
of the active kinase conformation is the short β6-β9 β sheet, stabilized by two hydrogen bonds, 
immediately C-terminal to the DFG motif (32). The absence of this β sheet leads to a 
destabilizing effect on proximal residues within the active site, D432 and D414 (Fig. 5.4).      
Segments missing from the structure are indicated by dashed lines and include a large 
noncanonical loop between β strands 4 and 5 conserved within the eIF2α kinase family 
corresponding to residues 334-356 of PKR. A portion of the activation loop is also missing 
presumably due to disorder in its unphosphorylated state. The residues which are missing vary 
slightly for each protein chain. Molecule A is missing residues 441-450, B is missing 440-450, 
and C is missing 440-443 and residue 449.  
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5.6 Comparison to the active conformation  
 Figure 5.4 shows an alignment of each molecule in the asymmetric unit to the 
phosphorylated kinase domain (2A19). Two sets of RMSD values for the alignment of Cα atoms 
are reported in Table 5.2. The first set of values is an alignment of the entire protein chain. In 
the second set, regions which obviously deviate from the 2A19 structure are omitted: the 
activation segment which swings out in protomers A and B and the segment of the activation 
loop which has shifted closer to the αC helix in protomer C. When these regions are omitted, the 
Cα atoms of each protomer align very well to the phosphorylated, active form of the kinase 
domain. The conformational changes to the region surrounding αEF associated with activation 
segment exchange are apparent in the alignment. G466 may serve as the flexible hinge 
 
Figure 5.4 Architecture of the kinase domain. A cartoon representation of protomer C is 
shown in two orientations. The N- and C-lobes are colored olive and cyan, respectively. The 
activation segment is colored red. Secondary features are annotated. Regions missing from the 
structure are represented by a dashed line. AMP-PN, a phosphate, and a magnesium ion are 
bound in the cleft between the two lobes.  
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facilitating the domain swap configuration and will be a target of mutational analysis to probe the 
complex in solution.  
Table 5.2 Alignment of Cα atoms to phosphorylated PKR kinase domain (2A19).  
  
 
 
 
 
 
Superposition of active site residues with the phosphorylated 2A19 structure provides 
evidence that each protomer is in a form that is competent for phosphoryl transfer. An enlarged 
view of the aligned active site is shown in Figure 5.5B. Note that the active site residues in 2A19 
make many of the conserved interactions with AMP-PNP and magnesium which are 
characteristic of the active kinase conformation (49). Residues critical for catalysis are rendered 
as sticks. AMP-PNP and the magnesium ions are from the 2A19 structure and bind at the 
conserved positions. However, the γ-phosphate is not correctly oriented for phosphoryl transfer. 
Its catalytically appropriate position is between the two magnesium ions directed toward the 
substrate hydroxyl which binds to the left of D414 (219). The magnesium ion binding positions 
are designated as I and II. For clarity, only the hydrogen bonding network for 2A19 is shown as 
the catalytic residues within each of our protomers occupy the same positions and make the 
same interactions. However, only a single magnesium ion is bound in our structure at MgII 
(Figure 5.10). The network of hydrogen bond interactions formed by protein residues and 
magnesium ions not only orient ATP but also provide a mechanism for charge transfer during 
the reaction (31). The only protein residue which directly engages the phosphates is K296 which 
stabilizes the α- and β-phosphates. Backbone residues from the G-loop also typically make 
phosphate interactions (219) but in 2A19 the loop is too far away. Additional charge 
Region aligned  Protein Chain # Atoms aligned RMSD 
Entire 
A 252 4.528 
B 252 4.728 
C 257 1.297 
With omissions 
A 237 0.699 
B 237 0.745 
C 250 0.782 
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neutralization and stability is imparted on the phosphates by the coordinated magnesium ions. 
MgI is coordinated by D432 and the β-phosphate and is typically also coordinated by the γ-
phosphate. MgII interacts with α-, β-, and γ-phosphates, D432, and the carbonyl oxygen from 
N419. The catalytic residue, D414, is stabilized by hydrogen bond interactions with N419 and 
K416. K416 interacts with the γ-phosphate and remains bound during all the steps of the 
reaction pathway (50). In our structure, the γ-phosphate is hydrolyzed but remains proximally 
bound by interactions partly mediated by K416. D414 acts as a catalytic base during phosphoryl 
transfer by positioning the substrate hydroxyl for in-line nucleophilic attack on the γ-
phosphorous atom and accepting a proton during the reaction (50).  
The catalytic apparatus is linked to helix αC and more distantly to the back-to-back 
interface by three pathways. 1) E308 orients K296 with a crucial salt bridge interaction (Fig. 
5.4B). 2) R413 coordinates with pT446 and stabilizes the activation loop. This tethering 
interaction is a conserved mechanism for activation within the ‘RD’ family of kinases (44). In 
PKR, the phosphorylated moiety is further stabilized by K304 and R307 providing a linkage 
between the activation loop and helix αC (Fig. 5.4B). 3) A conserved hydrophobic spine called 
the R-spine, shown as a surface representation in Figure 5.4B, has a stabilizing effect on a 
proximal catalytic residue, D432. The completed spine provides rigidity to the catalytic core and 
is typically disrupted in inactive kinase structures (42). In PKR, the spine begins with F433 
which burrows into the hydrophobic core of the protein. L312 from helix αC interdigitates into the 
spine and Y323 from β4 completes the spine on the back of the protein. Y323 links the R-spine 
to the back-to-back interface by engaging in a hydrogen bond triad formed with Y293 and D289 
from the interacting partner (Fig. 5.6). In other kinases Y323 is often replaced with a leucine (43) 
and in PKR mutation to alanine abolishes activity (39). Above Y323, a hydrophobic pocket 
created by residues from helix αC, β4, and β5 provides a docking site for I288 from the 
reciprocal protomer (Figure 5.6D). Thus, the active site is intimately linked to both helix αC and 
the dimer interface by several allosteric pathways. These stabilizing linkage pathways may 
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provide a mechanism for how back-to-back dimerization induces a catalytically competent 
conformation within the active site.  
 Basic residues involved in coordination of the phosphorylated threonine 446 deviate 
substantially in the absence of a phosphorylated moiety. These include K304 and R307 
emanating from the αC helix and R413 from the canonical HRD motif. However, the absence of 
phosphocoordinating interactions does not perturb positioning of the αC helix or residues within 
the active site suggesting dimerization may promote the active state. αC is correctly oriented so 
that E308 can hydrogen bond to K296, a conserved interaction characteristic of active kinases 
(31). Interestingly, in protomer A, a sulfate from the crystallization solution is bound in place of a 
phosphorylated moiety. The sulfate is coordinated by K304 and R413. Similar observations 
 
Figure 5.5 Comparison to phosphorylated PKR. (A) Alignment of each unique protomer in 
our asymmetric unit to the phosphorylated PKR kinase domain (PDB: 2A19). The hinge where 
the αEF helix flips out is indicated. A hypothetical path for missing residues in protomer A is 
indicated by a dashed line. The phosphorylated threonine (446) in 2A19 is indicated as sticks.  
(B) View of the active site.  Residues important for catalysis are rendered as sticks with the Cα 
carbon shown as a sphere. AMP-PNP, magnesium (grey spheres), and pThr446 (TPO446) are 
from 2A19. α-, β-, and γ-phosphates are labeled. Hydrogen bond interactions are denoted as 
black dashed lines. The R-spine is shown in surface representation. Green and purple arrows 
represent linkage pathways from helix αC to the active site. Note that the phosphate 
orientations are slightly distorted. K296 typically does not interact with the α-β bridging oxygen 
and the γ-phosphate is not correctly oriented for phosphoryl transfer. The correct position of the 
γ-phosphate is between the two magnesium ions for in-line transfer onto the substrate hydroxyl.  
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have been reported for other kinases (220) and it is theorized that anions are coordinated by 
phosphate binding pockets which are formed prior to phosphorylation (32).  
The glycine rich G-loop is a dynamic element of the kinase structure and its 
conformation changes during the catalytic cycle (221). Thus, it is not surprising that this region 
is a source of structural deviation between each of our protomers and 2A19. B-factor 
measurements support that this is a conformationally dynamic region (Figure 5.5). Structures 
containing transition state analogs have revealed how the loop clamps around the active site 
during catalysis shielding it from the solvent and helping to position ATP (222-224). In the 2A19 
structure, the loop is shifted away from the active site and is not within hydrogen bonding 
distance of the phosphate. In protomer A, the backbone carbonyl from G279 is close enough to 
make a weak hydrogen bond (3.6 Å) with the β-phosphate.        
The B-factors also highlight the stability imparted to helix αG by complex formation with 
eIF2α. The 2A19 protomer is bound by eIF2α via this helix and is much less flexible in this 
region than the unbound protomers present in our structure. This observation correlates with the 
2A19 complex structure in which a back-to-back dimer is in complex with a single eIF2α. The 
molecule lacking an eIF2α binding partner is disordered at the eIF2α binding site and 
coordinates for αG and αD helices are missing from the structure (29).  
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5.7 Analysis of interfaces: back-to-back (IF2) 
Table 5.3 PISA analysis of interfaces.  
a∆G reflects the thermodynamic gain by buried surface area. Electrostatic contributions are not 
included. 
Interface Protein chains Description 
Interface 
area (Å2) 
∆Ga 
(kcal/mol) 
Hydrogen 
bonds 
Salt 
bridges 
IF1 A:B Front-to-front exchange 1252 -7.0 12 4 
IF2 B:C Back-to-back 863 -5.5 8 6 
IF2 A:A Back-to-back 829 -4.3 8 6 
IF3 C:C Front-to-front no exchange 810 -6.2 6 2 
 
Figure 5.6 B-factor measurements. Cartoon representation of the dynamic features within the 
crystal environment. Cα B-factors for each protomer and the phosphorylated 2A19 structure are 
indicated as a blue to red spectrum on an absolute scale. The tubular representation is relative 
to each protein chain with a wider tube indicating regions with higher B-factors.  
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The back-to-back interfaces formed between protein chains B and C within the 
asymmetric unit and between asymmetric units by two A protomers are nearly identical as 
evidenced by alignment and analysis by PDBePISA (IF2, Fig. 5.6A, Table 5.3) (216). The 
assembly is essentially identical to the previously reported PKR back-to-back interface (30, 39) 
as well as the interface formed by the PKR homologue PERK (217). Several images of the 
back-to-back interface formed between protomers B and C are presented in Figure 5.6. 
Residues from the α0 helix on the top of the N-lobe contribute to the interface via two bifurcated 
salt bridges from between R262 and D266 (Fig. 5.6B). A hydrogen bond triad is formed between 
Y323, D289, and Y293 near the αC helix (Fig. 5.6C). Mutagenesis to disrupt these interactions 
blocks PKR autophosphorylation capability (39) but does not abolish dimerization (65). The C-
terminal portion of the αC helix is stabilized by a hydrogen bond interaction between D316 and 
H322 (bottom of Fig. 5.6D). Additional interactions include two hydrogen bonds in the center of 
the interface formed between N324 from each protomer involving the side chain amide and 
main chain carbonyl (Fig. 5.6C). With the exception of H286, the interface is symmetrical. In one 
half of the interface H286 (protomer B, magenta) hydrogen bonds to the main chain carbonyl of 
C326 (protomer C, green). In the other half, H286 from protomer C is involved in a water 
mediated interaction with R262 (Fig. 5.6B).  
Without a structure of the monomeric kinase domain, only assumptions can be made 
about the allosteric linkage between the dimer interface and active site conformation. Structural 
homologs may provide insight. PknB forms a similar back-to-back dimer and structures are 
available in both monomeric (225) and dimeric forms (206, 208). The structures demonstrate 
the conformational changes to helix αC associated with dimerization which, as previously 
discussed, often regulates the on/off switching mechanism in protein kinases (51). Monomeric 
structures of PknB were generated by mutating the residue corresponding to I288 in PKR 
(leucine in PknB) to aspartic acid (225) suggesting that I288 is critical to the interface. In both 
PKR and PknB, this residue contributes to the dimer by burying into a hydrophobic pocket 
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formed between αC, β4, and β5. A surface representation of the pocket is shown in in Figure 
5.6D. In Section 5.6 an allosteric pathway was presented which linked the dimer interface to the 
active site via the R-spine (Fig. 5.4). The intimate link between dimerization and the active site 
can now be fully appreciated with the images of the dimer interface shown in Figure 5.6.  The R-
spine is completed by Y323 which is right below the hydrophobic pocket and hydrogen bonds to 
the residue immediately preceding I288 (D289).     
 
 
Figure 5.7 Back-to-back interface. (A) Alignment of back-to-back dimers. Both back-to-back 
dimers (B:C and A:A) are aligned. Color coding in this Figure is as in Figure 5.3. Residues 
contributing to the interface are shown for B:C in (B-D). A top-down view looking down on the N-
lobe is shown in (B). In (C) the view is rotated 90° and tilted down slightly. A surface 
representation is shown in (D) to illustrate how I288 packs into a hydrophobic pocket formed 
between αC, β4, and β5. 
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5.8 Analysis of interfaces: front-to-front without exchange (IF3) 
The front-to-front interface without activation segment exchange (IF3) is formed between 
C protomers across two asymmetric units. The αEF helix from one protomer docks into the cleft 
formed between the αEF and αG helices on the reciprocal protomer (Fig. 5.7B). Electrostatic 
interactions which stabilize the interface include a salt bridge between D500 at the base of αG 
and K521 from the loop connecting αH and αI and a hydrogen bond triad which is formed 
between T496 from αG, S461 from αEF, and Q463 immediately following αEF. Perhaps the only 
significant contribution from hydrophobic residues is I460 which is buried between αEF helices. 
Few electrostatic interactions and little buried surface area (810 Å2) suggests the interface may 
be an artifact of crystal packing. However, similar interfaces utilizing the αEF and αG helices 
have been reported for trans-autophosphorylation complexes of PAK1 (226) (see Fig. 5.10) and 
PknB (212). The interface may also represent a step toward formation of the exchanged 
conformation.  
 
 
 
 
Figure 5.8 Front-to-front interface without exchange. (A) Surface representation of the 
interface. (B) View of the interface. Residues contributing to the interface are rendered as sticks 
and elements of the secondary structure are labeled.  
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5.9 Analysis of interfaces: front-to-front with exchange (IF1) 
The most provocative interaction within the crystal is the front-to-front interface with 
exchanged activation segments formed between protein chains A and B (IF1, Fig. 5.9). As is 
typical in domain swapped oligomers, the exchanged portion of each protomer makes the same 
interactions in the reciprocal protein chain as in the monomeric form (227). Additional 
interactions are gained along the interface formed by the exchanging portions. These new 
interactions, which are absent in the monomer, may provide some of the thermodynamic 
impetus for formation of the domain swapped structure. Most of the residues participating in the 
interaction are shown in Figure 5.9B. In 5.9F, a surface representation of protomer A provides a 
helpful visual which illustrates how exchanged αEF arms dock into the reciprocal protomer. The 
discussion of the interface will begin by comparing the activation loops in the exchanged 
conformation to the monomeric configuration of the activation loop in the 2A19 structure. Panels 
C-D show an alignment of 2A19 onto protomer B. Note that in our structure, a portion of the 
region presumably involved in exchange, residues 440-450, is unresolved and is indicated by 
dashed lines in Figure 5.9C. Moving from N- to C-terminus, the region extended from the 
monomeric conformation begins immediately C-terminal to β9, moves through the αEF helix, 
and ends at helix αF (Fig. 5.9C). A glycine (G466) N-terminal to helix αF may serve as a flexible 
hinge facilitating extension of the activation segment. The interface is formed by docking of αEF 
helices into the cleft formed between helices αF, αG, and αI on the opposite protein chain which 
is normally occupied by the αEF helix in its monomeric form. Many of the interactions anchoring 
the αEF helix into the cleft are the same in monomeric and dimeric forms and some are highly 
conserved in kinases. Panels D and E illustrate the interactions which anchor αEF in both the 
monomer and dimer. R526 from the loop between αJ and αI anchors the C-terminal portion of 
the activation loop by engaging in a salt bridge with E458 at the base of αEF (Fig. 5.9D). This is 
a highly conserved interaction and mutation of the corresponding residues in PKA leads to 
decreased catalytic efficiency (204). Also, in both monomeric and domain swapped forms, Q459 
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stabilizes the HRD motif by a hydrogen bond to the main chain carbonyl of R413 (Fig. 5.9B, not 
shown in 2A19 alignment). Additional interactions anchor αEF to αG (Fig. 5.9E). R499 from αG 
is positioned proximal to the backbone to make hydrogen bond interactions with main chain 
carbonyls of R453, L452, and M455. At the tip of the αEF arm a hydrogen bond triad stabilizes 
the final portion of the activation segment which is resolved in our structure. Residues involved 
include R453 and Y454 from the activation loop and E460 from αF (Fig. 5.9E). The hydrophobic 
character of the tyrosine is highly conserved in kinases and this position is invariably occupied 
by a tyrosine, tryptophan, or phenylalanine. In cases where the tyrosine is replaced by 
tryptophan or phenylalanine, the glutamate from αF is typically replaced with a hydrophobic 
residue as well (32).  
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Figure 5.9 Exchanged front-to-front interface. (A) Surface and cartoon representations of the 
interface. AMP-PN and phosphate are shown as ball and stick. Magnesium is a grey sphere. 
Protomers are identified A and B as in Figure 5.3. (B) Top-down view of the interface. 
Interacting residues are rendered as sticks and labeled. Cα atoms are shown as spheres. 
Elements of secondary structure are labeled. (C-D) Alignment of the interface with 2A19. A key 
is provided left of panel (C). In (C), a hypothetical path for the missing segments of the protein 
chain is indicated by a dashed line. Panels (D, E) indicate the interactions that occur in both 
dimer and monomeric configuration. Note the interaction between Q459 and main chain 
carbonyl of R413 is not included. (F) Surface representation of protomer B with residues 
participating in the interaction colored according to the key.    
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Electrostatic interactions are gained as αEF helices pass by one another to dock into the 
reciprocal protomer. Note that some of these interactions are also associated with a lost 
interaction in the monomeric form. For example, in the monomeric structure Y465 hydrogen 
bonds to the R413 side chain, providing further stability to the phosphocoordinating site. In the 
dimer, Y465 assumes two different conformations dependent on the protein chain. In protomer 
B, it is oriented toward the side chain of S462 from protomer A (Fig. 5.8B). On the opposite side 
of the interface, Y465 from protomer A is more favorably orientated to participate in a hydrogen 
bond interaction with the side chain amine from Q459 in protomer B (right side of Fig. 5.8B). 
The only residue to gain an interaction in the dimer configuration is S462 which forms a 
symmetrical hydrogen bond interaction in which each side chain hydroxyl interacts with the 
reciprocal backbone carbonyl. In the monomer, the S462 side chain interacts with the backbone 
of D464 but the main chain carbonyl does not have an interacting partner.  
Analysis of the interfaces with PISA indicates the face-to-face dimer with activation 
segment exchange has a larger surface area and predicted dimer stability than any other 
interface in the crystal (Table 5.3). However, the thermodynamic contribution of this parameter 
to complex formation should be interpreted with caution due to the structural changes required 
to form the interface. A majority of residues within the C-lobe and αEF arm buried in the dimer 
would also be buried in the monomer. Docking of the exchanged portion of the αEF arm 
(residues 451-465) into the C-lobe in the monomeric configurations yields a buried surface area 
of 616 Å2 and ∆G = -4.2 kcal/mol. Thus, the change in buried surface area between monomeric 
and dimeric forms is only 636 Å2. The tip of the N-lobe is also buried in the dimer yet this 
surface contributes only 119 Å2 and predicted ∆G of -0.2 kcal/mol. Curiously, despite the 
presence of charged amino acids in this region, none are correctly oriented to contribute 
electrostatic interactions. The N-lobe interaction surface may be an artifact of crystal packing. 
Structural homology with other kinase domain trans-autophosphorylation complexes is 
discussed in a subsequent section. Most complexes utilize the general mechanism of 
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exchanged αEF helices docking into the reciprocal site on the opposite protomer but differ in 
protomer symmetry. Very few are oriented to utilize the N-lobe in the interaction surface and for 
those that do, the buried surface area is similarly small. Note that the large loop connecting β4 
and β5, comprising residues 334-356, is unresolved in the structure and would be oriented 
toward the front-to-front interface. This loop contains an abundance of polar and acidic amino 
acids and could electrostatically contribute to the interface. Mass spectrometry has identified 
this loop as a region which becomes heavily phosphorylated (182). Although PKR was extracted 
from yeast and modification could be due to endogenous kinases rather than PKR 
autophosphorylation.   
5.10 Comparisons to similar structures 
 PKR belongs to a family of kinases which require activation loop phosphorylation as an 
on/off switching mechanism yet paradoxically have no upstream kinase to activate them in vivo. 
For many members of this family, incubation of purified, unphosphorylated enzyme with ATP 
and magnesium results in activation loop phosphorylation, demonstrating that a basal level of 
autophosphorylation activity persists in the ‘inactive’ state (33). Thus, phosphorylation likely 
serves to shift a preexisting equilibrium towards a more activate state. A structure elucidating 
how autophosphorylation of a latent kinase may occur in trans by activation loop exchange was 
first determined for check point kinase 2 (Chk2) (228). Similar complexes have since been 
reported (229-232). These structures adopt a similar conformation as observed in our interface, 
utilizing exchange of the αEF helix to bring the activation loop within close proximity of the 
catalytic apparatus of the opposing protomer. Figure 5.9 presents a structural comparison 
between PKR and two similar activation segment exchange complexes, Chk2 and SLK. An 
additional trans-autophosphorylation complex for PAK1 is also included and will be discussed 
subsequently. The distances between the catalytic aspartate and the primary and/or secondary 
phosphoacceptor sites within the activation loop are indicated in the enhanced view of the active 
site presented left of the surface representation. For complexes engaged in activation segment 
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exchange (PKR, Chk2, and SLK) the distances range from 6.3 Å in Chk2 to 18.9 Å in SLK. As 
shown in the magnified view of the active site, the residues comprising the catalytic machinery 
are properly oriented for phosphoryl transfer yet the substrate hydroxyl is too remote in the 
crystallographic configuration. These complexes are generally symmetrical and both protomers 
could function as either enzyme or substrate. Brownian motion is proposed to transiently orient 
the complex for phosphorylation (233). Note that only Ser/Thr kinases are discussed here yet 
similar complexes engaged in activation segment exchange have been described for tyrosine-
specific kinases as well. These complexes exchange activation segments but do not exchange 
the αEF helix. The substrate tyrosine is typically much closer to the catalytic aspartate, however, 
the active site is disassembled in each protomer (234).   
A unique asymmetrical trans-autophosphorylation complex has also been described for 
PAK1 in which only one monomer extends its activation loop into the opposite monomer (226). 
The structure can be described as an enzyme-substrate complex. The enzyme accepting the 
activation loop contains a bound AMP-PNP and utilizes its own activation loop as the substrate 
docking site. N- and C-lobes clamp down on the substrate and the enzyme is poised for 
catalysis. This geometry is structurally distinct from the substrate molecule, which is in an open 
conformation and free of ligand. A similar asymmetric complex has been reported for PknB, 
although the activation loops were less resolved in the structure and both protomers adopted 
similar conformations (212). Both complexes bury αEF and αG helices within the interfacial area 
similar to the front-to-front dimer formed without activation segment exchange (IF3) in our 
crystal. The interfaces reported in both studies are supported by functional analyses correlating 
mutagenesis of key interfacial residues with decreased catalytic activity. Interestingly, members 
of the Pkn kinase family also form a back-to-back dimer similar to PKR which is essential for 
activity (PknB: (206, 208), PknD: (209), PknE: (207)). Thus, PknB forms two essential dimeric 
configurations mediated by different regions of the protein. Monomeric structures of PknB are 
also available providing the structural basis for dimerization driven allostery of the active site 
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(225). In the monomeric state, the N- and C-lobes are shifted relative to each other and the αC 
helix is rotated orienting the essential glutamate away from the active site. These structural 
insights have coalesced into a mechanistic model for the PknB activation mechanism in which 
back-to-back dimerization mediates formation of the active kinase conformation and back-to-
back dimers phosphorylate other monomers or dimers in trans via the face-to-face interface 
(212, 225). The model is structurally analogous to the arrangement of protomers within our 
crystal. 
 
5.11 Analysis of ligands bound in the active site 
 Structure 2, the primary topic of discussion in this Chapter, was co-crystallized with 
AMP-PNP yet electron density for the γ-phosphate is missing from the structure. The current 
structure is modeled with each protomer bound in its active site by AMP-phosphoramidate 
(AMP-PN), a magnesium ion, and a proximal phosphate. The assignment of the AMP-
phosphoramidate and neighboring phosphate are based solely on the appearance of the 
Figure 5.10 Kinase trans-autophosphorylation complexes. PDB IDs and literature 
references: PKR, to be determined; Chk2, 2CN5 (228); SLK, 2J51 (230); PAK1, 3Q4Z (226). 
Note PAK1 contains inactivating mutations K229R and D389N. 
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electron density map. This model predicts that AMP-PNP was hydrolyzed within the crystal and 
the terminal phosphate remained proximally bound to the protein. Commercial preparations of 
AMP-PNP have been shown to be contaminated with decomposition products of AMP-PNP 
(235). Thus, an alternative possibility is that contaminating ADP from the commercially supplied 
AMP-PNP preferentially bound to the protein during crystallization. In this scenario, the proximal 
phosphate is instead a sulfate obtained from the crystallization solution. The atomic scattering 
factors are similar for phosphorous and sulfur (atomic numbers: Z = 15 and 16, respectively) so 
that the electron density map alone is insufficient to discern the chemical identity. The analysis 
proceeds assuming the ligand assignments are correct however methods which probe the 
chemical identity of the molecules contained within the crystal are required.  
Figure 5.10 shows the interactions stabilizing the ligands within the active site. Protomer 
B is shown with the exchanged portion of protomer A entering on the right. Note that each 
protomer within the crystal contains the same bound ligands and, with exception to the glycine 
rich G-loop, adopt similar residue conformations. AMP-PN binds in a hydrophobic pocket in the 
back of the hinge region between the N- and C-lobes. The pocket is formed primarily by I273, 
V281, V294, F368, and F421. Of particular note is F421 which emanates from β7 within the C-
lobe to stabilize the adenosine ring by pi stacking interactions. Together with V281, V294, and 
residues within the C-lobe, F421 forms a hydrophobic spine (C-spine) which regulates 
conformational dynamics. The adenosine ring completes the spine linking protein dynamics and 
ATP binding (204). The phenyl ring which forms the foundation for ATP binding is unique to 
PKR as kinases typically contain a leucine in place of F421 (236). At the back of the binding 
pocket, main chain atoms from E367 and C369 within the hinge region make hydrogen bond 
interactions with exocyclic and cyclic nitrogens, respectively, of the pyrimidine ring. Interactions 
are described moving towards the terminal phosphate. The only interaction stabilizing the ribose 
sugar is a hydrogen bond between the 2′-OH and the backbone carbonyl from S418. The α-
phosphate and the bridging α,β-phosphate oxygen are stabilized by the catalytically important 
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K296. Mutation of this residue, even to arginine, disrupts catalysis in most kinases (31). The β-
phosphate is stabilized via the G-loop by G279. The G-loop is a dynamic element within kinases 
and functions during the catalytic cycle by opening and closing to bind and release ATP and 
ADP. Structures of eukaryotic Ser/Thr kinases co-crystallized with transition state analogs are 
limited but demonstrate how the G-loop closes during catalysis to stabilize the phosphates for 
phosphoryl transfer (222-224). The β-phosphate is also stabilized by D432. In our structure, only 
a single magnesium ion is bound at the MgII binding site and magnesium site occupancy is 
discussed further below. A view of magnesium bound at the MgI site is provided in Figure 5.4 
for the 2A19 structure. Magnesium ions bind on opposite faces of the ATP phosphates. MgI is 
coordinated by D432 and the β- and γ-phosphates. In our structure, MgII is bound by N419, 
D432, the hydrolyzed phosphate, and the α- and β-phosphates. When present, MgII also 
coordinates with the terminal phosphate to position it for in-line phosphoryl transfer. The free 
phosphate is bound proximal to AMP-PN and interacts with many of the same moieties that it 
would in its intact state including MgII and K416. Presumably, water served as a nucleophile to 
hydrolyze the terminal phosphate and, in the absence of a true substrate, the phosphate 
retained many of its interactions to remain bound. The phosphate is shifted away from the active 
site so that it gains an additional coordination from the side chain of S418. In some sense, the 
presence of the hydrolyzed phosphate recapitulates some of the observations from PKA. Co-
crystallization with ATP, Mg2+, and a dummy substrate peptide whose phosphoacceptor serine 
had been mutated to alanine yielded a structure with partially hydrolyzed ATP. The hydrolyzed 
phosphate remained bound in a similar position as transition state analogs (237). Relative to the 
PKA structure, the phosphate in our structure is shifted ~5 Å away from the active site yet still 
interacts with many of the same moieties. Thus, the dummy substrate peptide retained the 
hydrolyzed phosphate within the active site. 
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Hydrolysis of AMP-PNP has previously been observed during co-crystallization as 
reported in several publications (238-243) and several unpublished structures deposited on the 
PDB (3IED, 4BWP, 4U7O, 5C3Y, 5H9B). Catalysis of the terminal phosphate within free 
solution has also been reported by many different types of enzymes including alkaline 
phosphatase (244, 245), ATPases (246, 247), a motor domain (248), a calcium pump (240), but 
only one kinase, PKA (249). Thus, hydrolysis of the γ-phosphate from AMP-PNP is a relatively 
common phenomenon. In some crystallographic studies, acidic crystallization solutions, where 
AMP-PNP is unstable, may induce hydrolysis (241-243). The pH of the solution used to grow 
our crystals was not acidic (pH = 7.5) and hydrolysis is likely the consequence of enzymatic 
action.  
 
Figure 5.11 View of bound ligands. (A) A view of the active site of protomer B is shown 
(magenta). The exchanged portion of protomer A is shown in cyan. AMP-PN and the phosphate 
are shown in ball and stick representation. Magnesium is shown as a grey sphere. Residues 
contributing to the hydrophobic pocket are shown as yellow sticks. Residues contributing 
electrostatic interactions are shown as grey sticks with oxygen and nitrogen colored red and 
blue, respectively. Hydrogen bonds are drawn liberally as black dashed lines with a 3.2 Å cutoff. 
(B) 2-dimensional view of ligand stabilizing interactions. Most of the residues shown in (A) are 
flattened into a 2-dimensional interaction map for added clarity. Hydrogen bonds are drawn as 
red dashes. A pi stacking interaction between F421 and the adenine ring is shown as two green 
circles connected by a dashed line. The hydrophobic surface created by V294 and V281 is 
shown as a curved green line.    
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In a structural analysis of PKA, the slow rate of AMP-PNP hydrolysis was exploited 
yielding valuable crystallographic snapshots of the phosphoryl transfer mechanism (249). 
Crystals were obtained in complex with AMP-PNP and a substrate peptide and two sets of 
diffraction data were obtained ~3 and ~5 months after crystal appearance. In the first data set, 
the γ-phosphate is partially transferred to the substrate serine and has been fully transferred 
after ~5 months. While neither structure represents a transition state per se (only starting end 
points of phosphoryl transfer) the structures provide insight into the phosphoryl transfer 
mechanism, primarily with respect to the role of magnesium ions. Most kinases utilize two 
magnesium ions to catalyze phosphoryl transfer which were historically assigned as the 
activating (Mg1) and inhibitory (Mg2) ions. This terminology is misleading and arises from the 
observation that high concentrations of magnesium decrease catalytic activity. In fact, ADP 
release from the active site, rather than phosphoryl transfer, is the rate-limiting step and is 
modulated by magnesium concentration (250). In the 2A19 structure, which is also bound by 
intact AMP-PNP, the magnesium ions bind the canonical positions and are labeled as MgI and 
MgII in Figure 5.4. In our structure, only MgII is present but it occupies the same position as 
MgII from 2A19. This corroborates the observations from the PKA structures where release of 
MgI occurred coincident with phosphoryl transfer (249). It is also in agreement with structural 
studies on CDK2 which suggest that ADP is released from the active site in complex with MgII 
as the rate limiting step during catalysis (251).  
5.12 Future directions 
The crystal structures reported here suggest that PKR forms a trans-
autophosphorylation complex during activation. The experiments proposed in this section will 
probe whether the complex forms in solution and its role during activation. Additional 
crystallographic approaches and their rationale are also described. For additional clarity, the 
various experiments are organized in Table 5.4.  
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Table 5.4 Future directions.  
Approach Remarks 
cis vs. trans  
His-tag catalytically inactive PKR (K296R / D414N) and 
examine whether it is phosphorylated by WT PKR. Does 
any phosphorylation occur (32P)? Is the activation loop 
phosphorylated (anti-TPO446 Western)?   
S462A Destabilize domain swap configuration. 
G466L Impede domain swap by reducing flexibility. 
N441G These substitutions promote domain swap. N441 and 
D464 H-bond to anchor the N- and C-terminal portions of 
the activation segment together. D464G 
R445G 
Similar to N441:D464, R445 anchors N- and C-terminal 
portions of the activation segment by H-bond interactions 
to backbone carbonyls.   
Y454  pAzF / pBpa Directly probe domain swap by crosslinking. 
T496A / Q463A / S461A Mutations designed to disrupt the front-to-front interface 
without exchange (IF3). May be combined or made 
individually.   D500A / K521A 
Optimization of other 
crystallization solutions 
0.1 M HEPES (pH 7.0), 5 % v/v Tacsimate, 10 % w/v 
PEG-MME 5,000 must be optimized. 
Co-crystallization with drug 
candidates Structural mechanism of activation by small molecules. 
Co-crystallization with ssRNA May induce folding within basic domain. 
Co-crystallization with heparin Confirm heparin binding site (91). May also stabilize basic domain.  
Co-crystallization with substrate 
peptide 
Structural information is lacking for how substrate binds in 
the active site of PKR. 
Co-crystallization with transition 
state analogs 
Limited structural information on mechanism of phosphoryl 
transfer. Could stabilize exchanged complex.   
Crystallization of I288D The homologous mutation in PknB generated a monomeric structure (225). 
Crystallization of phospho-PKR 
Crystal structure of active PKR is phosphorylated on 
threonine 446 (29). Yet other phosphorylation sites are 
present within the kinase domain (182, 252). How do these 
alternative sites regulate catalytic activity? 
Crystallization of full-length PKR 
alone and with dsRNA 
Currently only structures of individual domains are 
available. Some evidence suggests the dsRBD engages 
the kinase in an auto-inhibitory interaction (54). Other 
studies indicate PKR exists in a more open conformation 
(38, 60). This discrepancy may be resolved by a full length 
structure. A complex containing dsRNA would be 
invaluable to understanding activation.   
132 
 
A reexamination of PKR activation by assays which discriminate between cis versus 
trans-autophosphorylation mechanisms is required. Both cis (34) and trans (35-38) mechanisms 
have been reported. These assays are interpreted by the ability of wild-type PKR to 
phosphorylate PKR molecules containing inactivating mutations. The two species are separated 
by a tag(s) inserted onto PKR. A His-tag is sufficient to generate separation from wild-type PKR 
on an SDS-PAGE gel (36). These experiments will be repeated in our laboratory. Activation will 
be probed by both 32P incorporation and Western blots using antibodies specific for 
phosphorylated T446 and T451. Additionally, this assay will be combined with the mutations 
discussed below in various configurations to provide further insight into the requirements for 
autophosphorylation. Note, however, that activation of PKR molecules in solution can be 
conceptualized as a multi-step, self-perpetuating activation cascade (61). The slower initial 
steps which activate latent kinase molecules may differ from the more efficient subsequent 
reactions in which activated PKR molecules phosphorylate latent PKR. A model which 
incorporates both cis and trans mechanisms at different steps of the activation pathway may be 
required to reconcile with the functional data.  
The hypothesis that the exchanged activation segment complex represents a trans-
autophosphorylation complex predicts that disruption of interfacial residues will reduce catalytic 
efficiency. However, the mechanism of domain exchange presents a challenging obstacle in 
designing mutations to specifically destabilize the strand-exchanged dimer. Inherent to the 
domain swapped configuration is restoration of the interactions that would stabilize the domain 
within its folded monomeric form within the reciprocal protomer in the dimer. Mutation to 
interfacial residues will invariably have an effect on the monomeric conformation, complicating 
interpretation of functional analysis. Candidate residues for mutational analysis are limited. 
Indeed, the only residue whose interactions are unique to the dimer configuration is S462 which 
will be mutated to alanine. Mutagenesis of interfacial residues is a classical approach to 
confirming the significance of complexes trapped within crystals. To circumvent the issues 
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previously addressed, investigators of domain swapping interactions typically employ an 
additional approach that probes the hinge region by mutagenesis (227). In PKR, a flexible 
glycine, G466 (see Fig. 5.4A), presumably functions as the hinge to facilitate exchange. 
Conceptually, proline is the residue of choice to reduce flexibility. However, proline residues 
actually often function as the hinge and facilitate domain swapping by adopting a more 
favorable conformation in the exchanged configuration (227). Therefore, bulkier residues will be 
introduced to impede exchange. A similar approach was used to confirm activation segment 
exchange in SPAK kinase (232). Conversely, mutations will be introduced designed to promote 
domain swapping by disrupting interactions which anchor the N- and C-terminal portions of the 
activation segment together (N441, R445, and D464, Table 5.4). Mutants containing S462A, 
G466L, N441G, D464G, or R445G will test the trans-autophosphorylation complex by functional 
analyses for PKR activity. S462A and G466L are expected to decrease activity while stimulatory 
effects are anticipated from N441G, R445G, and D464G.   
The front-to-front interface without activation segment exchange (IF3) will be probed by 
the classical mutagenesis approach. Refer to Figure 5.7 for an image of the interface and Table 
5.4 of a list of target residues. The electrostatic interactions which stabilize the interface are 
limited and only include a hydrogen bond triad between T496, Q463, and S461 and a salt bridge 
between D500 and K521. Similar to other mutations, the effects of mutagenesis will be 
screened by functional assays for PKR activity. The functional relevance of the back-to-back 
interface is already well established (39). It may be helpful to include mutations which 
selectively disrupt the back-to-back interface in the cis- vs. trans-autophosphorylation assays to 
provide information on the PKR assembly process. Screening mutational effects by 
quantification of oligomeric equilibrium constants is an appealing approach but may not be 
applicable to this system. The presence of multiple interfaces and weak oligomerization in 
solution complicates the analysis. We have previously measured PKR dimerization by 
134 
 
sedimentation equilibrium analytical ultracentrifugation to obtain a dissociation constant of ~500 
µM (35, 91). 
Analysis of the oligomeric configuration of PKR molecules within solution will also be 
probed by crosslinking. Classic methodologies combining bifunctional crosslinking agents with 
analysis by mass spectrometry are considered. A more elegant approach is afforded by 
unnatural amino acid mutagenesis of a tyrosine residue, Y454, which interacts with the 
reciprocal protomer at the tip of the αEF arm. Y454 is positioned similarly in the monomer and 
the domain swapped configurations and is within hydrogen bonding distance to E480 (see Fig. 
5.8E). A method to introduce unnatural amino acids with unique chemistries into proteins is well 
established (253) and has been utilized by our laboratory to site-specifically label PKR with 
fluorescent probes (65). The system adds an amino acid to the genetic code by co-expression 
of an aminoacyl-tRNA synthetase/suppressor tRNA pair which reassign the amber stop codon 
(TAG) to encode for the amino acid. Y454 will be replaced with a photoreactive crosslinker, 
either p-azido-L-phenylalanine (pAzF) or p-benzoyl-L-phenylalanine (pBpa). Exposure to UV 
light activates the amino acids for crosslinking and complexes can be analyzed by SDS-PAGE. 
Bands corresponding to dimer confirm activation segment exchange and will be further 
validated by mass spectrometry. pAzF is the desirable substitution, generating minimal 
structural perturbations by replacing the tyrosine hydroxyl with the reactive azide. However, the 
bulkier pBpa has a longer lived excited state and different reaction chemistry (254) and may 
produce a crosslinked complex where pAzF fails. The probes will be introduced at other sites 
within the protein to probe the back-to-back and front-to-front interfaces and as negative 
controls. Note that pBpa has already been introduced at sites to probe the back-to-back 
interface. Higher-order oligomers appear on an SDS-PAGE gel and are dependent on pBpa and 
UV light confirming the efficacy of this approach (D. Mouser, S. Hesler, and J. Cole, 
unpublished results).     
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The proposed mechanism for PKR activation is phosphorylation of two threonines within 
its activation loop, T446 and T451 (255). T446 is unresolved in our structure but T451 is located 
at the tip of the exchanged portion of the αEF helix as the final residue resolved in this region. 
The hydroxyl is 8.6 Å from the catalytic aspartate in the reciprocal protomer and structural 
rearrangements may mediate formation of a complex to phosphorylate T451 in trans. Similar 
rearrangements may orient T446 for phosphorylation yet this is even more speculative given 
that it is absent from our structure. Phosphorylation of the residue corresponding to T446 is 
conserved in most ‘RD’ kinases and the structural relevance is well established (256). However, 
homology does not provide a function for T451 phosphorylation since this residue is not typically 
phosphorylated in other kinases. Most Ser/Thr kinases contain a threonine or serine at this 
position yet its function is seldom annotated (32). Although, a catalytically function for this 
residue has been proposed from structural analyses on PKA (237). Substrate peptide induces a 
reorientation of the residue so that it engages in a trigonal bonding interaction with the catalytic 
aspartate (D414 in PKR) and neighboring lysine (K416 in PKR). The interaction is proposed to 
orient the catalytic aspartate carboxylate for proton abstraction. It is unclear whether 
phosphorylation of T451 is compatible with this catalytic mechanism. Note, however, that while 
phosphorylation of T451 is often referenced in the literature, evidence for this modification is not 
convincing. The prescribed function of T451 as a phosphoacceptor site is deduced from the 
correlations between T451A mutations and phosphomimetic mutations, enzymatic activity, and 
Western blots with antibodies against phosphorylated T451. However, a catalytic role for T451 
would be perturbed by mutation and antibodies may not be specific for T451. Mass 
spectrometry has failed to detect phosphorylation of T451 even though T446 is phosphorylated 
in the analysis (48, 182). Furthermore, in the structure of the phosphorylated PKR kinase, only 
T446 is phosphorylated (29). A reexamination of T451 phosphorylation is necessary prior to its 
assignment as a phosphoacceptor site in our putative trans-autophosphorylation complex.  
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Finally, additional crystallographic approaches will be pursued. Additional 
crystallographic conditions, such as crystallization by Tacsimate / PEG-MME 5,000 (see Fig. 
5.2), require optimization. Another structure exhibiting domain swapping in a front to front 
arrangement generated from an additional crystallographic condition and possibly space group 
would provide further validity to the structures reported here. The ability to make diffraction 
quality crystals brings a valuable technology to the laboratory which synergizes with many other 
projects. An ongoing project to identify small molecule activators of PKR (S. Hesler and J. Cole, 
unpublished results) would benefit greatly from a facile method to analyze the structural function 
of any hits. We have previously characterized heparin mediated activation of PKR and used 
mutagenesis to identify a positively charged pocket partially formed by helix αC as the heparin 
binding site (91). Although, alternative sites have been proposed (179). A structure of PKR 
bound to heparin would resolve the discrepancy and provide valuable mechanistic insight into 
how heparin induces activation. The original motivation behind crystallographic analysis of the 
229-kinase construct was to obtain structural information on the basic region. Unfortunately, 
residues 229-256 are unresolved in our structure. The basic region exhibits cursory 
resemblance to arginine rich motifs (ARMs), short stretches enriched in basic residues which 
bind RNA (257). One of the most well characterized ARMs is HIV-1 Rev which has been shown 
to fold into an alpha helix upon binding its target RNA, RRE (258, 259). Thus, a ligand may be 
required to induce folding within the basic region and co-crystallization trials with short ssRNAs 
are currently underway. Under the assumption that our structure represents an enzyme-
substrate complex, the front-to-front interfaces recapitulate some of the observations from the 
PKR-eIF2α complex. In both structures, the substrate for phosphorylation (T446 in PKR and 
S51 in eIF2α) and neighboring residues are disordered. A structure containing substrate peptide 
bound at the active site is unavailable, necessitating assumptions for how substrate may 
interact from homologous kinases where such information is available. Such a complex may 
also provide information on the role of T451 during activation. Structural information on the 
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Ser/Thr kinase transition state gleaned from co-crystallization with transition state analogs is 
limited (222, 223, 260). Dissociative (SN1) and associative (SN2) mechanisms for phosphoryl 
transfer have been proposed which differ primarily in the relative distances and bonding 
interactions between the β-phosphate, γ-phosphate, and substrate hydroxyl during the transition 
state (250). Molecular dynamics simulations indicate a dissociative mechanism is more likely 
(50). A structure of PKR containing a transition state analog would provide much needed 
information on the nature of phosphoryl transfer but also may stabilize activation loops in the 
front-to-front interface in active sites of reciprocal protomers. Finally, a structure of monomeric 
PKR would provide valuable structural information on the conformation changes associated with 
the assembly of PKR molecules into the activating complex. Structural investigations of the Pkn 
family of kinases, which are structural homologous to PKR and form similar interfaces, are a 
useful guide (261). A monomeric structure of PknB was produced by mutating residues 
contributing to the back-to-back interface. One residue is conserved in PKR, I288, which packs 
into a hydrophobic pocket on the back of the αC helix (Fig. 5.6).   
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Chapter 6: Host and viral protein regulators of PKR 
6.1 Introduction 
The canonical PKR activators are long stretches of duplex RNA. However a protein 
activator, PACT, has been identified more recently (92). PACT activates PKR in response to a 
variety of cellular stressors to induce apoptosis in the absence of viral infection (96). Similar 
observations have been reported for the mouse ortholog, RAX (262). PACT contains two N-
terminal dsRBDs homologous to PKR (dsRBD1 and 2) and a dsRBD at the C-terminus that 
lacks residues that mediate RNA binding (D3). The model describing PACT-mediated PKR 
activation hinges upon the proposed autoinhibitory intramolecular interaction within PKR 
between dsRBD2 and the kinase domain (see Section 1.4) as well as the proposed role of the 
dsRBDs in mediating protein-protein interactions (54, 55). PKR is stimulated in a concerted 
mechanism whereby dsRBD1 and 2 from PACT relieve autoinhibition by engaging dsRBD1 and 
2 in PKR and D3 interacts with the kinase domain to promote activation (94, 95). A MBP-D3 
fusion construct binds PKR weakly yet is able to potently activate PKR in vitro. However, full 
length PACT is required for PKR activation in vivo (95). Phosphorylation of two sites within D3, 
S246 and S287, increases PKR affinity and activation potency (97, 263). S246 appears to be 
constitutively phosphorylated and S287 phosphorylation transduces the stress response signal. 
The upstream activating kinase is unknown (97). Phosphomimetic (SD) mutations functionally 
substitute for phosphorylation (97, 263). Deletion mapping and alanine scanning experiments 
have identified a region within the N-lobe of the PKR kinase domain corresponding to residues 
328-335 which interacts with D3 (98). In NMR experiments, addition of D3 to a labeled peptide 
consisting of residues 326-337 from PKR produced chemical shifts, indicating binding. The 
same effect occurred upon addition of PKR-dsRBD2, supporting the hypothesis that D3 and 
dsRBD2 interact with the same site on the kinase domain (98). Note, however, that an 
alternative site within the C-lobe has been proposed to maintain the dsRBD2-kinase 
autoinhibitory interaction (55).     
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The solution structure of the first dsRBD from PACT has been solved (PDB ID 2DIX; 
RIKEN Structural Genomics Initiative) (Fig. 6.1D). PACT is the human homologue to Xlrbpa and 
the two proteins share ~67% sequence identity within dsRBD2 (Fig. 6.1C). The crystal structure 
of Xlrbpa dsRBD2 in complex with dsRNA is presented in Fig 1.2B. D3 belongs to a class of 
motifs categorized as type-B dsRBDs which resemble the canonical dsRBD in sequence yet 
lack the residues necessary for dsRNA binding (Fig. 6.1B) (93, 164). To date, the structure of 
only a single type-B dsRBD has been solved, dsRBD5 from STAU1 (STAU1-5) (264). The 
structure reveals how the domain has retained a group of conserved residues which engage in 
hydrophobic packing interactions in the region between α1 and α2 to stabilize the dsRBD αβββα 
fold. A sequence alignment between ‘true’ (type-A) and ‘false’ (type-B) dsRBDs which is 
relevant to this study is shown in Fig. 6.1B. Domain 3 from PACT and TRBP both contain the 
appropriate conserved hydrophobic residues which stabilize the dsRBD fold.  Thus, it is likely 
that, like STAU1-5, they form the canonical αβββα structure. Based on the sequence alignment 
(Fig. 6.1B) the expected positions for the phosphorylated residues within PACT-D3 are 
indicated on the structure of PACT-dsRBD1 shown in Figure 6.1D. S246 is expected to replace 
a RNA-binding residue in region 1 within helix α1. S287 resides in the β2-β3 loop expected to 
be bigger in both PACT-D3 and TRBP.         
PKR activation is intricately controlled in vivo by PACT and its functional antipode TRBP 
(Tar RNA Binding Protein). TRBP is homologous to PACT in sequence and domain 
organization, with tandem dsRBDs at the N-terminus and a type-B dsRBD at the C-terminus 
(265). TRBP was originally identified as an endogenous component which enhances HIV 
replication (266). This activity has been attributed to sequestration of dsRNA by the dsRBDs 
(267). However, subsequent analyses have indicated that TRBP directly interacts with PKR to 
inhibit it (268). The proposed interaction mechanism is similar to PACT where the N-terminal 
dsRBDs interact with the dsRBDs of PKR. In TRBP, the third domain elicits an inhibitory effect 
(269). As shown in Figure 6.1A and C the third domains of TRBP and PACT are highly 
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homologous. Thus, the residues which confer the stimulatory phenotype to PACT must be 
highly specific. PACT and TRBP both homodimerize and can interact with one another allowing 
for precise control of PKR activity within the cell (265, 270). The PACT-TRBP interaction 
prevents the stimulatory interaction between PACT and PKR. Phosphorylation of S287 within 
PACT in response to stress inhibits the TRBP interaction to promote PKR activation (271, 272). 
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Figure 6.1 Structure of PACT. (A) Domain organization. (B) Structure based sequence 
alignment of dsRBDs. The protein name is indicated and the number after the hyphen 
corresponds to the respective dsRBD within each protein. Values in parenthesis represent the 
amino acids shown in the alignment. A combination of resources was used to generate a 
sequence alignment. The consensus residues which contribute to RNA binding (cyan) and the 
dsRBD fold (green) are adapted from (13). Sequences were first aligned in Clustal Omega 
(180). An additional alignment was performed in Pymol for the sequences with associated 
structures. The alignment was further manipulated by hand guided by the interpretations of 
Gleghorn et. al. (93). The phosphorylated residues within domain 3 of PACT are indicated in 
magenta. (C) Pairwise amino acid percent identity matrix for alignment shown in (B). Prepared 
by Clustal Omega (180). (D) Structure of PACT dsRBD1 (PDB ID 2DIX). Amino acids are color 
coded according to the alignment shown in (B). Cα atoms are shown as spheres. The alignment 
suggests PACT-D3 adopts a similar fold. Hypothetical locations for the two phosphorylation 
sites in D3 (S246 and S287) are shown in magenta.  
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Viruses whose propagation is inhibited by PKR often develop methods to inhibit PKR 
activation. Examples include RNAs that irreversibly bind PKR, proteins which inhibit PKR 
dimerization, and proteins that act as decoy phosphorylation substrates (9). Influenza encodes a 
26 kDa protein, NS1, which is not part of the virion but is expressed during infection. NS1 is a 
multifunctional protein which interacts with a variety of host components to promote viral 
replication (99). The primary role of NS1 appears to be inhibition of the cellular 3′-end 
processing system which results in retention of host mRNAs in the nucleus (273). By 
sequestering host mRNA in the nucleus, NS1 increases the amount of viral RNA translated. 
NS1 has also been associated with inhibition of PKR. Influenza mutants lacking NS1 are 
attenuated in mice yet replication is rescued in mice containing PKR knockouts (274). The 
mechanism of PKR inhibition remains controversial. Some studies indicate that NS1 binds and 
sequesters viral dsRNA from PKR (275, 276) while others show NS1 binds directly to PKR to 
inhibit activation (100-102). NS1 inhibits PKR activation by both dsRNA and PACT (100, 101). 
The PKR interaction site has been mapped to residues 123-127 in NS1 (100). The NS1 
interaction site on PKR is mapped to the linker region and a mechanism of inhibition has been 
proposed where NS1 locks PKR in an auto-inhibited state (101).  
NS1 contains a unique N-terminal RNA binding domain and a C-terminal effector domain 
(ED) separated by a short ~15 residue linker (Fig. 6.2A) (277). A disordered C-terminal tail has 
a strain-specific length up to 33 amino acids and interacts with host components, although its 
contribution to virulence is unclear (278). The RNA-binding domain dimerizes to form a six-
helical bundle (279, 280). The structure of the RNA-binding domain in complex with dsRNA 
reveals how two long helices lay along the duplex making contacts with the RNA backbone (Fig. 
6.2B) (281). The first crystallographic studies of the isolated effector domain (ED) reported 
multiple dimeric interfaces (282-284). Biochemical and biophysical analysis of isolated effector 
domain constructs support the helix-helix interface shown in Figure 6.3C in which a highly 
conserved tryptophan (W187) packs into a hydrophobic pocket on the reciprocal protomer (283, 
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285, 286). The isolated ED dimerizes weakly in solution (286) yet several studies indicate that 
this activity contributes to cooperative assembly of NS1 molecules onto dsRNA. Cryo-EM 
studies have detected tubular filamentous assemblies of NS1 molecules onto long duplex RNAs 
(287). Mutation of the invariant interfacial tryptophan decreases RNA binding affinity (285). 
Virulence is severely attenuated in influenza viruses expressing a truncated NS1 lacking the ED 
yet can be partially rescued by attachment of heterologous dimerization domains (288). The 
structures of full length NS1 (287, 289) have led to a mechanistic model which reconciles much 
of the crystallographic and functional data. The model proposes that the relative orientations of 
the RNA binding domain and the effector domain change to promote different oligomeric 
configurations of the effector domain. These changes facilitate the myriad of binding interactions 
and functions attributed to NS1 (289). The proposed assembly of NS1 molecules on a dsRNA is 
shown in Figure 6.2D.  
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Figure 6.2 NS1 domain organization and structure. (A) NS1 domain organization. The 
positions of residues implicated in PKR interaction (IMDKN) are indicated in purple. The 
conserved tryptophan (W187) which mediates dimerization is also shown in yellow. Color 
coding is maintained throughout the figure. (B) Dimer of the RNA-binding domain in complex 
with dsRNA. Residues which contribute to the interaction are shown as sticks. For clarity 
nucleotide bases are omitted. (PDB: 2ZKO, (281)). (C) Dimeric structure of the effector domain 
(PDB: 3D6R, (283)). PKR-binding residues and W187 are shown is sticks. Note that in this 
strain of influenza contains a N127R mutation in the PKR binding site. (D) Proposed assembly 
of NS1 molecules onto dsRNA. Full length NS1 containing a truncation to the linker region (∆80-
84) crystallizes as a dimer (PDB: 4OPA, (289). Effector domains dimerize via the interface 
shown in (C) across a 2-fold crystallographic symmetry axis. Three asymmetric units are shown 
in (D). PKR-binding residues and W187 are shown as spheres. Importantly note that duplex 
RNA has been manually added. This model is adapted from references: (285, 289).    
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The purpose of this study is to examine the mechanisms by which protein regulators 
modulate PKR activity. NS1 and PACT elicit opposite effects yet both are proposed to operate 
by controlling the same conformational switch in PKR. PACT interacts with a region in the 
kinase domain to break an intramolecular autoinhibitory interaction between PKR-dsRBD2 and 
the kinase domain (98). NS1 interacts with the linker region (residues 170-230) to lock PKR into 
the autoinhibited conformation (100, 101). However both these mechanisms are incompatible 
with evidence which indicates PKR does not adopt the autoinhibited conformation in the latent 
state (reviewed in Section 1.4). Heparin and dsRNA both activate PKR by facilitating kinase 
domain dimerization (63, 91). Thus it seems likely that PACT activates PKR by promoting 
oligomerization or by inducing a similar allosteric effect within the activate site as mediated by 
the back-to-back PKR dimer interface. The interactions of PACT and NS1 with PKR have been 
assayed primarily by the use of two-hybrid assays and co-immunoprecipitation assays often in 
crude or partially purified lysates (92, 95, 96, 100, 101). These assays cannot distinguish the 
stoichiometry of the interacting complexes or whether additional components are involved. Here 
we apply sedimentation velocity analytical ultracentrifugation using purified protein preparations 
to probe these interactions.         
Results 
6.2 Characterization of NS1 and PKR interaction 
 We have expressed the effector domain of NS1 encoding residues 74-230 from H1N1 
influenza A/Puerto Rico/8/1934 (NS1-ED) containing a N-terminal his-tag. As an initial step 
toward analyzing the interaction with PKR we characterized the association state of NS1-ED by 
sedimentation velocity in AU200 buffer. In agreement with earlier reports (285, 286) the effector 
domain dimerizes in solution (Fig. 6.3A). The time difference curves were fit to a monomer-
dimer equilibrium model in SEDANAL (118). The Kd obtained from the fit was 7.1 µM (4.47, 
9.73) with a monomer s value of 1.80 S (1.78, 1.82) and dimer s value of 2.50 S (2.50, 2.51) 
and rmsd of 0.0347. A similar sedimentation velocity protocol was employed to investigate the 
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interaction of NS1-ED with PKR. NS1-ED was titrated against PKR up to a 2:1 molar 
equivalence ratio. Our analysis does not detect the interaction with PKR which has been 
reported in the literature (100, 101). The NS1-ED monomer-dimer equilibrium causes 
concentration dependent formation of a complex at 2.50 S. However, a species does not form at 
sedimentation coefficient values above ~3.4 S where PKR freely sediments.   
 
6.3 Characterization of PACT 
In agreement with earlier reports (92, 94) full length PACT resides in the insoluble 
fraction when expressed in E. coli. Attempts to optimize expression and cell lysis protocols 
failed to yield soluble protein. A His-tagged version of PACT was solubilized with 4 M urea and 
refolded while bound to Ni2+-NTA resin by running a decreasing gradient of urea. The His-tag 
was cleaved prior to most of the assays reported here. The initial set of experiments were 
designed to examine the refolded protein (Fig. 6.4). The protein readily aggregates at 20 °C so 
most experiments are performed at 4 °C. The circular dichroism spectra indicates the presence 
of secondary structure with minima at 208 and 222 nm characteristic alpha helical content (290) 
 
Figure 6.3 Characterization of NS1 and PKR. (A) Dimerization of the NS1 effector domain. 
Sedimentation velocity was used to monitor the concentration dependence of NS1-ED 
oligomerization. Measurements were obtained in AU200 buffer at 20 °C and 55,000 rpm using 
interference optics. The data are represented as c(s) distributions which are normalized by area. 
Parameters obtained from fitting the data to a monomer-dimer equilibrium model are reported in 
the text. (B) Analysis of NS1-ED:PKR interaction. Sedimentation was monitored at 50,000 rpm 
in AU200 buffer at 20 °C and 55,000 rpm using interference optics. Samples were prepared at a 
fixed concentration of PKR with addition of NS1-ED. Sedimenting species are labeled. The trace 
for PKR alone is drawn thinner to show the distributions underneath.  
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(Fig. 6.4A). PACT sediments as a strongly associated dimer with a corrected sedimentation 
coefficient (s20,w) of 3.8 S (Fig. 6.4B). Misfolded protein are expected to aggregate. 
Sedimentation velocity was used analyze the interaction of a 20 bp dsRNA with PACT at 4 °C in 
200 mM NaCl (Fig. 6.4C). The distributions shift to a sedimentation coefficient of ~6 S as PACT 
is added indicative of complex formation. The data fit well to a model where the PACT 
homodimer interacts with the RNA to form a 2:1 complex with a Kd = 94 nM and RMSD = 
0.00816 OD. For comparison, full length PKR binds to the same 20 bp dsRNA with an affinity of 
300 nM in 200 mM NaCl at 20 °C (62). This result demonstrates that PACT is competent to bind 
dsRNA with high affinity and indicate that the refolding protocol was successful. Finally, 
resistance to proteolytic digestion by trypsin indicates regions that are protected (Fig. 6.4D). In 
the protease titration PACT remains largely intact until addition of a 1:2,500 ratio of 
trypsin/PACT. In contrast, a 1:20,000 ratio induces substantial cleavage of PKR within the 
unstructured linker region (59). The ~17 kDa intermediate band that forms from proteolysis of 
PACT presumably corresponds to either of the dsRBDs or D3 which are all approximately equal 
in size and expected to have molecular weights of ~15 kDa. Taken together, these analyses 
indicate PACT is refolded and suitable for further characterization.    
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6.4 Interaction studies with PKR 
Sedimentation velocity was used to investigate the interaction between PACT and PKR 
at 4 °C in 200 mM NaCl (Fig. 6.5A). Under these conditions, PKR exists as a monomer with s20,w 
= 3.5 S and PACT is a dimer with s20,w = 3.8 S. Mixtures were prepared at multiple PACT:PKR 
ratios. Formation of a complex would result in the appearance of higher s species. However, the 
 
Figure 6.4 Characterization of full length PACT. (A) Circular dichroism analysis of the 
refolded protein. (B) Sedimentation velocity analysis. Sedimentation was monitored at 50,000 
rpm by the interference optical system in AU200 buffer at 4 °C. c(s20,w) distributions normalized 
by amplitude are shown with the raw data in the inset. PACT sediments as a strongly 
associated dimer with s20,w = 3.8 S. The data were fit to a discrete species model yielding a 
molecular weight of 65.3 kDa (predicted monomer = 34.7 kDa). (C) Interaction with duplex 20 
bp RNA. g^(s20,w) distributions are normalized by area. Samples contained 1.5 µM 20 bp dsRNA 
and the indicated equivalence ratio of PACT. The data were fit a model where the PACT dimer 
binds the RNA to form a 2:1 complex. The fit produced a Kd = 94 nM (76, 114) with an RMSD of 
0.00816 OD. The fitted complex sedimentation coefficient was s20,w = 5.98 S (5.90, 6.05). (D) 
Limited proteolysis of PACT. Full length PACT(his) was incubated at 0.67 mg/ml with various 
ratios of PACT/trypsin for one hour at 4 °C. A 3 hour incubation yielded the same digestion 
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c(s20,w) distributions of the mixtures appear as sums of the individual components, indicating that 
PACT and PKR do not interact under these conditions. We introduced the phosphomimetic 
mutations within D3 purported to enhance PKR affinity (263). S246D/S287D PACT has a 
slightly higher sedimentation coefficient (s20,w = 3.9 S) than the wild-type protein indicating that it 
may adopt a more compact structure (Fig. 6.5B). Like wild-type PACT, the c(s20,w) distributions 
are the sum of individual components indicating that in our analysis the phosphomimetic 
mutations do not promote a PACT PKR interaction. Activation of PKR by PACT was assayed by 
monitoring the stimulation of 32P incorporation from [γ-32P]ATP into PKR (Fig. 6.5C). The data 
are quantitated in Figure 6.5D and normalized to the autophosphorylation of PKR in the 
absence of an external activator. Control samples demonstrate that a 40 bp dsRNA activates 
PKR. However, both wild-type and S246D/S287D PACT fail to activate PKR and actually inhibit 
the baseline activation. At elevated PACT concentrations an additional band appears lower on 
the gel which corresponds to phosphorylated PACT. Thus, PKR can phosphorylate PACT 
indicating the two proteins must at least transiently interact. PACT activation is allegedly RNA-
independent (92) yet RNA can contaminate purification of RNA-binding proteins (291). 
Additional samples were included in the S246D/S287D PACT experiment to ask whether PACT 
promotes dsRNA-induced activation of PKR. PACT inhibits activation by 40 bp dsRNA at higher 
concentration (1.8 µM), presumably due to competition for the RNA. At lower concentrations 
(0.2 µM) PACT facilitates a slight increase in ds40 induced activation. An assay to investigate 
this result has not been performed.    
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6.5 PACT domain 3 
Our functional analysis of refolded PACT confirmed the protein was competent to bind 
dsRNA indicating at least one of the dsRBDs was properly folded. However the only functional 
analysis for D3 is PKR activation and our results disagree with published observations (92). 
Previous studies have had success with purification of a recombinant isolated D3 construct from 
 
Figure 6.5 Full length PACT and PKR. (A) Sedimentation velocity analysis of WT PACT and 
PKR. c(s20,w) distributions are normalized by amplitude and offset. Sedimentation was monitored 
at 50,000 rpm by the interference optical system in AU200 buffer at 4 °C. Loading 
concentrations of PACT and PKR are indicated along the traces. A dashed vertical line indicates 
the sedimentation coefficient of PKR and a solid line is drawn for PACT. (B) Sedimentation 
velocity analysis of S246D/S287D PACT and PKR. Experimental conditions and data 
representation are as in (A). (C) Activation assays with PACT. 200 nM PKR was assayed for 
activation by both wild-type (top) and S246D/S287D PACT (bottom). The assay was performed 
in P50 buffer at 32 °C over a 20 min time course. A duplex RNA consisting of 40 bp served as a 
positive control. PKR phosphorylates PACT and the position of the two proteins are indicated on 
the gel. The symbols correspond to quantitated values shown in (D). (D) Quantitation of 
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the soluble fraction of E. coli lysates (94). We created domain constructs to match the previous 
report (94). A construct encoding dsRBD1 and 2 consists of residues 1-194. The isolated D3 
construct contains residues 195-313. The dsRBD1+2 construct is insoluble indicating this is the 
region responsible for insolubility of the full length protein. However the D3 construct is soluble 
and was purified to high yield. As a first step toward characterizing the interaction of D3 with 
PKR we measured the protein concentration dependence of self-association of the newly 
isolated construct. D3 was much more stable than the full length protein permitting experiments 
at 20 °C. Like the full length protein, D3 sediments as a strongly associated dimer with an s20,w = 
2.41 S (Fig. 6.6A). Others have found that domain 3 induces dimerization of full length PACT 
and its homologue Xlrbpa (292). In Xlrbpa, the region which mediates dimerization has been 
mapped to the last five residues at the C-terminus. 
Next, we performed binding assays with PKR. The analyses on full length PACT were 
performed at 4 °C in AU200 buffer (200 mM NaCl). We have probed for a D3-PKR interaction at 
20 °C in AU200, AU75 (75 mM NaCl), and P50 (50 mM KCl, 5 mM MgCl2) buffers and the 
sedimentation profiles are similar. The data generated in P50 buffer is presented in Figure 6.6B 
since P50 is the buffer used in activation assays. PACT-D3 and PKR have different 
sedimentation coefficients so the two species are resolved by c(s) analysis. Like full length 
PACT we do not detect a complex between D3 and PKR. However, domain 3 induces 
concentration-dependent activation of PKR (Fig. 6.6C). Activation is weak, with a maximum 
~1.8-fold over PKR background activity occurring at 6 µM D3, corresponding to a 30-fold molar 
excess over PKR. Similar to activation by RNA (63) and heparin (91), the activation curve is 
bell-shaped, implying that PACT induces dimerization similar to other activators. Activation 
implies, of course, that D3 and PKR interact. The complex may be transient or too weak to 
detect by sedimentation velocity. To trap the complex we employed chemical crosslinking with 
the homobifunctional amine-reactive crosslinker disuccinimidyl suberate (DSS) (Fig. 6.6D). 
Samples were prepared with a fixed concentration of PKR and titration of D3 up to a 10-fold 
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molar excess. Addition of DSS induces concentration-dependent formation of D3 dimer adducts 
but a PKR-D3 crosslink is not detected. Additional samples were included to ask whether ATP 
and magnesium facilitates complex formation. However no PACT-D3 crosslink was detected in 
these samples either. We have extended the titration to higher D3-PKR stoichiometries (up to 
700 µM D3) but still did not detect a complex (data not shown). At elevated concentrations of 
D3, crosslinking by DSS induces a laddering effect indicating D3 may form even higher 
oligomeric species than dimer.        
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Figure 6.6 PACT domain 3 and PKR. (A) Sedimentation velocity analysis of PACT D3 
construct. Sedimentation was monitored at 50,000 rpm by the interference optical system in 
AU200 buffer at 20 °C. Domain 3 sediments as a strongly associated dimer with s20,w = 2.41 S. 
The data were fit to a discrete species model to yield a molecular weight of 30,591 Da 
(expected monomeric weight = 15,173 Da). (B) Sedimentation velocity analysis of PACT-D3 
and PKR. The experiment was conducted in P50 buffer at 20 °C. Each distribution is normalized 
to peak amplitude and offset along the y-axis. Loading concentrations of PACT-D3 and PKR are 
indicated along each distribution. Vertical lines indicate the sedimentation coefficients for PACT-
D3 (solid line) and PKR (dashed line). (C) Activation assays with PACT-D3. 200 nM PKR was 
assayed for activation by the domain 3 construct in P50 buffer at 32 °C over a 20 min time 
course. The 40 bp dsRNA serves as a positive control. The phosphorimage is shown on the top. 
The data and quantitated in the plot below and normalized to the activation of PKR in the 
absence of activator. Activation by ds40 is indicated by a red square. (D) Chemical crosslinking. 
PKR was titrated with PACT-D3 in P50 buffer. DSS was added to 10-fold molar excess and the 
reaction was allowed to proceed for 30 min at RT. Samples were resolved on a 4-12% 
acrylamide tris-glycine gel run under denaturing conditions and visualized by Coomassie Blue 
staining. The final three lanes contain 400 µM ATP plus 5 mM MgCl2. The molecular weights of 
the protein ladder are indicated on the left (kDa) and the species within the gel are indicated on 
the right. Concentration dependent formation of a PACT-D3 dimer is detected however a PACT-
PKR adduct is not formed.        
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6.6 Discussion 
 This study reports the analysis of two RNA-binding proteins reported to interact with 
PKR and elicit opposite effects. However, our analyses do not detect complex formation with 
either protein. The commonality between all the proteins under investigation is their RNA-
binding activity and this behavior may rationalize the experimental differences. Co-
immunoprecipitation in cell extracts or two-hybrid experiments are the primary assays which 
have defined the interactions between PKR and NS1 (100-102) or PACT (92, 94-97). 
Convincing control experiments are sometimes included to rule out co-precipitation of proteins 
on a single RNA (92, 101). However, these controls are often not incorporated into the studies 
which have defined the protein-protein interaction sites. One study has demonstrated that the 
RNA-binding domains of NS1 are required for PKR interaction (102) and another showed that 
NS1 interacts with a region encompassing the dsRBDs and linker on PKR (101). The models for 
PACT and TRBP modulation of PKR activity postulate that high-affinity interactions between the 
dsRBDs anchor protein-protein interactions and the third domains of PACT or TRBP elicit 
opposite enzymatic effects (269). Mutations to RNA-binding residues within PKR’s dsRBDs 
(K60A, K64A, K150A, K154E, see Fig. 1.2) diminish interaction with both PACT or TRBP in a 
two-hybrid assay (269). Based on these effects the residues have been implicated in direct 
protein-protein interactions. However, it seems more likely that an interaction facilitated by 
dsRNA produced false positive results in the two-hybrid assays. PACT, TRBP, and NS1 belong 
to an expanding family of RNA-binding proteins reported to directly engage PKR. ADAR (293), 
NF90 (294), DUS2 (295), and the herpes simplex virus type 1 protein Us11 (296) have all been 
identified by pulldown assays and are implicated in PKR inhibition by direct protein-protein 
interactions.  
 Additional experimental differences may contribute to the divergent outcomes between 
our analysis of PACT- and NS1-PKR interactions and earlier reports. In previous PACT and 
NS1 studies, PKR is typically obtained from cellular extracts of human cell lines and partially 
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purified using an affinity tag. Cellular components which remain bound to PKR or post-
translational modifications which would not be present in our PKR preparations may contribute 
to the interaction between PACT or NS1. Both the NS1 and PACT protein constructs used in the 
studies are also different. We have used NS1 from the H1N1 influenza A/Puerto Rico/8/1934 
(PR8) virus whereas PKR-NS1 interactions have primarily been characterized in the context of 
NS1 from H3N2 A/Udorn/1972 (Udorn) (100, 101). PR8 contains the residues at positions 123-
127 which have been implicated in PKR interaction (100). However, Udorn NS1 has a 7 residue 
addition to the C-terminal tail and additional amino acid changes which may be important for 
binding PKR. We have obtained a plasmid encoding full length Udorn NS1 to test for strain 
specific PKR interactions.      
Our NS1 study supports the PKR inhibition model in which NS1 shields duplex RNA 
from PKR (275, 276). The alternative model suggests that residues 123-127 within NS1 directly 
engage the N-terminal region of PKR to lock PKR in an autoinhibited state (100, 101). Residues 
123-127 were identified by the effects of mutagenesis on co-immunoprecipitation in cell extracts 
(100). However, RNase was not added to the assay and residues 123-127 are located proximal 
to the effector domain dimeric interface (see Fig. 6.2C, D). The dimerization activity of the 
effector domain is critical for cooperative association of NS1 molecules onto duplex RNA (286, 
297). Thus, it is possible that mutagenesis of residues 123-127 affects RNA binding rather than 
PKR interaction. Filamentous assemblies of NS1 onto RNA has been observed by cryo-EM 
(287) and a model has been proposed in which NS1 encapsulates the RNA with effector 
domains forming an oligomeric chain along the outside of the complex (289) (Fig. 6.2D). NS1 
has been implicated in the inhibition of other antiviral proteins which respond to viral RNA 
including 2′-5′-oligo (A) synthetase (298) and RIG-I (299). The encapsulating assembly of NS1 
molecules around an RNA would provide a common mechanism to inhibit a variety of 
intracellular immune receptors.     
156 
 
Similar to our NS1 analysis, we do not detect formation of a PKR-PACT complex in 
sedimentation velocity experiments. Full length PACT does not activate in PKR 
autophosphorylation assays, however, the isolated D3 construct weakly activates. We are 
unable to characterize the activation mechanism since a complex is not formed in sedimentation 
velocity experiments or captured by chemical crosslinking. The absence of measurable complex 
formation may be explained by a weak, transient interaction between PKR and D3 below the 
detection limits of the optical system in the analytical ultracentrifuge. Phosphorylation enhances 
PKR dimerization affinity by ~ 500-fold and we have previously proposed a branched chain 
reaction model to explain how strong PKR activation can be induced by dimerization at 
concentrations well below the Kd for latent enzyme (61). By analogy, weak complex formation 
between the PACT-D3 and PKR may serve to initiate a cascade of PKR autophosphorylation 
resulting in activation. 
The experimental differences previously addressed in the context of NS1-PKR 
interaction studies extend to the PACT-PKR investigations. PKR prepared from cellular extracts 
of human cell lines may contain post-translational modifications or additional components which 
contribute to the interaction. In support of this, the results from one study indicates the PACT-
PKR interaction may be specific to certain cell lines (300). Others have found that PACT 
actually inhibits PKR activation in some cell types (271). Also analogous to the NS1 interaction 
study, the PACT constructs used here are different from those previously analyzed. The original 
PACT expression vector contained a frameshift mutation at the 3′-end which results in a 
construct encoding the wild-type sequence at residues 1-300 with five random amino acids at 
the C-terminal end (KLCSI) (92). The mutation is addressed in a subsequent study (95) 
although it was not corrected and it appears as though this mutated form of PACT is used in all 
subsequent analyses. Others have had difficulties recapitulating the stimulatory effect of PACT 
in vivo and have analyzed the mutant form of PACT (PACT∆13) to resolve the discrepancy 
(271). PACT∆13 activates PKR more potently than wild-type PACT in certain cell lines but both 
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forms of PACT have no effect in others. The C-terminal residues in the PACT homologue Xlrbpa 
mediate protein dimerization (292). We have expressed PACT∆13 and characterized its 
association state by sedimentation velocity. The experiment was performed under different 
conditions than wild-type PACT. However, PACT∆13 was monomeric up to the highest 
concentration assayed. It may be worthwhile to extend the analysis to further characterize 
PACT∆13 and the effect of PACT oligomerization on PKR activation. A PACT-TRBP interaction 
is proposed to inhibit the stimulatory interaction between PKR and PACT (271). Likewise, 
formation of the PACT dimer may prohibit PKR binding and activation by a similar mechanism.         
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Chapter 7: Conclusions 
The canonical activators of PKR are long stretches of duplex RNA regions (>30 bp) 
present in viral transcripts. However, an expanding family of RNAs characterized by limited 
regions of extended duplex has been described as PKR activators. These RNAs lack the 
minimal duplex length requirements for PKR activation and alternative structural elements are 
proposed to modulate PKR activity. Notably, single-stranded regions and a 5′-triphosphate (5′-
ppp) were reported to be important determinants for activation when attached to minimally 
structured regions. This class of minimally structured RNAs has been defined as ss-dsRNAs 
although the structural variability of RNAs within this category has become increasingly broad.  
We began our analysis of the ss-dsRNA motif by creating a 15 bp duplex stem capped 
by a tetraloop and flanked by 15 nt single-stranded tails. To gain insight into the contribution of 
the single-stranded regions to PKR activity we systematically dissected each tail in 5 nt 
increments and characterized the effects on binding affinity and activation. Activation 
distributions reveal a bell-shaped activation profile suggesting that, like duplex RNAs, ss-
dsRNAs mediate PKR dimerization to induce activation by formation of the RP2 complex. We 
have previously characterized the length dependence of perfect duplexes on binding affinity and 
activation. Activation by dsRNAs requires a 2:1 binding stoichiometry and activation potency 
increases with the population of the RP2 species. Under the conditions we analyzed the ss-
dsRNAs all bind two PKR, however, not all activate. Thus, ss-dsRNAs do not exhibit the same 
strict requirement for binding stoichiometry as perfect duplexes. Our measurements detect a 
weak correlation between tail length, binding affinity, and activation potency. Deletion of the tails 
drastically reduces binding affinity and abolishes activation. However, some constructs with 
intermediate tail lengths bind with only moderate affinity yet activate potently. Conversely, other 
constructs bind tightly but fail to activate. The composition of nucleotides within the tails is not 
identical and there may be nucleotide identity preferences for activation. Alternatively, the 
variability may reflect specific conformational requirements which determine how two PKR 
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molecules interact on the RNA. Our model for PKR activation by duplex regions postulates that 
dsRNA serves as a scaffold for the assembly of PKR monomers. Single-stranded regions may 
have a more activate role in coordinating the orientation of interacting PKR molecules. In this 
scenario longer tail lengths may not promote the appropriate assembly of PKR monomers 
bound to the RNA.  
More broadly, the results imply that single-stranded regions interact with PKR and can 
induce activation. The isolated dsRBD construct does not exhibit the same magnitude increase 
in affinity toward an ss-dsRNA containing tails as observed in full length PKR indicating single-
stranded region engage a region outside the dsRBD. Based on this analysis we extended our 
study to examine interactions between isolated ssRNAs and PKR domain constructs. We used 
analytical ultracentrifugation to determine the affinity of single-stranded RNA and other nucleic 
acids toward different regions of PKR and the contribution of the 5′-ppp to binding. Our analysis 
identifies a previously unrecognized RNA binding site N-terminal to the canonical kinase domain 
boundary (the basic region). The basic region and the dsRBD bind single-stranded nucleic acids 
with low micromolar affinities. Both regions also engage dsRNA although the affinity of the 
dsRBD for duplex region is ~100-fold tighter. We developed a crosslinking assay to gain insight 
into the how an RNA containing duplex and single-stranded regions engages these two distinct 
regions on PKR. PKR constructs containing a TEV protease cleavage site were crosslinked to 
32P-15-15-15 containing 4-thiouridine. The TEV cleavage distributions indicate that RNA 
contacts the basic region in the context of full length PKR. Isolated ssRNA weakly activates full 
length PKR and a kinase domain construct containing the basic region. The affinity and 
activation potency of isolated ssRNA is most likely insufficient to elicit an effect in vivo. 
However, anchoring interactions between the dsRBD and duplex regions may promote an 
interaction between auxiliary single-stranded RNA and the basic region by induced proximity 
effects (166). This type of bivalent complex may be responsible for PKR activation by ss-
dsRNAs. 
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Activation by ss-dsRNAs has been reported to be dependent on a 5′-ppp. However, our 
analysis of the ss-dsRNA motif does not recapitulate these observations. We show that RNAs 
produced by in vitro transcription reactions are efficiently dephosphorylated by enzymatic 
treatment yet PKR stimulation is not affected. The relative binding affinities support the activity 
measurements. In the context of 15-15-15 affinity is only moderately enhanced for the 5′-ppp 
form so that the populations of RP2 species formed by interaction with 5′-ppp and 5′-OH 15-15-
15 are similar. We extended our analysis of single-stranded RNA interactions to localize the 5′-
ppp recognition site using the PKR domain constructs. However, we find there is no specific 5′-
ppp binding site. Instead, affinity toward both the dsRBD and the basic region is enhanced by 
the presence of a 5′-ppp. The enhancement is moderate and similar in magnitude as observed 
in the context of full length PKR binding 15-15-15. The isolated helicase domain of RIG-I also 
binds 5′-ppp RNAs with slightly enhanced affinities and this activity has been attributed to a 
nonspecific electrostatic effect (197). However, RIG-I contains a C-terminal domain which 
imparts 5′-ppp specificity by a cluster of basic residues molded to cradle the triphosphate (196). 
The isolated CTD binds to an RNA containing a 5′-ppp with 12,000-fold enhanced affinity 
relative to the 5′-OH form (197).  
The basic region binds nucleic acids with moderate affinity, contributes to enzymatic 
activation, and is conserved among PKR orthologs. These observations provided the impetus 
for structural analysis of this region. We crystallized a kinase domain construct containing the 
basic region and obtained an atomic resolution structure by X-ray diffraction. Unfortunately, the 
basic region is unresolved in the structure and we are currently attempting to stabilize the basic 
region by co-crystallization with heparin and ssRNA. However, a unique arrangement of PKR 
molecules within the crystalline lattice challenges the current models for PKR activation. PKR 
forms an oligomeric chain consisting of alternating back-to-back and front-to-front interfaces. 
The back-to-back interface is similar to those previously reported (29, 30). Two front-to-front 
interfaces are formed. One is formed by crystallographic symmetry across two asymmetric units 
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and involves interactions between αG and αEF helices. The other occurs within the asymmetric 
unit and is formed by activation segments which are exchanged between reciprocal protomers. 
Similar arrangements have been reported for other kinases and functional data indicate that 
they represent trans-autophosphorylation complexes (33, 230). Mutational analysis indicates the 
back-to-back PKR dimer interface is critical for function (39). Experiments to investigate the 
front-to-front interface have not yet been performed. A structural homolog to PKR, PknB, may 
provide insight, both into the allosteric coupling between dimer interface and active site residues 
and the mechanistic relevance of the front-to-front interface. PknB forms a back-to-back 
interface similar to PKR which is also important for function (206, 208). In the monomeric 
structure of PknB, the N- and C-lobes are misaligned and the αC helix is rotated, positioning the 
catalytically important glutamate away from the active site (225). A front-to-front interface has 
also been reported for PknB and is also essential for enzymatic function (212). Based on these 
observations, a model has been proposed in which the back-to-back dimer interface activates 
the enzyme. Subsequently, the active dimer phosphorylates other PknB molecules in trans via 
the front-to-front interface (212, 225). The proposed model is strikingly similar to the 
arrangement of molecules within the asymmetric unit of structure 2 (Fig. 5.3B) suggesting PKR 
may achieve activation loop phosphorylation by a similar mechanism. The functional assays 
proposed in Section 5.12 are required to assess the role of the front-to-front interface during 
PKR activation. If experiments support the front-to-front interface, models for PKR activation 
must be revised to account for a trimeric complex. Previously, we have correlated activation 
potency with the ability of molecules to facilitate PKR dimerization (62, 63, 91, 119). However, a 
trimeric PKR complex may be the more enzymatically relevant species.  
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Appendix 1: Nucleic acid sequences and molar extinction coefficients 
Table A1.1 Sequences and molar extinction coefficients of nucleic acids.  
 
 
Nucleic acid Sequencea ε260
b  
(M-1cm-1) 
15-15-15 GGAGAACUUAAUGCCGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCCUUACAAACCUGACU 517184 
15-15-15 ∆T 
(GAAA) 
GGAGAACUUAAUGCCGGAGACCAAAGACUUGAAAAAGUCUUUGGUCU
CCCUUACAAACCUGACU 531851 
15-15-15 ∆T 
(UUUU) 
GGAGAACUUAAUGCCGGAGACCAAAGACUUUUUUAAGUCUUUGGUCU
CCCUUACAAACCUGACU 519511 
15-15-15 ∆T 5′-GGAGAACUUAAUGCCGGAGACCAAAGACUU-3′  3′-UCAGUCCAAACAUUCCCUCUGGUUUCUGAA-5′ 500938 
15-15-10 GGAGACAAUAAUACAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCAAACCUGACU 497376 
15-15-5 GGAGAACUUAAUGCCGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCAGACU 453418 
10-15-15 GGACAUAAUAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCCAAACAAACAUAACU 490269 
10-15-10 GGAGAACUUAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCAAACCUGACU 414156 
13-15-10 GGACCAUAAUAUAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCAAACCUGACU 485892 
13-15-5 GGACCAUAAUAUAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCAGACU 444663 
10-15-5 GGACAAUAUAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCAAACU 416785 
5-15-15 GGACAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCCAAACAAACAUAACU 447230 
5-15-10 GGAUAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCAAACAUAACU 413329 
5-15-5 GGAGAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCAGACU 341236 
15-15-0 GGAGAACUUAAUGCCGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCC 404417 
0-15-15 GGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCCUUACAAACCUGACU 380311 
0-15-0 GGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCC 340834 
15-10-15 GGAGACAAUAAUACAGGAGACCAAAUCCGUUUGGUCUCCCAAACAAACAUAACG 455786 
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Table A1.1 Continued.  
a Sequences are written 5′ to 3′ with duplex regions underlined.  
b ss-dsRNA ε260 values are determined by the protocol outlined in Materials and Methods. Duplex RNAs 
are derived from the hypochromic effect upon annealing the single-stranded RNAs. For single-stranded 
nucleic acids the extinction coefficient provided by the commercial supplier was used.   
   
Nucleic acid Sequencea ε260
b  
(M-1cm-1) 
15-5-15 GGAGAAUAGAAUACAGCGACUCCGGUCGCACAUAAGAUAAGAGG 404000 
0-5-0 GCGACUCCGGUCGC 117499 
U30 UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU 291200 
U15 UUUUUUUUUUUUUUU 145700 
ppp-Het30 GGAGAACUUAAUGCCGGAGACCAAAGACUU 309700 
Het30 GGAGAACUUAAUGCCGGAGACCAAAGACUU 309700 
dT30 dTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdT 243600 
dHet30 dGdGdAdGdAdAdCdUdUdAdAdUdGdCdCdGdGdAdGdAdCdCdAdAdAdGdAdCdUdU 298300 
ds20 5′-GGAGAACUUCAUGCCCUUCG-3′ 3′-CCUCUUGAAGUACGGGAAGC-5′ 321800 
ds30 5’-GGAGAACUUCAUGCCCUUCGGAUAAGGACU-3’ 3’-CCUCUUGAAGUACGGGAAGCCUAUUCCUGA-5’ 514375 
ds40 5'-GGAGGAUGUUAAUUGGCGUGUCUUGUCUGCAACGGUAUUC-3' 3'-CCUCCUACAAUUAACCGCACAGAACAGACGUUGCCAUAAG-5' 661950 
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Appendix 2: Hydrodynamic parameters from sedimentation velocity 
Table A2.1 Hydrodynamic properties of nucleic acids. 
Nucleic acid Buffer Massa s (Svedbergs)b 
s20,w 
(Svedbergs)c f/f0
d 
IVT ppp-15-15-15 AU75 20,659 3.12 3.21 1.54 
IVT HO-15-15-15 AU75 20,359 3.19 3.28 1.49 
Synthetic HO-15-15-15 AU75 20,359 3.06 3.17 1.56 
∆T-ppp-15-15-15 AU75 19,398 2.79 2.89 1.38 
∆T-HO-15-15-15 AU75 19,098 2.86 2.96 1.63 
ppp-5′UCCG-15-15-15 AU75 20,583 2.98 3.09 1.54 
ppp-3′UCCG-15-15-15 AU75 20,583 2.98 3.09 1.63 
ppp-15-15-15-GAAA AU75 20,730 3.15 3.26 1.63 
ppp-15-15-15-UUUU AU75 20,622 3.12 3.23 1.76 
ppp-15-15-10 AU75 19,138 2.87 2.95 1.69 
ppp-15-15-5 AU75 17,532 2.82 2.90 1.78 
ppp-10-15-15 AU75 19,106 2.93 3.01 2.05 
ppp-10-15-10 AU75 17,516 2.93 3.01 1.88 
ppp-13-15-10 AU75 18,443 2.95 3.05 1.71 
ppp-13-15-5 AU75 16,866 2.82 2.92 1.70 
ppp-10-15-5 AU75 15,909 2.77 2.85 1.84 
ppp-5-15-15 AU75 17,506 2.90 2.97 1.87 
ppp-5-15-10 AU75 15,909 2.80 2.88 1.64 
ppp-5-15-5 AU75 14,366 2.73 2.80 1.76 
ppp-15-15-0 AU75 15,917 2.80 2.88 1.86 
ppp-0-15-15 AU75 15,798 2.66 2.73 1.59 
ppp-0-15-0 AU75 11,057 2.46 2.52 1.65 
ppp-15-10-15 AU75 17,577 2.66 2.74 1.53 
ppp-15-5-15 AU75 14,522 2.43 2.50 1.82 
ppp-0-5-0 AU75 4,658 1.54 1.60 1.39 
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Table A2.1 Continued Hydrodynamic properties of nucleic acids. 
a Masses predicted based on composition.  
b Uncorrected sedimentation coefficient obtained by fitting to a single discrete species model.  
c Sedimentation coefficient corrected to standard conditions (water at 20 °C). 
d Frictional ratio. 
 
 
 
 
 
 
 
 
 
 
  
Nucleic acid Buffer Massa s (Svedbergs)b 
s20,w 
(Svedbergs)c f/f0
d 
ppp-15-15-15 AU200 20,659 3.21 3.36 1.58 
ppp-15-15-0 AU200 15,917 2.90 3.03 1.73 
ppp-0-15-15 AU200 15,798 2.66 2.78 1.83 
ppp-0-15-0 AU200 11,057 2.47 2.58 1.55 
ppp-15-15-15 AU75+Mg2+ 20,659 3.36 3.45 1.78 
ppp-0-15-0 AU75+Mg2+ 11,057 2.54 2.61 1.60 
ppp-15-15-15 AU60+Mg2+ 20,659 3.43 3.53 1.74 
ppp-0-15-0 AU60+Mg2+ 11,057 2.53 2.60 1.90 
U30 AU75 9,123 1.67 1.74 1.66 
U15 AU75 4,528 1.21 1.25 1.70 
Het30 AU75 9,683 2.05 2.12 1.41 
ppp-Het30 AU75 9,923 2.12 2.19 1.39 
dT30 AU75 9,064 1.43 1.48 1.93 
dHet30 AU75 9,203 1.67  1.73 1.67 
ds20 AU200 (4 °C) 12,108 1.64 2.74 1.27 
ds30 AU75 19,164 3.16 3.27 1.44 
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Table A2.2 Hydrodynamic properties of ss-dsRNA ∙ PKR complexes. 
ss-dsRNA∙Protein Buffer Massa s (Svedbergs)b 
s20,w 
(Svedbergs)c f/f0
d 
ppp-15-15-15∙PKR AU75 82,754 4.88 5.04 1.60 
ppp-15-15-15∙PKR2 AU75 144,848 8.02 8.30 1.33 
IVT HO-15-15-15∙PKR AU75 82,454 4.76 4.91 1.64 
IVT HO-15-15-15∙PKR2 AU75 144,548 8.39 8.68 1.27 
Synthetic HO-15-15-15∙PKR AU75 82,514 4.64 4.79 1.80 
Synthetic HO-15-15-15∙PKR2 AU75 144,608 8.23 8.51 1.34 
∆T-ppp-15-15-15∙PKR AU75 81,492 4.46 4.61 1.63 
∆T-ppp-15-15-15∙PKR2 AU75 143,587 7.42 7.68 1.36 
ppp-15-15-15-GAAA∙PKR AU75 82,825 4.88 5.04 1.60 
ppp-15-15-15-GAAA∙PKR2 AU75 144,919 8.02 8.30 1.33 
ppp-15-15-15-UUUU∙PKR AU75 82,717 4.73 4.89 1.73 
ppp-15-15-15-UUUU∙PKR2 AU75 144,811 7.97 8.25 1.36 
ppp-5′UCCG-15-15-15∙PKR AU75 82,677 4.88 5.04 1.60 
ppp-5′UCCG-15-15-15∙PKR2 AU75 144,772 8.02 8.30 1.33 
ppp-15-15-10∙PKR AU75 81,233 5.01 5.17 1.61 
ppp-15-15-10∙PKR2 AU75 143,327 7.57 7.83 1.44 
ppp-15-15-5∙PKR AU75 79,627 4.71 4.86 1.71 
ppp-15-15-5∙PKR2 AU75 141,721 7.86 8.13 1.39 
ppp-10-15-15∙PKR AU75 81,201 4.84 4.99 1.78 
ppp-10-15-15∙PKR2 AU75 143,295 7.80 8.06 1.45 
ppp-13-15-10∙PKR AU75 80,538 5.46 5.65 1.77 
ppp-13-15-10∙PKR2 AU75 142,632 7.43 7.69 1.69 
ppp-13-15-5∙PKR AU75 78960.9 5.05 5.23 1.55 
ppp-13-15-5∙PKR2 AU75 141055 7.09 7.34 1.49 
ppp-10-15-10∙PKR AU75 79,611 4.88 5.04 1.70 
ppp-10-15-10∙PKR2 AU75 141,705 7.36 7.61 1.50 
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Table A2.2 Continued Hydrodynamic properties of ss-dsRNA ∙ PKR complexes. 
ss-dsRNA∙Protein Buffer Massa s (Svedbergs)b 
s20,w 
(Svedbergs)c f/f0
d 
ppp-10-15-5∙PKR AU75 78,004 4.80 4.96 1.67 
ppp-10-15-5∙PKR2 AU75 140,098 7.40 7.65 1.47 
ppp-5-15-15∙PKR AU75 79,601 4.43 4.57 1.86 
ppp-5-15-15∙PKR2 AU75 141,695 7.13 7.37 1.55 
ppp-5-15-10∙PKR AU75 78,004 4.64 4.79 1.68 
ppp-5-15-10∙PKR2 AU75 140,098 6.94 7.18 1.54 
ppp-5-15-5∙PKR AU75 76,460 4.67 4.82 1.67 
ppp-5-15-5∙PKR2 AU75 138,555 7.12 7.36 1.50 
ppp-15-15-0∙PKR AU75 78,012 4.75 4.90 1.70 
ppp-15-15-0∙PKR2 AU75 140,106 7.19 7.43 1.52 
ppp-0-15-15∙PKR AU75 77,893 4.95 5.11 1.54 
ppp-0-15-15∙PKR2 AU75 139,987 6.82 7.05 1.54 
ppp-0-15-0∙PKR AU75 73,151 4.58 4.73 1.60 
ppp-0-15-0∙PKR2 AU75 135,246 6.19 6.40 1.66 
ppp-15-10-15∙PKR AU75 79,671 4.76 4.92 1.60 
ppp-15-10-15∙PKR2 AU75 141,766 6.48 6.70 1.62 
ppp-15-5-15∙PKR AU75 76,616 4.71 4.87 1.63 
ppp-15-5-15∙PKR2 AU75 138,711 6.87 7.10 1.54 
ppp-0-15-0∙PKR AU75 66752.5 4.16 4.32 1.46 
ppp-15-15-15∙PKR AU200 82,754 5.17 5.46 1.60 
ppp-15-15-0∙PKR AU200 78,012 4.96 5.23 1.62 
ppp-0-15-15∙PKR AU200 77,893 4.72 4.98 1.68 
ppp-0-15-0∙PKR AU200 73,151 4.52 4.78 1.60 
ppp-15-15-15∙PKR AU75+Mg2+ 82,754 5.48 5.73 1.60 
ppp-15-15-15∙PKR2 AU75+Mg2+ 144,848 6.98 7.23 1.63 
ppp-0-15-0∙PKR AU75+Mg2+ 73,151 4.58 (fixed)e 4.80 1.62 
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Table A2.2 Continued Hydrodynamic properties of ss-dsRNA ∙ PKR complexes. 
a Masses predicted based on composition.  
b Uncorrected sedimentation coefficient obtained by fitting to a single discrete species model.  
c Sedimentation coefficient corrected to standard conditions (water at 20 °C). 
d Frictional ratio. 
e The value of s(RP) and s(RP2) could not be measured for these RNAs and were fixed to the values 
measured in AU75 buffer. 
 
Table A2.3 Hydrodynamic properties of single-stranded nucleic acid ∙ PKR complexes. 
ss-dsRNA∙Protein Buffer Massa s (Svedbergs)b 
s20,w 
(Svedbergs)c f/f0
d 
ppp-0-15-0∙PKR2 AU60+Mg2+ 135,246 6.19 (fixed)e 6.40 1.70 
ppp-0-15-0∙dsRBD AU75 31,319 3.07 3.18 1.58 
ppp-0-15-0∙dsRBD2 AU75 51,581 4.34 4.49 1.37 
ppp-15-15-15∙dsRBD AU75 40,922 3.56 3.69 1.78 
ppp-15-15-15∙dsRBD2 AU75 61,184 4.74 4.91 1.54 
ppp-15-15-15∙dsRBD3 AU75 84,446 5.90 6.11 1.39 
Nucleic acid∙Protein Buffer Massa s (Svedbergs)b 
s20,w 
(Svedbergs)c f/f0
d 
U30∙PKR AU75 71,218 4.34 4.50 1.50 
U30∙PKR2 AU75 133,312 6.31 6.54 1.50 
U15∙PKR AU75 66,623 4.04 4.18 1.50 
ppp-Het30∙PKR AU75 72,017 4.40 4.56 1.50 
ppp-Het30∙PKR2 AU75 134,112 6.36 6.59 1.50 
Het30∙PKR AU75 71,778 4.38 4.54 1.50 
Het30∙PKR2 AU75 133,872 6.36 6.58 1.50 
dT30∙PKR AU75 71,159 4.33 4.49 1.50 
dT30∙PKR2 AU75 133,253 6.31 6.53 1.50 
dHet30∙PKR AU75 71,298 4.34 4.50 1.50 
dHet30∙PKR2 AU75 133,392 6.32 6.54 1.50 
U30∙dsRBD AU75 29385 2.71 2.80 1.50 
U30∙dsRBD2 AU75 49,647 3.53 3.65 1.50 
ppp-Het30∙dsRBD AU75 30,185 3.55 3.67 1.18 
ppp-Het30∙dsRBD2 AU75 50,447 4.85 5.02 1.11 
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Table A2.3 Continued Hydrodynamic properties of single-stranded nucleic acid ∙ PKR 
complexes. 
a Masses predicted based on composition.  
b Uncorrected sedimentation coefficient. In most fits the sedimentation coefficient is calculated from a 
frictional ratio of 1.50.    
c Sedimentation coefficient corrected to standard conditions (water at 20 °C). 
d Frictional ratio.  
 
 
Nucleic acid∙Protein Buffer Massa s (Svedbergs)b 
s20,w 
(Svedbergs)c f/f0
d 
Het30∙dsRBD AU75 29,945 3.55 3.67 1.18 
Het30∙dsRBD2 AU75 50,207 4.85 5.02 1.11 
dT30∙dsRBD AU75 29,326 2.70 2.80 1.50 
dT30∙dsRBD2 AU75 49,588 3.52 3.65 1.50 
dHet30∙dsRBD AU75 29,465 2.70 2.80 1.50 
dHet30∙dsRBD2 AU75 49,727 3.52 3.65 1.50 
U30∙185-kinase AU75 51,030 3.81 3.95 1.50 
U30∙185-kinase2 AU75 92,938 5.09 5.27 1.50 
U30∙229-kinase AU75 46,559 3.39 3.51 1.50 
U30∙229-kinase2 AU75 83,995 4.71 4.88 1.50 
ppp-Het30∙229-kinase AU75 47,359 3.46 3.58 1.50 
ppp-Het30∙229-kinase2 AU75 84,795 4.77 4.94 1.50 
Het30∙229-kinase AU75 47,119 3.44 3.56 1.50 
Het30∙229-kinase2 AU75 84,555 4.75 4.92 1.50 
ds30∙229-kinase AU75 59,600 4.25 4.40 1.50 
ds30∙229-kinase2 AU75 94,035 5.44 5.63 1.50 
dT30∙229-kinase AU75 46,450 3.38 3.50 1.50 
dT30∙229-kinase2 AU75 83,936 4.71 4.87 1.50 
U30∙242-kinase AU75 44,934 3.31 3.43 1.50 
U30∙242-kinase2 AU75 80,745 4.59 4.75 1.50 
ds30∙242-kinase AU75 54,975 4.19 4.33 1.50 
ds30∙242-kinase2 AU75 90,786 5.32 5.51 1.50 
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Table A2.4 Hydrodynamic properties of ds20 ∙ PACT complex. 
a Masses predicted based on composition.  
b Uncorrected sedimentation coefficient.  
c Sedimentation coefficient corrected to standard conditions (water at 20 °C). 
d Frictional ratio.  
 
  
dsRNA∙PACT Buffer Massa s (Svedbergs)b 
s20,w 
(Svedbergs)c f/f0
d 
ds20∙PACT2 AU200 (4 °C) 81,480 3.68 5.98 1.26 
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